Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3001788	s-aldos	pmol/l (pmol/l)	3992	5115	0.90%
3001788	s-aldos	— (—)	999	1204	100.00%	Distribution not available
3001788	p-aldos	pmol/l (pmol/l)	774	962	0.00%
3001788	fp-aldos	pmol/l (pmol/l)	626	757	0.00%
3001788	s-aaldos	pmol/l (pmol/l)	115	125	0.80%
3001788	s-valdos	pmol/l (pmol/l)	114	161	0.62%	Distribution not available
3001788	s-aldos	pmol/l____ (pmol/l)	79	101	0.00%
3001788	p-aldos	— (—)	68	71	100.00%	Distribution not available
3001788	s-aldos	PMOL/L (pmol/l)	21	24	0.00%
3001788	p-aldos	PMOL/L (pmol/l)	15	15	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Hyperaldosteronism

402

114

55.34

307.65

3.0

1.2

1178.20

300.00

pmol/l

2.14

388

103

Antihypertensive medication - note that there are other indications

1063

695

8.17

307.65

1.5

1.3

512.25

391.13

pmol/l

0.57

932

608

Hypertensive diseases (excluding secondary)

1499

854

10.66

307.65

1.6

1.3

464.17

347.04

pmol/l

0.87

1340

733

Hypokalaemia

794

527

17.30

307.65

1.7

1.3

631.96

290.58

pmol/l

1.54

591

456

Hypertension, essential

1884

1441

7.65

307.65

1.5

1.3

470.85

309.34

pmol/l

1.39

1668

1244

Benign neoplasm: Adrenal gland

1177

345

53.46

307.65

1.4

1.3

314.97

302.18

pmol/l

0.18

1103

292

Metabolic disorders

1759

3157

3.41

307.65

1.5

1.3

442.09

336.12

pmol/l

0.87

1493

2768

Secondary hypertension

466

161

32.36

307.65

2.5

1.1

993.30

470.49

pmol/l

0.87

426

123

Other disorders of fluid, electrolyte and acid-base balance

1174

1375

8.57

307.65

1.5

1.3

525.39

280.94

pmol/l

1.75

908

1177

Hypertensive diseases

1922

1468

7.64

307.65

1.5

1.3

479.76

316.80

pmol/l

1.44

1699

1266

Benign neoplasm of other and unspecified endocrine glands

1279

624

25.91

307.65

1.4

1.3

390.11

309.24

pmol/l

0.52

1193

524

Cardiovascular diseases (excluding rheumatic etc)

1263

1074

6.90

307.65

1.6

1.3

490.35

360.60

pmol/l

0.86

1128

927

Disorders of other endocrine glands

1178

2551

4.72

307.65

1.9

1.2

651.70

306.53

pmol/l

2.33

1049

2172

Hypertension

1922

1467

7.65

307.65

1.5

1.3

479.76

316.80

pmol/l

1.44

1699

1266

Cardiovascular diseases

1065

900

6.42

307.65

1.6

1.3

515.94

336.53

pmol/l

1.14

945

772

Endocrine, nutritional and metabolic diseases

1116

1519

3.76

279.67

1.5

1.3

585.49

293.87

pmol/l

1.56

967

1327

Other heart diseases

671

861

5.16

269.97

1.4

1.3

322.75

353.77

pmol/l

0.37

594

734

Exclusions for E4_PCOS_BROAD

507

953

5.59

256.75

1.5

1.3

547.74

352.08

pmol/l

0.46

434

823

Other disorders of adrenal gland

241

189

14.46

254.73

1.5

1.2

784.16

316.84

pmol/l

0.55

207

164

Hypertensive heart and/or renal disease

431

478

6.76

235.72

1.4

1.3

310.32

314.23

pmol/l

0.02

374

394

Anaemias

336

216

10.19

232.21

1.4

1.2

708.63

363.40

pmol/l

0.57

283

189

Heart failure and antihypertensive medication

343

284

8.02

203.43

1.3

333.84

412.99

pmol/l

0.33

282

244

Cerebrovascular diseases (FINNGEN)

449

578

5.56

201.36

1.3

1.2

324.94

322.35

pmol/l

0.02

383

490

Diseases of arteries, arterioles and capillaries (FINNGEN)

384

412

6.59

200.16

1.3

1.2

301.89

332.23

pmol/l

0.17

324

338

Adrenocortical insufficiency

189

158

13.57

192.18

1.6

1.2

351.54

332.19

pmol/l

0.10

157

138

Hypertensive Heart Disease

348

446

6.05

175.51

1.4

1.3

306.42

318.62

pmol/l

0.07

305

369

Disorders of lipoprotein metabolism and other lipidaemias

1164

2750

2.61

173.74

1.4

1.3

312.16

292.52

pmol/l

0.41

1025

2408

Hypothyroidism (congenital or acquired)

305

221

7.85

164.46

1.6

1.2

1082.87

308.80

pmol/l

1.00

263

194

Benign neoplasms

1323

3015

2.41

163.81

1.4

455.32

368.02

pmol/l

0.48

1159

2549

All chronic kidney diseases

891

2599

2.78

161.34

1.4

1.3

370.17

382.60

pmol/l

0.08

755

2196

Type 2 diabetes, wide definition

1176

3045

2.47

158.79

1.4

309.41

346.58

pmol/l

0.50

1010

2626

Hypothyroidism, levothyroxine purchases

297

220

7.68

157.85

1.6

1.2

753.62

308.80

pmol/l

0.70

256

194

Hypothyroidism and >3 levothyroxin purchases

297

220

7.68

157.85

1.6

1.2

753.62

308.80

pmol/l

0.70

256

194

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1349

3549

2.28

151.04

1.3

1.4

316.58

386.02

pmol/l

0.97

1132

3087

Diabetes mellitus

1433

3767

2.22

149.74

1.3

1.4

319.03

390.44

pmol/l

1.10

1205

3286

Diabetes, varying definitions

1422

3775

2.21

146.69

1.3

1.4

318.94

390.30

pmol/l

1.10

1195

3293

Sleep apnoea

1387

4026

2.20

144.45

1.4

314.90

374.33

pmol/l

0.90

1206

3445

Type 2 diabetes

1374

3618

2.22

143.98

1.3

1.4

319.29

390.04

pmol/l

1.02

1160

3149

Sleep apnoea, including avohilmo

1430

4050

2.16

141.24

1.4

316.03

378.39

pmol/l

0.98

1244

3467

Hypo-osmolality and hyponatraemia

331

752

4.50

131.93

1.3

429.39

281.37

pmol/l

0.90

283

643

Diabetes, insulin treatment (Kela reimbursement)

1407

4003

2.11

131.42

1.3

1.4

313.58

375.80

pmol/l

0.97

1185

3473

Atrial fibrillation and flutter

370

528

4.60

131.35

1.4

1.2

355.41

319.46

pmol/l

0.28

333

443

Diabetes medication

1434

4034

2.10

130.73

1.3

1.4

315.78

385.63

pmol/l

1.17

1207

3513

Pure hypercholesterolaemia

979

2585

2.43

128.92

1.4

1.3

288.57

282.14

pmol/l

0.25

859

2257

All kidney diseases

1377

4456

2.09

128.90

1.4

364.61

366.55

pmol/l

0.02

1179

3862

Headache

960

3130

2.40

128.71

1.4

419.06

326.59

pmol/l

0.41

829

2706

Heart failure, not strict

1085

3230

2.29

126.27

1.3

1.4

372.69

316.22

pmol/l

0.71

906

2784

Type 2 diabetes, definitions combined

1276

3495

2.15

123.24

1.4

329.16

391.40

pmol/l

0.81

1101

3037

Depression medications

287

233

6.27

122.93

1.4

1.2

413.44

310.93

pmol/l

2.09

249

207

Type 2 diabetes, strict (exclude DM1)

1280

3516

2.14

122.76

1.4

328.70

391.16

pmol/l

0.82

1104

3055

Other nutritional deficiencies

1019

4184

2.26

122.52

1.4

450.92

360.85

pmol/l

0.41

890

3611

General symptoms and signs

1392

3350

2.10

122.44

1.4

507.81

322.61

pmol/l

1.07

1188

2897

Cardiac arrhythmias

786

1940

2.63

121.50

1.4

1.5

354.61

422.81

pmol/l

0.62

708

1706

Other (not insulin) diabetes medications

1333

3787

2.09

120.21

1.3

1.4

313.47

385.30

pmol/l

1.11

1142

3289

Type 2 diabetes, definitions combined, including avohilmo

1266

3484

2.12

118.74

1.4

329.26

392.20

pmol/l

0.82

1088

3031

Malaise and fatigue

756

2347

2.57

117.77

1.3

1.4

364.91

314.73

pmol/l

0.60

632

2008

Chronic kidney disease

507

1598

3.12

117.74

1.3

367.80

357.92

pmol/l

0.05

422

1318

Hypothyroidism, drug reimbursement

178

144

8.79

117.71

1.5

1.2

893.40

302.76

pmol/l

0.55

158

125

Other CVD (FINNGEN)

186

187

7.80

117.25

1.3

312.89

417.18

pmol/l

0.30

150

149

Pain in throat and chest

1117

3018

2.21

116.89

1.4

336.22

337.94

pmol/l

0.02

966

2588

Atrial fibrillation and flutter with reimbursement

304

402

4.85

113.47

1.4

1.2

355.46

329.50

pmol/l

0.14

272

332

Episodal and paroxysmal disorders

1368

3419

2.05

113.10

1.4

488.36

333.19

pmol/l

0.84

1185

2933

Renal failure

702

2374

2.56

110.13

1.3

363.30

332.05

pmol/l

0.26

574

1991

Obesity and other hyperalimentation

948

4091

2.21

108.98

1.4

441.73

363.25

pmol/l

0.32

834

3521

Obesity

945

4082

2.21

108.80

1.4

442.49

363.57

pmol/l

0.32

831

3513

Abnormalities of breathing

1129

3070

2.12

105.93

1.4

514.93

340.69

pmol/l

0.77

981

2634

Abnormal blood-pressure reading, without diagnosis

142

181

8.34

105.18

1.7

1.3

315.07

344.18

pmol/l

0.32

128

154

Other heart diseases, wide

1224

3672

2.04

104.50

1.4

330.40

398.68

pmol/l

0.97

1061

3180

Renal tubulo-interstitial diseases

1179

4299

2.03

104.14

1.3

1.4

353.94

372.68

pmol/l

0.20

997

3714

Malignant neoplasm of adrenal gland, including Hilmo

27.82

104.13

1.4

1.3

231.45

403.78

pmol/l

1.39

Tramadol

1071

3044

2.14

103.42

1.4

414.58

358.57

pmol/l

0.23

916

2627

Obesity due to excess calories

727

3104

2.38

100.84

1.4

340.11

383.73

pmol/l

0.60

633

2675

Biguanides

1250

3865

1.97

97.51

1.3

1.4

302.66

383.90

pmol/l

1.37

1069

3335

Glucagon-like peptide-1 (GLP-1) analogues

503

1861

2.76

94.62

1.3

1.4

320.27

369.02

pmol/l

0.39

429

1588

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

503

1861

2.76

94.62

1.3

1.4

320.27

369.02

pmol/l

0.39

429

1588

Paroxysmal tachycardia

249

482

4.36

91.38

1.4

1.3

271.97

333.54

pmol/l

0.51

222

402

Symptoms and signs involving the circulatory and respiratory systems

1206

3075

1.98

91.23

1.4

523.05

340.66

pmol/l

0.88

1044

2639

Neoplasms

883

2111

2.21

89.77

1.4

480.51

395.15

pmol/l

0.30

771

1778

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

403

792

3.24

89.57

1.3

342.82

340.90

pmol/l

0.02

352

679

Abnormalities of heart beat

514

1913

2.64

89.02

1.3

310.43

334.62

pmol/l

0.55

444

1621

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1271

4593

1.88

88.82

1.3

1.4

420.16

348.40

pmol/l

0.39

1057

3999

Non-invasive ventilation

328

838

3.43

87.34

1.4

1.5

341.00

385.90

pmol/l

0.42

299

741

Hyperkalaemia

133

200

6.95

84.81

1.4

1.3

433.20

289.52

pmol/l

1.10

101

171

Sleep disorders (combined)

1342

3814

1.85

84.37

1.4

334.78

380.35

pmol/l

0.57

1163

3263

Hypertensive Renal Disease

14.12

83.11

1.4

1.3

367.29

215.95

pmol/l

1.37

Dyspnoea

1158

4468

1.89

82.93

1.3

1.4

505.63

325.31

pmol/l

0.82

993

3841

Cushing syndrome

15.64

82.25

1.5

1.2

253.57

326.75

pmol/l

0.66

Hard cardiovascular diseases

1084

3317

1.95

81.72

1.3

1.4

408.96

322.08

pmol/l

0.45

931

2869

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

1160

4195

1.88

81.34

1.3

1.4

431.02

349.57

pmol/l

0.43

999

3632

Hyperlipidaemia, other/unspecified

482

1685

2.61

79.95

1.4

1.3

347.58

277.07

pmol/l

0.79

410

1445

STROKE

720

2194

2.24

79.87

1.3

1.4

301.18

327.73

pmol/l

0.61

627

1908

Insulin medication

758

2963

2.15

79.73

1.3

1.4

299.10

394.00

pmol/l

1.15

622

2545

Statin medication

812

2138

2.16

79.29

1.4

1.5

423.55

379.49

pmol/l

0.27

704

1885

Nausea and vomiting

415

1490

2.76

78.31

1.4

303.79

483.91

pmol/l

1.16

336

1293

Implicit Sepsis

978

3762

1.93

75.64

1.3

1.4

437.54

345.24

pmol/l

0.40

828

3234

Hypopituitarism

160

326

5.11

74.22

1.5

1.3

1010.58

307.47

pmol/l

0.57

139

277

Asthma, unspecified (mode), excluding more controls

694

2297

2.19

74.10

1.4

646.17

328.91

pmol/l

0.89

597

2010

Drug-induced adrenocortical insufficiency

10.81

73.90

1.5

1.3

461.16

350.59

pmol/l

0.35

Implicit Sepsis, including avohilmo

1048

4025

1.88

73.70

1.3

1.4

432.05

346.05

pmol/l

0.40

896

3471

GASTRO-related operations

878

2161

2.05

73.42

1.4

487.46

334.27

pmol/l

0.67

752

1880

Any gastric operation

878

2161

2.05

73.42

1.4

487.46

334.27

pmol/l

0.67

752

1880

Any reimbursement code in KELA

622

1324

2.38

73.27

1.4

523.42

381.12

pmol/l

0.40

542

1183

First line medication for Crohn's disease

1326

4073

1.76

71.88

1.4

437.78

348.97

pmol/l

0.51

1118

3530

Oedema, not elsewhere classified

444

1745

2.52

69.99

1.3

317.57

311.11

pmol/l

0.10

378

1485

Condition for Implicit Sepsis (Organ dysfunction codes)

1073

4096

1.83

69.38

1.3

1.4

433.96

346.19

pmol/l

0.43

922

3537

Ischemic heart diseases

1045

3375

1.86

68.78

1.3

1.4

407.49

311.30

pmol/l

0.48

880

2924

Asthma, unspecified (mode)

710

2466

2.10

68.72

1.4

638.29

326.20

pmol/l

0.89

608

2142

Neurological diseases

955

2497

1.93

67.92

1.4

478.08

337.23

pmol/l

0.68

831

2159

Other arrhythmias

813

3099

1.98

67.44

1.4

305.09

403.55

pmol/l

1.32

720

2674

Insulin, intermediate and long-acting

704

3368

2.04

66.68

1.3

1.4

295.34

379.09

pmol/l

1.12

577

2865

Other headache syndromes

539

2410

2.26

66.60

1.5

1.4

347.13

345.51

pmol/l

0.01

470

2057

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

160

358

4.64

66.34

1.5

1115.50

418.93

pmol/l

0.57

142

315

Other bacterial diseases, including avohilmo

1239

4493

1.73

65.54

1.4

337.40

370.97

pmol/l

0.44

1055

3898

Disorders of mineral metabolism

160

361

4.58

65.54

1.4

1.3

1087.95

289.75

pmol/l

0.65

133

312

Asthma, excluding more controls

906

2417

1.94

65.30

1.4

581.31

327.01

pmol/l

0.95

782

2124

Symptoms and signs involving cognition, perception, emotional state and behaviour

1179

4549

1.74

64.65

1.3

1.4

313.38

373.82

pmol/l

1.10

1005

3929

Other soft tissue disorders, not elsewhere classified

1118

3583

1.79

64.35

1.3

1.4

358.75

357.26

pmol/l

0.01

942

3111

Used for control exclusion in common control thyroid runs

1205

3487

1.75

63.27

1.4

533.90

318.61

pmol/l

1.08

1019

3006

Pain in limb

1002

3518

1.82

63.11

1.3

1.4

333.16

358.81

pmol/l

0.29

835

3057

Neurological diseases, wide definition

328

537

3.10

63.01

1.5

357.56

400.93

pmol/l

0.59

287

475

Codeine

1073

3243

1.80

62.54

1.4

350.52

362.63

pmol/l

0.11

934

2807

Asthma (only as main-diagnosis), excluding more controls

843

2417

1.94

62.37

1.4

586.18

327.01

pmol/l

0.90

734

2124

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

494

2207

2.27

61.98

1.4

1.3

542.96

390.89

pmol/l

0.32

430

1885

Insulin, combination of fast acting with intermediate-acting or long-acting

758

3574

1.94

61.97

1.3

1.4

299.10

378.28

pmol/l

1.12

622

3046

Dipeptidyl peptidase 4 (DPP-4) inhibitors

669

2587

2.05

61.90

1.3

304.67

335.45

pmol/l

0.32

555

2190

Opioids

1113

3272

1.77

60.48

1.4

466.71

362.24

pmol/l

0.51

943

2834

Percutaneous Coronary Intervention

968

3255

1.82

60.37

1.3

1.4

400.42

304.59

pmol/l

0.44

825

2813

Asthma

933

2600

1.87

60.02

1.4

571.33

324.23

pmol/l

0.96

807

2267

Disorders of gallbladder, biliary tract and pancreas

1177

4303

1.71

59.87

1.4

405.46

347.73

pmol/l

0.28

1016

3687

Medical observation and evaluation for suspected diseases and conditions

757

1945

2.01

59.86

1.5

1.4

389.65

293.65

pmol/l

1.77

637

1681

Asthma (mode)

926

2635

1.86

59.40

1.4

575.50

323.85

pmol/l

0.98

806

2299

Primary adrenocortical insufficiency

13.28

58.86

1.7

1.2

254.50

312.85

pmol/l

0.38

Complications of surgical and medical care, not elsewhere classified

1194

4739

1.69

58.83

1.3

1.4

426.73

345.44

pmol/l

0.43

1026

4086

Coronary revascularization (ANGIO or CABG)

963

3256

1.81

58.77

1.3

1.4

401.38

304.52

pmol/l

0.44

820

2814

Migraine

617

2341

2.07

58.73

1.4

518.62

358.66

pmol/l

0.48

542

2029

Other metabolic disorders

200

576

3.55

58.23

1.5

1.3

323.81

315.89

pmol/l

0.11

173

499

Oral corticosteroids

1251

4402

1.68

58.03

1.4

444.13

344.04

pmol/l

0.58

1068

3794

Obesity related asthma

494

2270

2.21

57.86

1.4

1.3

548.43

327.63

pmol/l

0.55

437

1934

Major coronary heart disease event

1015

3447

1.78

57.82

1.4

403.42

302.93

pmol/l

0.50

864

2970

Symptoms and signs involving the nervous and musculoskeletal systems

724

3837

1.91

56.86

1.4

424.51

362.59

pmol/l

0.18

635

3262

Other bacterial diseases

1132

4438

1.70

56.77

1.3

1.4

328.44

368.03

pmol/l

0.53

954

3840

ILD medications: prednisolone, methylprednisolone, prednisone

1265

4250

1.67

56.48

1.4

447.30

342.99

pmol/l

0.61

1074

3670

Emergency coronary revascularization (for ACS)

1019

3523

1.76

56.47

1.3

1.4

392.71

304.24

pmol/l

0.42

865

3031

Postprocedural endocrine and metabolic disorders, not elsewhere classified

188

531

3.62

56.42

1.5

1.3

327.57

318.34

pmol/l

0.12

166

462

Codeine or tramadol medication

1297

4283

1.66

56.33

1.4

343.56

373.04

pmol/l

0.32

1123

3678

Asthma (only as main-diagnosis)

858

2600

1.86

55.84

1.4

578.91

324.23

pmol/l

0.90

747

2267

Dizziness and giddiness

911

4003

1.78

55.65

1.3

1.4

307.73

378.18

pmol/l

1.14

776

3439

Disorders of parathyroid gland

294

1073

2.76

55.62

1.4

1.2

708.54

301.81

pmol/l

0.61

249

911

Persons encountering health services in other circumstances, wide

1310

4119

1.64

54.87

1.4

325.27

376.90

pmol/l

0.75

1122

3549

ILD medications

1296

4295

1.64

53.78

1.4

443.18

343.99

pmol/l

0.59

1105

3709

Asthma (diagnoses ohter than nonallergic)

1038

4978

1.70

53.47

1.4

543.93

324.25

pmol/l

0.94

900

4278

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1266

4115

1.64

53.44

1.4

329.82

377.07

pmol/l

0.66

1100

3546

Syncope and collapse

532

2140

2.10

53.10

1.4

1.3

509.86

306.42

pmol/l

0.54

451

1825

Parasetamol

774

2080

1.89

52.08

1.4

329.53

386.18

pmol/l

0.54

657

1814

Other antidepressants

1144

3524

1.67

50.47

1.4

336.85

368.29

pmol/l

0.32

969

3037

Malignant neoplasm of endocrine gland, including Hilmo

161

444

3.75

50.36

1.4

1.3

273.02

333.17

pmol/l

1.94

138

388

Malignant neoplasm of endocrine gland

149

391

3.95

50.13

1.4

1.3

275.64

343.15

pmol/l

2.05

129

341

Inflammatory bowel disease treatment related agents

1294

4498

1.61

50.12

1.4

439.05

345.12

pmol/l

0.55

1109

3884

Other diseases of intestines

1192

4079

1.64

50.09

1.3

1.4

448.97

356.74

pmol/l

0.48

1019

3536

Complications of procedures, not elsewhere classified

961

4591

1.70

49.79

1.3

1.4

453.71

345.06

pmol/l

0.48

821

3952

Persons encountering health services for specific procedures and health care

1237

4554

1.61

49.50

1.4

427.74

351.90

pmol/l

0.41

1060

3940

Low back pain

896

3496

1.74

49.27

1.4

316.03

396.08

pmol/l

1.16

767

3009

Insulin, fast-acting

457

2171

2.13

49.11

1.3

1.4

321.75

380.41

pmol/l

0.55

360

1842

Obesity, other/unspecified

442

2077

2.16

48.96

1.4

552.93

421.52

pmol/l

0.24

391

1790

Mood disorders, excluding more controls

1090

3885

1.66

48.78

1.4

348.05

366.92

pmol/l

0.19

940

3360

Spondylopathies

899

3071

1.74

48.18

1.3

1.4

283.34

356.46

pmol/l

1.34

773

2634

Ischaemic heart disease, wide definition

905

3235

1.74

48.12

1.3

1.4

299.01

334.87

pmol/l

0.52

754

2785

Exclusions for E4_PCOS_CONSORTIUM

860

3075

1.76

48.08

1.5

1.4

482.43

350.16

pmol/l

0.55

737

2699

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

795

3956

1.76

47.67

1.3

350.73

330.11

pmol/l

0.18

698

3360

Volume depletion

135

342

4.03

47.44

1.2

1.3

467.69

279.05

pmol/l

1.06

107

292

Disorders of thyroid, IBD co-morbidities

194

400

3.36

47.14

1.3

1.5

339.13

391.89

pmol/l

0.73

164

352

Disorders of the thyroid gland

1058

4198

1.64

46.75

1.4

569.20

317.25

pmol/l

1.15

907

3600

Disorders of calcium metabolism

114

258

4.56

46.65

1.4

1.3

1367.94

309.29

pmol/l

0.61

219

Pain, not elsewhere classified

353

1550

2.31

46.23

1.3

1.4

371.33

336.47

pmol/l

0.26

310

1324

Abnormal findings on examination of blood, without diagnosis

561

2645

1.94

45.82

1.4

1.3

337.28

344.77

pmol/l

0.06

476

2207

Autoimmune diseases excluding thyroid diseases

1154

3896

1.61

45.66

1.4

405.67

326.09

pmol/l

0.42

987

3366

Intracranial trauma

598

2110

1.93

45.59

1.4

325.67

343.70

pmol/l

0.38

515

1834

Chronic lower respiratory diseases

1347

4578

1.56

45.58

1.4

514.35

322.59

pmol/l

1.08

1156

3963

Implicit bacterial Sepsis, including avohilmo

546

2339

1.96

45.42

1.2

1.3

336.55

295.97

pmol/l

0.70

454

1962

Hyperparathyroidism

244

902

2.72

45.20

1.4

1.2

779.84

308.94

pmol/l

0.59

209

767

Type 1 diabetes

308

1288

2.42

44.99

1.3

1.4

273.14

424.11

pmol/l

1.17

239

1123

Insulin, fast-acting or short human

459

2261

2.05

44.81

1.3

1.4

320.56

365.48

pmol/l

0.42

362

1922

Benzodiazepine use

1149

4904

1.59

44.71

1.4

421.51

347.93

pmol/l

0.37

963

4253

Mood disorders

1175

4766

1.59

44.66

1.4

349.77

363.78

pmol/l

0.17

1013

4115

Diseases of oesophagus, stomach and duodenum

1197

4486

1.58

44.63

1.4

354.37

365.64

pmol/l

0.10

1015

3889

Other symptoms and signs involving the nervous and musculoskeletal systems

524

2710

1.96

44.57

1.4

472.64

388.87

pmol/l

0.18

462

2298

Lower back pain or/and sciatica

1221

4862

1.57

44.22

1.4

314.07

372.43

pmol/l

1.14

1052

4187

Mood [affective] disorders

1171

4769

1.58

44.10

1.4

349.13

363.92

pmol/l

0.18

1010

4117

Complications of medical and surgical care

862

4650

1.68

43.55

1.3

1.4

466.90

340.98

pmol/l

0.51

741

3992

Autoimmune diseases

1214

3919

1.58

43.43

1.4

513.35

326.37

pmol/l

0.90

1022

3386

Concussion

524

2084

1.96

43.41

1.4

332.18

343.27

pmol/l

0.19

452

1808

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

363

772

2.38

43.25

1.5

1.4

314.02

328.97

pmol/l

0.25

306

668

Implicit viral Sepsis, including avohilmo

382

1778

2.17

43.17

1.4

1.3

630.12

313.69

pmol/l

0.64

331

1501

Acute renal failure

286

1183

2.46

43.05

1.3

404.53

396.11

pmol/l

0.03

238

981

Care involving use of rehabilitation procedures

763

4002

1.73

42.95

1.4

323.38

347.94

pmol/l

0.38

664

3454

Dorsalgia

1079

3558

1.62

42.69

1.4

334.76

394.99

pmol/l

0.71

940

3065

Symptoms and signs involving the digestive system and abdomen

1062

3289

1.63

42.65

1.4

335.69

382.48

pmol/l

0.43

890

2856

Depression

1104

4678

1.59

42.55

1.4

351.46

366.08

pmol/l

0.17

955

4045

Fibromyalgia

164

511

3.29

42.41

1.5

1.4

452.76

367.32

pmol/l

0.34

145

463

Heart failure,strict

588

2198

1.88

42.04

1.2

1.3

314.55

325.31

pmol/l

0.08

468

1854

Infections, IBD-co-morbidities

167

349

3.41

41.82

1.4

439.32

407.82

pmol/l

0.14

139

307

Implicit bacterial Sepsis

487

2134

1.98

41.73

1.2

1.3

342.49

295.56

pmol/l

0.75

407

1788

Fever of other and unknown origin

600

2844

1.84

41.71

1.4

524.79

321.11

pmol/l

0.59

500

2444

Diverticular disease of intestine

805

2941

1.72

41.41

1.3

1.4

300.30

298.53

pmol/l

0.02

694

2525

Depression or dysthymia

738

2294

1.77

41.00

1.3

1.4

309.18

348.62

pmol/l

0.38

631

1981

Bacterial Sepsis

545

2419

1.88

40.03

1.2

1.3

336.95

295.05

pmol/l

0.75

458

2031

Asthma-related infections

675

3814

1.74

39.43

1.3

1.4

626.99

330.50

pmol/l

0.78

579

3263

Asthma, hospital admission 2, infections

675

3814

1.74

39.43

1.3

1.4

626.99

330.50

pmol/l

0.78

579

3263

Autoimmune diseases excluding thyroid diseases, strict definition

1079

3732

1.58

39.33

1.4

313.11

327.41

pmol/l

0.41

919

3223

Spondylosis

630

2773

1.79

39.21

1.3

1.4

279.52

356.73

pmol/l

1.24

550

2372

Cholelithiasis

929

3939

1.62

39.15

1.4

427.06

350.45

pmol/l

0.30

812

3353

Coronary atherosclerosis

719

2626

1.74

38.98

1.3

280.79

298.12

pmol/l

0.50

583

2254

Abdominal and pelvic pain

1040

3289

1.60

38.77

1.4

326.45

382.48

pmol/l

0.55

878

2856

Type 1 diabetes, wide definition, subgroup 1

254

1044

2.46

38.70

1.3

1.4

281.28

446.06

pmol/l

0.98

193

910

Other functional intestinal disorders

527

2585

1.87

38.68

1.3

1.4

355.80

358.73

pmol/l

0.02

436

2225

Cholelithiasis, broad definition with cholecystitis

956

3995

1.60

38.38

1.4

424.15

349.91

pmol/l

0.30

835

3404

General examination and investigation of persons without complaint and reported diagnosis

666

1944

1.79

38.11

1.4

317.37

293.77

pmol/l

0.87

579

1680

Hypothyroidism, other/unspecified

955

3953

1.60

37.80

1.4

575.62

320.35

pmol/l

1.03

819

3398

Implicit viral Sepsis

264

1119

2.39

37.70

1.3

799.52

325.58

pmol/l

0.65

224

933

Viral Sepsis

264

1120

2.39

37.62

1.3

799.52

325.40

pmol/l

0.65

224

934

Combinations of oral blood glucose lowering drugs

329

1530

2.18

37.62

1.3

310.27

373.24

pmol/l

0.41

273

1276

Genitourinary diseases

600

1641

1.85

37.54

1.4

312.67

367.25

pmol/l

0.41

504

1422

Persons encountering health services in other circumstances

483

2558

1.89

37.02

1.3

1.4

306.55

419.23

pmol/l

1.17

386

2191

Type 1 diabetes, wide definition

261

1110

2.38

36.87

1.3

1.4

280.33

436.70

pmol/l

0.99

197

967

Anxiety disorders, excluding more controls

924

3715

1.60

36.50

1.4

356.46

372.47

pmol/l

0.15

800

3229

523

2861

1.83

36.47

1.4

728.06

347.68

pmol/l

0.78

452

2465

Continuous positive airway pressure

194

588

2.78

36.39

1.3

1.5

280.92

347.90

pmol/l

0.71

166

512

Diseases of arteries, arterioles and capillaries

725

3173

1.69

36.33

1.3

278.99

329.33

pmol/l

0.79

608

2678

Other diseases of liver

257

1097

2.38

36.24

1.4

1.3

368.25

339.21

pmol/l

0.27

220

942

Hypothyreosis and Thyroxine purchase for inclusion criteria

995

4192

1.56

35.95

1.4

564.50

325.60

pmol/l

0.99

854

3601

Asthma, including avohilmo

1280

4751

1.49

35.91

1.4

499.83

325.26

pmol/l

0.92

1113

4084

Spinal stenosis

565

2325

1.81

35.88

1.3

269.87

347.39

pmol/l

1.00

481

1973

Nerve, nerve root and plexus disorders

1162

4635

1.51

35.65

1.4

335.91

367.86

pmol/l

0.35

991

3992

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

693

4087

1.68

35.40

1.4

355.27

346.78

pmol/l

0.09

603

3499

Erysipelas, including avohilmo

813

3731

1.62

35.30

1.3

1.4

313.33

338.58

pmol/l

0.36

689

3219

Pregnancy hypertension

480

2316

1.87

35.28

1.5

1.4

613.38

371.59

pmol/l

0.60

429

2044

Asthma, hospital admissions , main diagnosis only

905

5040

1.57

35.05

1.4

563.96

329.46

pmol/l

0.86

787

4345

Intestinal infectious diseases, including avohilmo, including avohilmo

1250

4697

1.49

35.00

1.4

340.90

366.01

pmol/l

0.32

1056

4068

Other dorsopathies, not elsewhere classified

1055

3565

1.54

34.55

1.4

344.93

394.49

pmol/l

0.54

901

3072

Migraine without aura

232

966

2.43

34.46

1.5

1.4

810.26

428.36

pmol/l

0.42

206

847

Sciatica+with lumbago

592

3031

1.74

34.46

1.3

1.4

308.28

401.51

pmol/l

1.17

521

2608

Pain in joint

621

2192

1.75

34.43

1.4

515.92

356.38

pmol/l

0.44

536

1897

Finngen Rheumatological endpoints

1022

3770

1.55

34.29

1.4

537.81

339.83

pmol/l

0.79

885

3245

Migraine with aura

281

1276

2.23

34.06

1.4

701.88

401.73

pmol/l

0.40

251

1096

Hypotension

214

866

2.51

33.90

1.3

303.47

276.61

pmol/l

0.46

169

715

Other CVD

242

1037

2.37

33.77

1.3

309.79

282.64

pmol/l

0.52

195

858

Disorder of lipoprotein metabolism, unspecified

156

540

2.94

33.64

1.5

1.3

305.02

279.84

pmol/l

0.44

131

453

Other intervertebral disc disorders

880

3323

1.59

33.43

1.4

306.73

393.66

pmol/l

1.23

767

2856

Aplastic and other anaemias

507

2594

1.80

33.37

1.3

533.72

304.19

pmol/l

0.56

411

2173

Examination and observation for other reasons

602

1944

1.76

33.20

1.4

754.52

293.77

pmol/l

1.20

510

1680

Intestinal infectious diseases

1032

5091

1.51

33.13

1.4

360.48

363.38

pmol/l

0.03

857

4421

Polyarthropathies

737

2889

1.65

33.07

1.4

494.77

331.57

pmol/l

0.60

634

2478

Bleeding

902

4072

1.56

32.95

1.4

1.3

335.70

359.41

pmol/l

0.20

768

3489

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1068

4491

1.51

32.84

1.3

1.4

342.72

375.61

pmol/l

0.42

918

3897

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

1103

4742

1.50

32.84

1.4

339.22

364.42

pmol/l

0.34

932

4113

Other and unspecified iron deficiency

399

2088

1.93

32.76

1.2

1.3

330.60

398.12

pmol/l

0.61

325

1767

Diarrhoea and gastroenteritis of presumed infectious origin

769

4307

1.60

32.70

1.4

349.22

376.38

pmol/l

0.32

635

3737

Recurrent or chronic depression

460

1716

1.88

32.62

1.4

334.61

382.22

pmol/l

0.34

394

1487

Cerebrovascular diseases

801

3490

1.60

32.48

1.3

306.77

329.76

pmol/l

0.31

665

2991

Convulsions, not elsewhere classified

268

1204

2.22

32.34

1.3

1.4

713.23

327.49

pmol/l

0.50

224

1032

Valvular heart disease excluding rheumatic fever

496

1962

1.82

32.20

1.2

1.4

275.23

356.51

pmol/l

0.83

412

1662

Hypothyroidism, strict autoimmune

749

3037

1.63

32.15

1.4

1.3

501.23

331.07

pmol/l

0.66

633

2614

Symptoms and signs involving the urinary system

831

3996

1.58

32.13

1.5

1.3

343.49

366.65

pmol/l

0.20

719

3415

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

642

3880

1.66

32.07

1.3

344.45

378.78

pmol/l

0.34

558

3305

Vocal cord dysfunction

144

423

3.03

32.04

1.4

310.90

487.00

pmol/l

1.14

128

379

Non-rheumatic valve diseases

492

1944

1.82

31.98

1.2

1.4

275.78

357.29

pmol/l

0.83

408

1646

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

522

2586

1.77

31.71

1.4

586.40

364.47

pmol/l

0.60

466

2280

Cholecystectomy

779

4194

1.59

31.50

1.4

1.3

445.91

344.41

pmol/l

0.35

686

3582

Angina pectoris

606

2367

1.71

31.45

1.3

287.35

297.29

pmol/l

0.21

515

2023

Exposure to unspecified factor

1105

5097

1.48

31.43

1.4

419.26

349.61

pmol/l

0.33

925

4418

Other pulmonary diagnosis

831

2626

1.59

30.97

1.4

499.89

323.55

pmol/l

0.77

699

2291

Other special examinations and investigations of persons without complaint or reported diagnosis

648

1945

1.70

30.85

1.4

679.61

293.65

pmol/l

1.08

565

1681

Other septicaemia

420

2146

1.86

30.85

1.3

380.69

350.69

pmol/l

0.19

354

1810

Other disorders of kidney and ureter

183

723

2.58

30.67

1.4

1.3

454.86

300.28

pmol/l

0.67

162

606

Nonalcoholic fatty liver disease

157

575

2.79

30.65

1.3

316.03

333.09

pmol/l

0.21

136

495

Other septicaemia, including avohilmo

428

2195

1.85

30.59

1.3

378.28

349.02

pmol/l

0.19

361

1855

Anxiety disorders

997

4572

1.50

30.55

1.4

357.75

370.76

pmol/l

0.15

866

3963

Any mental disorder

1150

3913

1.48

30.54

1.4

348.69

368.77

pmol/l

0.18

973

3385

Asthma/COPD (KELA code 203)

1020

4576

1.50

30.44

1.4

439.24

322.71

pmol/l

0.60

882

3961

Other anaemias

465

2443

1.80

30.38

1.2

1.3

544.68

304.35

pmol/l

0.53

378

2045

Explicit Sepsis

477

2457

1.78

30.24

1.3

366.79

365.48

pmol/l

0.01

400

2083

Other and unspecified anaemias

461

2427

1.80

30.23

1.2

1.3

544.18

304.75

pmol/l

0.53

376

2029

Haemorrhage from respiratory passages

352

1598

1.97

30.21

1.4

1.3

355.85

292.50

pmol/l

0.39

304

1329

Dorsopathies

1055

3580

1.50

30.05

1.4

345.92

394.17

pmol/l

0.52

901

3087

Neurotic, stress-related and somatoform disorders

987

4555

1.50

29.96

1.4

359.10

371.19

pmol/l

0.13

856

3950

Hernia of abdominal wall, postoperative

210

888

2.38

29.72

1.3

339.42

305.30

pmol/l

0.56

182

745

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

961

3727

1.51

29.62

1.3

1.4

325.12

333.22

pmol/l

0.15

791

3249

961

3727

1.51

29.62

1.3

1.4

325.12

333.22

pmol/l

0.15

791

3249

Lumbar disc prolapse

696

3217

1.61

29.44

1.3

1.4

309.03

394.13

pmol/l

1.11

599

2760

Constipation

963

4363

1.50

29.42

1.3

1.4

447.07

340.33

pmol/l

0.46

808

3760

Acute tubulo-interstitial nephritis

656

3427

1.63

29.33

1.3

1.4

351.66

389.49

pmol/l

0.35

556

2943

Explicit Sepsis, including avohilmo

484

2514

1.76

29.32

1.3

1.4

365.60

364.35

pmol/l

0.01

406

2132

Nutritional anaemias

539

3041

1.70

29.29

1.3

347.09

395.89

pmol/l

0.40

439

2585

Excluding asthma or asthma-COPD overlap

821

2626

1.57

29.12

1.4

503.58

323.55

pmol/l

0.78

692

2291

Erysipelas

606

3187

1.65

28.85

1.3

303.79

326.31

pmol/l

0.27

512

2723

Diseases of liver

409

2256

1.83

28.77

1.3

354.31

353.46

pmol/l

0.01

356

1912

Anxiety (asthma-related co-morbidities)

663

3139

1.62

28.42

1.5

1.4

393.03

406.99

pmol/l

0.11

574

2741

Glomerular disorders in diseases classified elsewhere

160

615

2.65

28.41

1.2

1.4

320.31

296.62

pmol/l

0.27

126

524

Disorders of eyelid, lacrimal system and orbit

933

4590

1.50

28.36

1.4

298.99

373.95

pmol/l

1.53

805

3931

Soft tissue disorders

1039

3601

1.48

28.32

1.4

474.60

357.57

pmol/l

0.53

865

3128

Autoimmune diseases related-to ILD

911

5108

1.50

28.26

1.4

320.26

366.13

pmol/l

0.80

791

4397

Abnormal findings on diagnostic imaging of other body structures

198

844

2.39

28.16

1.4

1.3

318.70

300.39

pmol/l

0.29

179

719

Covid-19 confirmed case

412

2290

1.81

28.09

1.3

326.60

431.71

pmol/l

0.89

336

1936

Gastrointestinal diseases

578

1708

1.71

28.03

1.4

1.5

516.81

346.98

pmol/l

0.46

494

1505

Benign neoplasm: Pituitary gland, craniopharyngeal duct

251

3.70

27.90

1.4

1443.00

350.34

pmol/l

0.48

216

ILD differential diagnosis

816

2635

1.56

27.81

1.4

504.38

323.85

pmol/l

0.78

688

2299

Iron deficiency anaemia

471

2678

1.74

27.80

1.2

1.3

336.67

413.52

pmol/l

0.70

385

2272

Diseases of the skin and subcutaneous tissue

1020

3467

1.48

27.57

1.4

450.56

362.70

pmol/l

0.37

868

2976

COPD differential diagnosis

815

2637

1.56

27.55

1.4

504.88

323.68

pmol/l

0.78

687

2301

Glomerular diseases

225

1022

2.23

27.53

1.2

1.3

357.59

406.49

pmol/l

0.19

179

852

Hypocalcemia

106

5.46

27.50

1.4

1.3

2639.17

333.79

pmol/l

0.61

Other general symptoms and signs

188

4.10

27.37

1.2

1.4

355.51

418.98

pmol/l

0.34

166

Influenza and pneumonia

1128

4856

1.44

27.29

1.4

332.50

373.43

pmol/l

0.62

935

4234

Certain infectious and parasitic diseases

1009

3424

1.48

27.27

1.4

569.04

324.58

pmol/l

1.00

844

2986

Bacterial infection, other or unspecified, including avohilmo

619

3150

1.62

27.23

1.3

321.64

373.51

pmol/l

0.52

511

2686

Other specific joint derangements/joint disorders

780

3152

1.55

27.13

1.4

509.01

338.17

pmol/l

0.65

661

2716

Septicaemia

453

2379

1.75

27.04

1.3

367.12

347.85

pmol/l

0.13

382

2019

Pain (limb, back, neck, head abdominally)

705

2215

1.60

27.01

1.3

1.4

339.68

359.89

pmol/l

0.13

597

1918

Unspecified kidney failure

125

434

2.93

26.93

1.3

1.4

308.82

279.50

pmol/l

0.32

102

359

Infections of the skin and subcutaneous tissue

644

4011

1.59

26.92

1.3

1.4

487.20

360.51

pmol/l

0.35

545

3440

Heart failure, strict

611

2620

1.63

26.86

1.2

1.3

310.07

334.09

pmol/l

0.23

485

2204

Dermatitis and eczema

1183

4937

1.42

26.86

1.4

405.25

350.58

pmol/l

0.27

1023

4244

Use of hypnotics and sedatives

1113

4433

1.44

26.73

1.4

431.95

344.95

pmol/l

0.44

953

3806

Osteopathies and chondropathies

624

3586

1.60

26.58

1.3

469.27

351.40

pmol/l

0.32

527

3094

Visual disturbances and blindness

574

3556

1.62

26.28

1.4

1.3

506.87

358.83

pmol/l

0.39

490

3034

Sub-endpoint used in defining T1D endpoints

315

1618

1.93

26.26

1.3

1.4

274.83

394.17

pmol/l

1.11

243

1394

Selective serotonin reuptake inhibitors

997

3538

1.47

26.18

1.4

362.30

368.21

pmol/l

0.04

842

3051

Major coronary heart disease event excluding revascularizations

612

2507

1.62

26.00

1.3

266.05

301.44

pmol/l

1.23

505

2135

All-cause Heart Failure

599

2583

1.62

25.86

1.2

1.3

307.77

334.29

pmol/l

0.25

475

2174

Epilepsy

308

1609

1.92

25.45

1.3

1.4

655.75

349.70

pmol/l

0.45

265

1365

Cough

411

2190

1.76

25.41

1.4

1.3

335.03

332.81

pmol/l

0.04

360

1868

Other disorders of urethra and urinary system

727

3294

1.54

25.38

1.4

354.03

363.18

pmol/l

0.09

613

2835

Functional dyspepsia

320

1703

1.90

25.32

1.4

1.3

335.61

397.38

pmol/l

0.45

277

1455

Rheumatism, unspecified

178

760

2.38

25.28

1.3

347.41

324.52

pmol/l

0.23

156

669

Visual disturbances

538

3324

1.63

25.07

1.4

1.3

327.23

364.07

pmol/l

0.49

463

2838

Gastro-oesophageal reflux disease

727

4036

1.53

24.98

1.4

314.27

365.86

pmol/l

0.74

606

3491

Psychiatric diseases

993

3427

1.46

24.71

1.4

348.52

376.18

pmol/l

0.22

827

2968

Primary hyperparathyroidism

154

624

2.52

24.61

1.4

1.3

328.49

348.22

pmol/l

0.16

133

531

Codes for special purposes

562

3493

1.61

24.58

1.3

1.4

321.89

403.12

pmol/l

1.11

473

2977

All anxiety disorders

671

3371

1.55

24.56

1.5

1.4

395.31

406.00

pmol/l

0.08

581

2928

Provisional assignment of new diseases of uncertain etiology

561

3487

1.61

24.54

1.3

1.4

321.86

403.40

pmol/l

1.11

472

2971

Non-selective monoamine reuptake inhibitors

400

2202

1.76

24.50

1.3

313.66

352.03

pmol/l

0.34

331

1892

Other/unspecified dorsalgia

398

2256

1.76

24.44

1.3

1.4

346.58

437.01

pmol/l

0.57

349

1935

COPD/asthma/ILD related infections

1061

3727

1.43

24.06

1.4

516.85

333.22

pmol/l

0.72

887

3249

COPD/asthma related infections

1061

3727

1.43

24.06

1.4

516.85

333.22

pmol/l

0.72

887

3249

All pneumoniae

1068

4928

1.41

23.72

1.3

1.4

326.00

373.19

pmol/l

0.77

877

4297

Substance abuse, excluding more controls

561

2950

1.60

23.54

1.3

1.4

316.06

385.04

pmol/l

0.72

457

2533

ILD medications: immunosuppressive drugs

677

4038

1.53

23.49

1.4

346.24

342.86

pmol/l

0.04

599

3483

Pneumonia, organism unspecified

965

4634

1.43

23.44

1.3

1.4

319.52

372.24

pmol/l

0.82

787

4032

Dermatitis

666

4293

1.53

23.30

1.4

318.84

353.96

pmol/l

0.64

575

3672

Bacterial infection, other or unspecified

552

2935

1.60

23.08

1.3

321.97

335.46

pmol/l

0.13

453

2494

Pneumonias (Asthma/COPD co-morbidities)

1059

4932

1.41

23.03

1.3

1.4

323.78

373.27

pmol/l

0.82

870

4298

Dental caries

286

1424

1.91

23.02

1.3

1.4

337.72

383.57

pmol/l

0.26

239

1212

Stroke, excluding SAH

602

2781

1.57

22.95

1.3

303.38

332.26

pmol/l

0.32

507

2347

Other and unspecified effects of external causes

314

1717

1.85

22.85

1.4

673.77

389.89

pmol/l

0.40

267

1479

Other neurological diseases

740

3854

1.50

22.84

1.3

299.30

367.46

pmol/l

1.02

624

3294

Caries of dentine

260

1295

1.96

22.41

1.3

1.4

321.14

374.99

pmol/l

0.29

218

1098

Irritable bowel syndrome

306

1673

1.85

22.29

1.4

336.28

405.53

pmol/l

0.53

267

1445

Somatoform disorder

202

959

2.13

22.21

1.4

325.43

361.26

pmol/l

0.46

176

839

Elevated blood glucose level

115

425

2.76

22.19

1.4

1.3

323.69

316.05

pmol/l

0.08

361

Polycystic ovarian syndrome, consortium definition

752

2893

1.50

22.18

1.4

538.30

348.79

pmol/l

0.73

642

2561

Shoulder lesions

767

3102

1.49

22.09

1.3

1.4

334.44

344.79

pmol/l

0.08

659

2691

Diseases of pulp and periapical tissues, including avohilmo

1039

3820

1.41

22.04

1.4

442.81

359.14

pmol/l

0.37

873

3311

Symptoms and signs concerning food and fluid intake

128

500

2.59

21.96

1.3

298.65

326.38

pmol/l

0.29

110

425

Adverse effects, not elsewhere classified

230

1152

2.02

21.86

1.5

1.4

763.55

389.38

pmol/l

0.41

203

1000

Carpal tunnel syndrome

652

3751

1.51

21.71

1.3

1.4

309.08

376.98

pmol/l

0.88

570

3230

Stroke, including SAH

632

2981

1.53

21.41

1.3

305.54

328.99

pmol/l

0.27

534

2526

Systemic connective tissue disorders

379

2232

1.71

21.40

1.3

332.56

329.14

pmol/l

0.05

322

1904

Personality disorders, excluding more controls

268

1423

1.90

21.26

1.4

490.93

507.85

pmol/l

0.04

227

1234

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1030

4943

1.39

21.18

1.3

1.4

324.37

371.94

pmol/l

0.77

841

4312

Other systemic involvement of connective tissue (FG)

282

1499

1.86

21.15

1.3

299.73

350.51

pmol/l

1.00

244

1277

Myocardial infarction

479

2070

1.63

21.05

1.2

1.3

247.01

305.14

pmol/l

2.22

392

1749

Rotator cuff syndrome

633

2873

1.53

21.02

1.3

1.4

342.57

304.37

pmol/l

0.37

544

2484

Other and unspecified dermatitis

558

3628

1.55

20.97

1.4

311.63

365.91

pmol/l

0.98

483

3110

Other anxiety disorders

492

2630

1.60

20.94

1.5

1.4

402.19

433.99

pmol/l

0.22

421

2282

Symptoms and signs involving the skin and subcutaneous tissue

751

4897

1.46

20.77

1.4

314.50

369.71

pmol/l

1.01

667

4190

Dialysis, with operation codes

148

637

2.36

20.74

1.3

1.4

467.88

301.45

pmol/l

2.92

125

534

Undetermined asthma, excluding more controls

155

680

2.31

20.68

1.4

1.3

1716.51

302.45

pmol/l

0.90

135

595

Gestational [pregnancy-induced] hypertension

266

1425

1.88

20.58

1.4

1.5

339.14

412.05

pmol/l

1.45

241

1257

Hypoparathyroidism

162

3.89

20.42

1.7

1.1

2000.94

288.13

pmol/l

0.50

141

Gonarthrosis [arthrosis of knee](FG)

754

2963

1.47

20.37

1.4

421.71

317.79

pmol/l

0.37

664

2530

Diabetic maculopathy, excluding more controls

122

485

2.55

20.32

1.3

1.4

268.41

322.24

pmol/l

0.65

408

Certain disorders involving the immune mechanism

220

1116

2.00

20.25

1.3

1.4

386.35

346.61

pmol/l

0.27

187

959

Other retinal disorders

651

3321

1.50

20.15

1.3

280.67

332.36

pmol/l

0.87

533

2829

Other diseases of pancreas

115

448

2.62

20.05

1.2

1.3

292.66

299.16

pmol/l

0.08

100

384

168

774

2.20

19.99

1.5

1.4

393.93

511.13

pmol/l

0.38

138

683

Diseases of the eye and adnexa

770

2643

1.47

19.89

1.4

597.13

363.05

pmol/l

0.67

659

2329

Myocarditis

4.86

19.89

1.5

1.1

345.31

284.97

pmol/l

0.50

Migraine without aura and triptan purchases

190

920

2.09

19.87

1.5

914.73

438.87

pmol/l

0.43

168

803

Early onset COPD, excluding more controls

212

1069

2.00

19.75

1.2

1.3

235.53

295.19

pmol/l

2.61

167

909

Abnormal findings on diagnostic imaging of lung

481

2902

1.58

19.69

1.3

366.56

322.93

pmol/l

0.27

420

2423

Other reaction to severe stress, and adjustment disorders

383

2311

1.67

19.68

1.4

364.83

450.49

pmol/l

0.67

328

2007

Hypothyroidism, strict autoimmune, 3 medication purchases required

826

3915

1.42

19.35

1.4

353.91

355.56

pmol/l

0.02

702

3373

Nephropathy related operations

148

661

2.28

19.08

1.3

1.4

464.78

301.74

pmol/l

2.83

126

561

Benign neoplasm of colon, rectum, anus and anal canal

643

3698

1.48

19.01

1.3

294.21

322.75

pmol/l

0.43

552

3132

1144

4294

1.36

18.98

1.4

501.45

328.40

pmol/l

0.75

972

3702

Atherosclerosis, excluding cerebral and coronary sclerosis

383

1817

1.67

18.94

1.2

1.3

277.11

348.65

pmol/l

0.60

309

1507

Heart failure and coronary heart disease

400

1702

1.66

18.93

1.2

1.3

319.24

297.99

pmol/l

0.33

321

1423

Periodontitis

1015

4737

1.37

18.89

1.4

316.14

366.06

pmol/l

0.63

873

4072

Disorders of choroid and retina

813

4027

1.42

18.88

1.3

285.49

338.43

pmol/l

1.13

676

3449

Non-ischemic cardiomyopathy

317

1446

1.75

18.82

1.2

1.3

290.16

377.94

pmol/l

0.61

255

1228

Chronic periodontitis, including avohilmo

1013

4736

1.37

18.79

1.4

316.83

365.54

pmol/l

0.61

871

4071

Undetermined asthma

155

711

2.21

18.63

1.4

1.3

1716.51

299.27

pmol/l

0.90

135

618

Other arthritis (FG)

326

1920

1.71

18.48

1.3

1.4

400.06

339.62

pmol/l

0.46

278

1626

Paralytic ileus and intestinal obstruction

260

1434

1.83

18.46

1.3

325.93

310.30

pmol/l

0.11

214

1206

Other disorders of lacrimal gland

398

2469

1.62

18.45

1.3

293.28

425.25

pmol/l

1.47

346

2123

Other endocrine disorders

202

3.34

18.45

1.4

1.3

1855.25

339.89

pmol/l

0.54

176

Other symptoms and signs involving the digestive system and abdomen

188

934

2.04

18.37

1.3

381.60

354.00

pmol/l

0.15

160

810

Cystitis

822

3466

1.42

18.35

1.4

477.46

364.37

pmol/l

0.42

712

2977

Migraine with aura and triptan purchases

177

863

2.07

18.22

1.3

1.5

907.47

427.01

pmol/l

0.41

159

760

Persons encountering health services for examination and investigation

587

1945

1.52

18.16

1.4

336.08

293.65

pmol/l

1.46

508

1681

COPD (mode)

305

1366

1.75

18.15

1.2

1.3

227.68

277.91

pmol/l

2.54

235

1154

Hernia

945

4587

1.37

18.03

1.3

1.4

410.18

349.80

pmol/l

0.23

805

3963

Urticaria and erythema

386

2390

1.63

18.02

1.4

599.22

405.34

pmol/l

0.33

337

2055

Ovarian cyst

351

1181

1.71

18.02

1.5

1.3

444.15

333.61

pmol/l

0.74

311

1043

Diseases of the respiratory system

636

2146

1.49

18.00

1.3

1.4

371.41

327.14

pmol/l

0.47

550

1876

Sequelae of external causes of morbidity and mortality

283

1618

1.77

17.90

1.2

1.3

384.54

374.70

pmol/l

0.03

237

1359

Myalgia

260

1450

1.81

17.88

1.3

1.4

334.10

408.50

pmol/l

0.47

224

1253

Benign thyroid growths and nodules

346

1940

1.67

17.73

1.3

388.32

317.69

pmol/l

0.43

304

1670

Cervicalgia

227

1218

1.88

17.70

1.3

324.97

426.22

pmol/l

0.58

192

1033

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

376

2.65

17.67

1.3

366.62

305.65

pmol/l

0.67

318

Acidosis

5.25

17.55

1.2

1.3

263.41

315.25

pmol/l

0.37

Cervical disc disorders

359

2199

1.64

17.54

1.4

323.54

373.75

pmol/l

0.48

317

1875

Mental and behavioural disorders due to psychoactive substance use

584

3643

1.48

17.42

1.3

1.4

319.42

384.16

pmol/l

0.84

476

3126

Soft tissue disorders related to use, overuse and pressure

293

1705

1.73

17.41

1.3

622.84

310.99

pmol/l

0.46

262

1466

Benign neoplasm: Colon

544

3437

1.49

17.29

1.3

310.97

324.26

pmol/l

0.15

461

2904

Vascular disorders of the intestines

285

2.89

17.21

1.1

1.4

359.74

299.10

pmol/l

0.41

242

Fall on same level

1141

4579

1.33

17.19

1.4

347.33

374.48

pmol/l

0.29

965

3976

Asthma-related pneumonia

359

2202

1.64

17.19

1.3

296.81

319.11

pmol/l

0.51

302

1863

Gout

275

1345

1.77

17.14

1.3

335.02

277.29

pmol/l

1.12

220

1087

Asthma-related pneumonia or sepsis

359

2205

1.63

17.10

1.3

296.81

319.00

pmol/l

0.50

302

1865

Asthma, hospital admissions 3, pneumonia

359

2205

1.63

17.10

1.3

296.81

319.00

pmol/l

0.50

302

1865

Extracorporeal dialysis

276

2.92

17.07

1.4

490.56

305.53

pmol/l

1.96

234

Viral and other specified intestinal infections, including avohilmo

283

1576

1.74

17.02

1.4

379.50

452.61

pmol/l

0.42

239

1389

Other chronic obstructive pulmonary disease, including avohilmo

518

2837

1.51

16.90

1.2

1.3

514.42

330.00

pmol/l

0.39

413

2393

Other specified/unspecified arthritis

288

1684

1.72

16.84

1.3

1.4

414.33

327.85

pmol/l

0.66

246

1417

Cervicocranial syndrome

126

555

2.30

16.82

1.5

1.3

351.68

382.24

pmol/l

0.21

106

481

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

529

3437

1.49

16.80

1.4

520.00

326.41

pmol/l

0.52

476

2947

Acute upper respiratory infections

1036

4643

1.34

16.72

1.4

538.90

325.87

pmol/l

0.89

886

3985

Gonarthrosis

641

2494

1.46

16.68

1.4

445.20

317.87

pmol/l

0.39

564

2127

Persons with potential health hazards related to communicable diseases

372

2306

1.61

16.67

1.5

1.4

384.16

466.57

pmol/l

0.49

323

2020

Diseases of the musculoskeletal system and connective tissue

498

1625

1.54

16.58

1.4

524.52

348.86

pmol/l

0.40

430

1403

Certain infectious and parasitic diseases, including avohilmo

690

2405

1.44

16.58

1.4

338.08

313.85

pmol/l

0.54

588

2087

Disorders resulting from impaired renal tubular function

153

3.63

16.50

1.4

401.04

308.95

pmol/l

0.50

136

Disorders of lacrimal system

460

2982

1.53

16.37

1.3

294.49

404.19

pmol/l

1.47

401

2569

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

226

2.78

16.34

1.3

1.4

314.68

335.38

pmol/l

0.15

194

Other joint disorders

846

3197

1.38

16.27

1.4

506.54

340.74

pmol/l

0.71

729

2756

Disorders of synovium and tendon

534

3070

1.48

16.19

1.3

1.4

344.50

355.66

pmol/l

0.07

461

2669

Pain in thoracic spine

167

835

2.02

16.11

1.3

344.35

487.01

pmol/l

0.58

144

719

Other systemic involvement of connective tissue

287

1698

1.70

16.11

1.3

300.28

335.21

pmol/l

0.67

248

1448

Dental pulpitis, including avohilmo

929

4411

1.35

16.11

1.4

447.54

360.18

pmol/l

0.35

785

3828

COPD

419

2191

1.56

16.10

1.2

1.3

303.10

286.25

pmol/l

0.09

331

1823

Disturbances of skin sensation

301

1804

1.68

16.09

1.5

1.4

309.25

485.70

pmol/l

1.40

268

1526

Other diseases of urinary system

944

3925

1.35

16.07

1.4

438.85

354.42

pmol/l

0.34

803

3378

Chronic apical periodontitis

1096

4654

1.32

16.05

1.4

331.46

370.68

pmol/l

0.55

926

4032

Substance abuse

561

3582

1.46

16.05

1.3

1.4

316.06

384.79

pmol/l

0.90

457

3075

Urinary track infection

591

2014

1.48

15.98

1.3

1.4

528.83

366.81

pmol/l

0.45

509

1785

Irregular menses

482

2401

1.52

15.97

1.4

590.84

367.17

pmol/l

0.53

416

2135

Gout, idiopatic and unspecified

243

1377

1.78

15.91

1.3

342.81

355.05

pmol/l

0.05

191

1128

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

119

526

2.30

15.81

1.3

235.43

297.38

pmol/l

2.26

108

441

Other diseases of upper respiratory tract

1067

4196

1.33

15.78

1.4

529.18

325.85

pmol/l

0.87

918

3605

Osteoporosis

281

1523

1.71

15.74

1.4

1.3

667.28

317.67

pmol/l

0.48

239

1307

Hyperhidrosis

116

3.97

15.72

1.5

1.4

317.77

335.53

pmol/l

0.15

101

Gout, FINNGEN

275

1608

1.71

15.70

1.3

335.02

335.60

pmol/l

0.00

220

1312

Care involving dialysis

101

417

2.47

15.69

1.4

469.17

305.98

pmol/l

2.13

350

Disorders of conjunctiva

843

4822

1.36

15.50

1.4

562.55

337.05

pmol/l

0.74

735

4165

Presence of other functional implants

578

2730

1.46

15.50

1.3

275.70

327.17

pmol/l

0.68

474

2322

Other symptoms and signs involving cognitive functions and awareness

446

2613

1.52

15.44

1.3

313.74

337.32

pmol/l

0.23

370

2222

Disorders of skin appendages

506

3426

1.48

15.42

1.4

354.16

405.84

pmol/l

0.38

443

2956

Other symptoms and signs involving the urinary system

117

519

2.29

15.42

1.4

1.3

293.14

303.62

pmol/l

0.10

101

427

Missing teeth due to accident, extraction or parodontitis

624

3934

1.42

15.40

1.3

324.05

332.43

pmol/l

0.09

515

3368

Peripheral artery disease

393

1989

1.57

15.39

1.2

1.3

268.01

346.31

pmol/l

0.77

314

1649

Diabetic nephropathy, excluding more controls

206

906

1.88

15.38

1.2

1.3

298.02

309.67

pmol/l

0.16

166

770

Ischaemic Stroke, excluding all haemorrhages

527

2643

1.47

15.26

1.3

303.46

332.67

pmol/l

0.30

440

2221

Injuries to the knee and lower leg

1173

4878

1.30

15.26

1.4

319.66

373.79

pmol/l

0.99

992

4221

Other aneurysm

217

3.05

15.24

1.5

1.4

265.48

331.63

pmol/l

1.05

188

Sequelae with surgical and medical care as external cause

222

1242

1.81

15.24

1.2

1.3

280.37

385.42

pmol/l

0.66

183

1038

Other blood glucose lowering drugs, excl. Insulins

158

791

2.02

15.23

1.2

1.3

293.63

319.71

pmol/l

0.25

128

651

Dysphagia

247

1425

1.75

15.21

1.3

305.06

406.72

pmol/l

0.74

207

1213

Other chronic obstructive pulmonary disease

398

2102

1.56

15.20

1.2

1.3

307.64

284.97

pmol/l

0.12

311

1749

Persons encountering health services for specific procedures, not carried out

108

466

2.35

15.20

1.5

1.4

445.01

338.99

pmol/l

1.01

399

Falls/tendency to fall

1054

3998

1.32

15.16

1.4

457.34

360.78

pmol/l

0.45

887

3486

Viral and other specified intestinal infections

206

1099

1.84

15.14

1.5

1.4

410.94

454.88

pmol/l

0.16

173

964

L04AD Calcineurin inhibitors

129

603

2.17

14.98

1.4

481.04

330.42

pmol/l

1.84

114

521

Disorders of vestibular function (Vertigo)

473

3112

1.49

14.96

1.4

1.3

290.70

355.72

pmol/l

1.09

414

2657

Oxycodone

373

2039

1.57

14.95

1.4

1.3

317.90

348.75

pmol/l

0.20

318

1721

Myocardial infarction, without ST-elevation

363

2087

1.58

14.90

1.2

1.3

240.71

342.24

pmol/l

1.22

293

1729

Transient ischemic attack

490

2642

1.48

14.88

1.3

285.03

335.82

pmol/l

0.63

417

2230

Malignant neoplasm, wide definition

860

3706

1.36

14.86

1.4

356.78

380.82

pmol/l

0.18

737

3187

Malignant neoplasm, including Hilmo

858

3699

1.36

14.84

1.4

357.00

381.33

pmol/l

0.18

738

3180

Gout, strict definition

183

973

1.90

14.80

1.3

355.95

389.01

pmol/l

0.11

139

795

Benign neoplasm of other and ill-defined parts of digestive system

197

1073

1.86

14.79

1.4

1.3

296.70

319.50

pmol/l

0.28

174

904

Sicca syndrome [Sjögren]

107

466

2.34

14.78

1.3

265.25

371.60

pmol/l

1.10

407

Other disorders of skin and subcutaneous tissue

721

4428

1.38

14.77

1.4

1.3

298.78

367.90

pmol/l

1.26

611

3790

Nonorganic sleeping disorders, excluding more controls

206

1137

1.83

14.76

1.6

1.4

397.36

540.21

pmol/l

0.55

185

995

Diaphragmatic hernia

358

2289

1.58

14.74

1.3

300.23

309.20

pmol/l

0.16

292

1943

Malignant neoplasm of urinary organs, including Hilmo

127

594

2.17

14.72

1.3

235.51

293.72

pmol/l

2.25

116

491

Gonarthrosis,primary

862

3861

1.35

14.67

1.3

401.19

314.73

pmol/l

0.34

749

3286

Kidney transplant status

239

2.91

14.60

1.4

512.31

339.53

pmol/l

1.52

208

Dialysis

151

3.46

14.59

1.5

1.4

404.80

340.55

pmol/l

0.47

136

Diseases of the ear and mastoid process

1120

4313

1.31

14.52

1.4

404.80

362.96

pmol/l

0.18

959

3735

Arthropathies

857

3203

1.36

14.50

1.4

635.84

340.75

pmol/l

1.05

732

2761

Gingival hyperplasia

168

3.30

14.32

1.7

1.3

389.40

331.71

pmol/l

0.51

144

Other disorders of eyelid

435

2753

1.50

14.22

1.3

290.60

340.78

pmol/l

0.66

373

2334

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

105

463

2.30

14.09

1.4

1.3

1356.31

343.45

pmol/l

0.48

402

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

630

4125

1.40

14.08

1.4

374.65

392.29

pmol/l

0.17

554

3562

Brachial plexus disorders

108

482

2.27

14.08

1.7

1.4

370.25

343.77

pmol/l

0.28

427

Unknown and unspecified causes of morbidity

289

2.67

14.01

1.4

1.3

410.82

324.73

pmol/l

0.71

247

Follow-up examination after treatment for conditions other than malignant neoplasms

392

1697

1.55

14.01

1.3

443.03

288.12

pmol/l

1.25

328

1461

Chronic pancreatitis

137

673

2.06

13.99

1.3

274.98

312.02

pmol/l

0.63

109

569

Urticaria

305

1904

1.61

13.93

1.4

666.04

373.80

pmol/l

0.42

268

1645

Other or unspecified ileus, impaction or obstruction

179

966

1.87

13.82

1.3

355.27

317.53

pmol/l

0.20

148

811

Extrapyramidal and movement disorders

378

2484

1.53

13.79

1.4

1.3

314.53

351.81

pmol/l

0.35

312

2097

Thyroiditis, ILD-related definition

129

623

2.10

13.79

1.5

1.4

348.45

369.50

pmol/l

0.14

103

550

Myocardial infarction, strict

413

1937

1.52

13.70

1.2

1.3

242.73

303.91

pmol/l

2.37

336

1629

Other diseases of blood and blood-forming organs

340

2.51

13.68

1.3

1.4

345.00

307.95

pmol/l

0.42

291

Arthrosis

682

2699

1.39

13.65

1.4

479.74

320.43

pmol/l

0.56

599

2313

Unspecified haematuria

390

2091

1.53

13.64

1.4

1.3

292.76

350.46

pmol/l

0.54

336

1721

Polyneuropathies and other disorders of the peripheral nervous system

219

1262

1.75

13.63

1.2

1.3

295.17

403.45

pmol/l

0.64

183

1042

Malignant neoplasm of kidney, except renal pelvis

104

464

2.28

13.60

1.3

223.63

297.21

pmol/l

2.67

389

Malignant neoplasm of urinary organs

111

509

2.21

13.57

1.3

226.67

296.45

pmol/l

2.68

100

428

Enthesopathies of lower limb, excluding foot

235

1383

1.71

13.55

1.3

339.37

420.21

pmol/l

0.41

198

1182

Cyst of kidney

354

2.47

13.52

1.3

1.4

566.44

299.01

pmol/l

0.53

301

Diabetic nephropathy

207

1165

1.78

13.44

1.2

1.3

298.02

300.07

pmol/l

0.02

166

973

Aortic aneurysm

204

1133

1.78

13.41

1.3

246.41

374.57

pmol/l

0.75

172

927

Deforming dorsopathies

279

1721

1.63

13.39

1.3

329.73

465.69

pmol/l

0.90

248

1477

Hernia of abdominal wall

443

3027

1.47

13.37

1.3

1.4

314.54

352.44

pmol/l

0.45

379

2556

Nontoxic goitre/thyroid nodule

299

1879

1.60

13.34

1.4

1.3

393.43

307.54

pmol/l

0.48

263

1618

Neuromuscular dysfunction of bladder

107

487

2.23

13.34

1.3

291.41

310.86

pmol/l

0.27

410

Generalized anxiety disorder

166

885

1.89

13.29

1.4

440.89

540.55

pmol/l

0.35

143

771

Other and unspecified drugs and medicaments

101

450

2.28

13.26

1.4

1.3

1397.87

350.01

pmol/l

0.48

390

Immunodeficiencies

231

2.83

13.13

1.5

1.4

560.26

386.04

pmol/l

0.44

202

Personality disorders

268

1646

1.64

13.13

1.4

490.93

488.86

pmol/l

0.01

227

1439

Chronic rhinitis, nasopharyngitis and pharyngitis

331

2137

1.56

13.11

1.4

686.87

351.74

pmol/l

0.54

285

1834

Bronchitis

1061

4951

1.29

13.02

1.4

443.62

343.40

pmol/l

0.49

909

4265

Other diseases of anus and rectum

285

1774

1.61

12.99

1.4

1.3

707.62

303.12

pmol/l

0.60

244

1520

Subjective visual disturbances

268

1651

1.64

12.99

1.4

1.3

337.02

348.83

pmol/l

0.15

233

1402

Thiazolidinediones

115

546

2.13

12.89

1.4

1.3

311.78

288.86

pmol/l

0.21

447

Congenital malformations, deformations and chromosomal abnormalities

563

3835

1.40

12.74

1.4

382.38

399.93

pmol/l

0.16

496

3320

Fracture of rib(s), sternum and thoracic spine

298

1892

1.59

12.74

1.3

259.20

370.34

pmol/l

1.16

239

1575

Abnormal results of function studies

103

471

2.22

12.71

1.4

331.45

318.16

pmol/l

0.13

399

Implicit fungal Sepsis, including avohilmo

346

2.44

12.71

1.3

375.77

320.40

pmol/l

0.60

288

Polyuria

214

1251

1.72

12.68

1.6

1.3

437.31

315.11

pmol/l

0.59

189

1030

Mixed hyperlipidaemia

135

3.40

12.64

1.6

1.3

297.49

305.81

pmol/l

0.06

116

Chronic periodontitis, complicated

556

3897

1.40

12.60

1.4

1.3

335.03

327.20

pmol/l

0.05

480

3312

Panic disorder

148

776

1.92

12.56

1.4

1.5

435.30

524.02

pmol/l

0.27

125

683

Diseases of inner ear

526

3586

1.41

12.55

1.4

1.3

294.85

345.30

pmol/l

0.90

459

3057

Noninfective enteritis and colitis

447

3094

1.45

12.53

1.4

357.00

404.46

pmol/l

0.42

392

2657

Other and unspecified nerve root and plexus disorders, also in other diseases

217

1280

1.71

12.47

1.4

1.3

336.61

400.82

pmol/l

0.36

185

1088

Cluster headache, wide

147

3.26

12.37

1.5

1.3

306.67

338.44

pmol/l

0.24

121

Phobic anxiety disorders

134

682

1.98

12.32

1.6

1.4

414.69

500.99

pmol/l

0.24

115

604

Disorders of lens

635

2873

1.38

12.32

1.4

468.05

334.65

pmol/l

0.36

526

2485

Other diseases of blood and blood-forming organs, wide

227

1361

1.68

12.28

1.3

432.07

410.56

pmol/l

0.08

189

1139

Behavioural syndromes associated with physiological disturbances and physical factors

920

4805

1.30

12.28

1.4

344.28

371.08

pmol/l

0.37

810

4140

Other disorders involving the immune mechanism, not elsewhere classified

138

3.34

12.26

1.2

1.4

354.03

472.39

pmol/l

0.61

122

Pre-eclampsia or poor fetal growth

286

1809

1.58

12.20

1.5

1.4

779.66

397.04

pmol/l

0.56

256

1586

Other and unspecified polyneuropathies, also in other diseases

192

1102

1.76

12.19

1.3

297.01

304.91

pmol/l

0.10

162

910

Vitamin deficiency, wide

207

2.85

12.16

1.4

1.3

608.56

330.79

pmol/l

0.59

177

Vitamin deficiency

207

2.85

12.16

1.4

1.3

608.56

330.79

pmol/l

0.59

177

L04AA Selective immunosuppressants

232

1404

1.67

12.12

1.4

393.10

342.71

pmol/l

0.63

205

1199

Other symptoms and signs involving the circulatory and respiratory systems

282

2.55

12.05

1.4

1.3

317.39

359.12

pmol/l

0.34

235

Senile cataract

585

2570

1.39

12.01

1.3

305.65

337.58

pmol/l

0.34

487

2219

Other noninfective gastroenteritis and colitis

243

1491

1.64

11.97

1.4

1.3

373.90

340.47

pmol/l

0.37

218

1265

Substance use, excluding alcohol

203

1190

1.72

11.95

1.3

1.4

352.44

420.48

pmol/l

0.34

170

1033

Diseases of the digestive system

418

2869

1.45

11.87

1.4

1.3

578.13

350.68

pmol/l

0.42

350

2421

Supplementary factors related to causes of morbidity and mortality classified elsewhere

310

2020

1.54

11.85

1.3

1.4

278.87

448.78

pmol/l

1.59

267

1711

Speech and linguistic disorders, excluding more controls

333

2.36

11.84

1.4

359.12

377.24

pmol/l

0.12

298

Abnormal involuntary movements

139

729

1.93

11.84

1.3

297.77

352.87

pmol/l

0.62

123

610

Intestinal stricture

293

1887

1.56

11.81

1.3

324.23

372.02

pmol/l

0.28

242

1580

Pruritus

125

633

2.00

11.80

1.4

1.3

269.65

365.22

pmol/l

1.22

107

544

Insulin, fast-acting (human)

140

737

1.92

11.78

1.3

1.4

275.90

339.39

pmol/l

1.01

100

644

Radiculopathy

157

858

1.85

11.76

1.3

271.89

465.27

pmol/l

0.90

139

714

Hyperfunction of pituitary gland

211

2.80

11.75

1.3

1.2

362.60

335.05

pmol/l

0.22

179

Benign neoplasm of brain and other parts of central nervous system

310

2.46

11.74

1.3

1.4

282.20

329.19

pmol/l

0.58

267

Allergic asthma (mode), excluding more controls

208

1202

1.70

11.72

1.4

375.51

353.65

pmol/l

0.26

181

1057

Other disorders of bladder

126

642

1.99

11.70

1.4

1.3

331.36

286.59

pmol/l

0.52

108

523

Injuries to the abdomen, lower back, lumbar spine and pelvis

386

2600

1.47

11.67

1.3

327.09

407.60

pmol/l

0.72

318

2213

Ulcer of lower limb, not elsewhere classified

147

789

1.88

11.67

1.2

1.3

267.56

295.22

pmol/l

0.45

113

654

Intracerebral haemorrhage

118

589

2.02

11.59

1.4

1.3

284.56

278.73

pmol/l

0.07

103

493

Abnormalities of gait and mobility

122

617

2.00

11.57

1.3

1.4

280.82

297.65

pmol/l

0.26

103

505

Nontoxic multinodular goitre

194

1136

1.72

11.50

1.3

280.36

299.33

pmol/l

0.50

171

971

Other abnormal findings of blood chemistry

225

2.72

11.49

1.2

1.4

533.90

341.99

pmol/l

0.45

198

Conjunctivitis

745

4559

1.32

11.48

1.4

591.83

340.54

pmol/l

0.73

650

3951

External causes of morbidity and mortality

608

2219

1.38

11.48

1.4

390.98

318.09

pmol/l

0.81

514

1943

Meniscus derangement

524

2493

1.40

11.47

1.3

1.4

276.97

317.83

pmol/l

1.86

437

2129

Pulmonary heart disease

274

1750

1.58

11.46

1.4

1.3

355.37

363.35

pmol/l

0.04

233

1463

Gout, unspecified

192

1122

1.73

11.46

1.3

344.97

374.68

pmol/l

0.11

154

912

Ventral hernia

235

1448

1.64

11.45

1.3

323.70

327.51

pmol/l

0.04

205

1214

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

134

3.29

11.45

1.3

1.4

349.17

460.63

pmol/l

0.55

119

Cutaneous abscess, furuncle and carbuncle

260

1642

1.59

11.44

1.3

1.4

708.42

407.33

pmol/l

0.33

219

1400

COPD related to multimorbidity

350

1983

1.50

11.42

1.2

1.3

232.41

336.36

pmol/l

1.24

275

1647

Abnormal findings on examination of urine, without diagnosis

198

2.83

11.39

1.4

1.3

343.91

328.48

pmol/l

0.12

170

Faecal incontinence

101

480

2.13

11.36

1.2

1.3

370.32

322.36

pmol/l

0.38

416

Other disorders of ear

882

4419

1.29

11.35

1.3

1.4

298.99

373.37

pmol/l

1.35

745

3814

Pulmonary embolism

274

1755

1.57

11.33

1.4

1.3

355.37

363.05

pmol/l

0.04

233

1469

Focal epilepsy

208

1246

1.68

11.31

1.2

1.4

768.18

349.08

pmol/l

0.42

180

1060

Pulmonary heart disease, diseases of pulmonary circulation

293

1906

1.55

11.30

1.4

1.3

345.19

357.85

pmol/l

0.07

249

1593

Spondylolisthesis/Spondylolysis

186

1082

1.73

11.30

1.3

321.84

432.35

pmol/l

0.56

166

920

Menorrhagia

313

1127

1.56

11.29

1.5

1.3

457.37

328.54

pmol/l

0.76

271

993

Other acute lower respiratory infections

487

3324

1.40

11.28

1.4

560.66

367.76

pmol/l

0.41

401

2846

Cardiodefibrillation

315

2077

1.52

11.27

1.3

337.68

335.21

pmol/l

0.02

271

1709

Focal epilepsy, strict definition

193

1135

1.71

11.25

1.3

1.4

278.99

343.28

pmol/l

1.24

167

957

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

248

1534

1.61

11.25

1.4

360.82

499.18

pmol/l

0.77

205

1336

Sleep disorders

881

4716

1.29

11.24

1.4

344.82

372.59

pmol/l

0.37

778

4063

Need for other prophylactic measures

293

2.47

11.19

1.5

1.4

586.45

360.99

pmol/l

0.42

249

Malignant neoplasm

810

3639

1.31

11.14

1.4

358.62

381.63

pmol/l

0.17

695

3125

Malignant neoplasm

810

3640

1.31

11.12

1.4

359.03

381.62

pmol/l

0.16

695

3126

Acute upper respiratory infections of multiple and unspecified sites

730

4049

1.32

11.09

1.4

359.53

336.66

pmol/l

0.46

637

3485

Disorders of adult personality and behaviour

273

1757

1.56

11.08

1.5

1.4

396.29

498.87

pmol/l

0.60

232

1538

Other extrapyramidal and movement disorders in other diseases

249

1570

1.60

11.06

1.4

1.3

341.76

325.76

pmol/l

0.18

221

1327

Heart failure and bmi 25plus

343

1526

1.51

11.05

1.2

1.3

303.53

277.96

pmol/l

0.55

276

1279

Cervicobrachial syndrome

212

1285

1.66

11.04

1.4

1.3

313.61

441.96

pmol/l

0.87

193

1101

Injuries to the thorax

426

2998

1.43

11.02

1.3

257.77

342.55

pmol/l

1.52

349

2532

Venous thromboembolism

493

3426

1.39

11.00

1.4

1.3

394.95

328.32

pmol/l

0.56

419

2906

Type of accident

288

1879

1.54

11.00

1.3

280.18

457.89

pmol/l

1.52

250

1591

Amenorrhoea

295

2.44

10.99

1.4

1.5

1912.53

364.54

pmol/l

0.51

265

ILD medications: azathioprine

146

800

1.84

10.89

1.3

1.4

376.07

312.61

pmol/l

1.14

128

692

Other external causes of accidental injury

762

2902

1.32

10.88

1.4

396.25

367.16

pmol/l

0.22

647

2533

Asthma and allergy, excluding more controls

122

622

1.95

10.87

1.5

1.4

374.17

395.17

pmol/l

0.16

107

552

Other sleep disorders

105

515

2.06

10.86

1.4

1.3

328.18

308.65

pmol/l

0.20

430

Trochanteric bursitis

153

852

1.81

10.83

1.3

290.38

315.41

pmol/l

0.46

140

745

COPD, hospital admissions

397

2329

1.44

10.68

1.2

1.3

307.85

330.90

pmol/l

0.10

310

1942

Other and unspecified tonsillitis

311

1716

1.51

10.64

1.5

616.33

393.16

pmol/l

0.31

274

1489

Allergic asthma (mode)

208

1235

1.65

10.63

1.4

375.51

352.44

pmol/l

0.28

181

1082

Conduction disorders

254

1291

1.58

10.61

1.2

1.4

301.35

389.47

pmol/l

0.51

226

1077

Cardiac murmurs and other cardiac sounds

396

2.19

10.58

1.3

300.47

367.55

pmol/l

0.76

334

Clear cell adenocarcinoma of kidney

241

2.58

10.57

1.3

1.4

227.36

317.48

pmol/l

2.14

209

Solid cancers, including Hilmo

811

3652

1.30

10.57

1.4

361.03

378.21

pmol/l

0.12

699

3136

Monoamine oxidase A inhibitors

124

652

1.92

10.55

1.4

1.3

409.57

297.60

pmol/l

1.07

101

555

Thoracic aortic aneurysm

141

773

1.84

10.53

1.4

1.3

264.03

295.28

pmol/l

0.59

121

637

Asthma and allergy

122

629

1.93

10.52

1.5

1.4

374.17

394.23

pmol/l

0.15

107

561

Specific personality disorders

222

1379

1.62

10.51

1.4

1.5

394.00

533.17

pmol/l

0.67

189

1210

Artificial joint operation, meniscal resection

857

4278

1.28

10.51

1.3

1.4

286.38

337.68

pmol/l

1.22

733

3665

Focal epilepsy, mode (most common among epilepsy diagnosis)

182

1075

1.71

10.48

1.2

1.3

834.35

344.70

pmol/l

0.43

159

909

Intracranial injury

547

3769

1.36

10.46

1.3

1.4

322.31

359.58

pmol/l

0.54

465

3229

Congenital malformations of the urinary system

266

2.48

10.44

1.3

1.5

448.17

387.56

pmol/l

0.34

227

Cerebral aneurysm, nonruptured

484

2.07

10.39

1.3

355.23

367.89

pmol/l

0.07

424

COPD, early/later onset

399

2347

1.43

10.38

1.2

1.3

306.92

330.55

pmol/l

0.11

312

1958

Accidents

757

2902

1.31

10.34

1.4

393.72

367.16

pmol/l

0.20

644

2533

Familial hypercholesterolemia

117

607

1.94

10.34

1.2

1.3

305.56

283.93

pmol/l

0.27

103

512

Chronic gastritis

246

1573

1.57

10.31

1.3

347.07

295.31

pmol/l

1.12

200

1328

Hyperkinetic disorders, excluding more controls

113

539

1.97

10.28

1.6

1.4

401.46

610.41

pmol/l

0.55

478

Atopic dermatitis, strict definition with reimbursement

282

1784

1.53

10.27

1.4

1.5

705.87

467.17

pmol/l

0.28

241

1554

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

188

976

1.69

10.27

1.5

439.98

527.05

pmol/l

0.35

161

852

Other congenital malformations

434

2.12

10.17

1.6

1.4

408.10

391.42

pmol/l

0.11

376

Factors influencing health status and contact with health services

245

764

1.62

10.17

1.4

336.95

286.72

pmol/l

0.83

211

671

Appendectomy

619

4458

1.33

10.17

1.4

313.03

384.08

pmol/l

1.29

546

3850

Any event in cancer register

859

3926

1.28

10.17

1.4

384.57

381.06

pmol/l

0.02

736

3379

Pre-eclampsia or eclampsia

206

1269

1.64

10.13

1.5

1.4

918.38

401.03

pmol/l

0.55

186

1104

Triptan medication for migraine, min. 3 purchases

537

2962

1.36

10.10

1.4

543.10

400.15

pmol/l

0.35

481

2596

Transplanted organ and tissue status

106

537

2.00

10.08

1.4

525.00

298.74

pmol/l

2.75

456

Azathioprine

146

820

1.80

10.08

1.3

1.4

376.07

321.59

pmol/l

0.89

128

707

Agoraphobia

129

3.16

10.07

1.5

1.4

486.62

411.93

pmol/l

0.20

112

Diseases of salivary glands

319

2168

1.48

10.06

1.3

325.65

434.79

pmol/l

0.88

277

1847

Insomnia

861

4716

1.27

10.01

1.4

348.26

372.45

pmol/l

0.31

761

4062

Congenital malformations of the urinary system, including avohilmo

284

2.39

9.98

1.3

1.4

449.15

382.09

pmol/l

0.41

244

Unstable angina pectoris

310

1636

1.50

9.98

1.3

284.37

291.34

pmol/l

0.10

247

1366

Osteoporosis with pathological fracture (FG)

379

2.19

9.97

1.3

268.83

275.60

pmol/l

0.08

316

Mental and behavioural disorders due to alcohol

455

3139

1.39

9.97

1.3

1.4

308.77

393.03

pmol/l

1.00

367

2685

Acute bronchitis

372

2555

1.43

9.96

1.3

635.93

380.07

pmol/l

0.42

306

2180

Glomerulonephritis

101

506

2.02

9.92

1.2

1.4

426.27

302.75

pmol/l

1.59

430

Extreme obesity with alveolar hypoventilation

196

2.71

9.92

1.3

381.43

324.75

pmol/l

0.40

172

All influenza

244

1572

1.56

9.90

1.3

1.4

352.29

389.69

pmol/l

0.21

206

1338

Peripheral arterial reconstruction

145

817

1.79

9.90

1.2

1.3

271.85

275.02

pmol/l

0.03

114

674

Type 1 diabetes, definitions combined

445

2.08

9.84

1.4

1.5

324.00

369.19

pmol/l

0.47

394

Disorders of psychological development

114

551

1.93

9.83

1.6

1.4

338.70

399.15

pmol/l

0.76

480

Benign paroxysmal vertigo

288

1928

1.50

9.82

1.3

261.22

323.52

pmol/l

2.62

246

1626

Primary gonarthrosis, bilateral

478

2923

1.37

9.80

1.3

280.98

296.03

pmol/l

0.48

418

2468

Adjustment and management of implanted device

165

968

1.72

9.79

1.4

1.3

283.03

283.07

pmol/l

0.00

145

789

Conjunctivitis (acute, non atopic)

274

1808

1.52

9.78

1.3

1.4

1038.78

374.80

pmol/l

0.72

244

1546

Abnormal serum enzyme levels

261

1651

1.53

9.75

1.4

1.3

287.36

339.72

pmol/l

0.35

225

1344

Leisure time condition

178

1068

1.68

9.72

1.3

1.4

292.34

316.03

pmol/l

0.46

151

907

Type 1 diabetes, strict (exclude DM2)

441

2.08

9.70

1.4

1.5

326.75

370.54

pmol/l

0.45

390

L01XX Other antineoplastic agents

264

2.43

9.65

1.3

247.60

312.31

pmol/l

0.92

231

Non-allergic asthma (mode), excluding more controls

167

977

1.70

9.65

1.3

1.4

336.38

325.95

pmol/l

0.12

146

849

Mouth breathing

373

2628

1.42

9.65

1.4

299.96

358.04

pmol/l

0.72

336

2221

Alcohol use disorder, Swedish definition

488

3264

1.36

9.65

1.3

1.4

361.76

378.35

pmol/l

0.08

404

2775

Contact with and exposure to communicable diseases

274

1813

1.51

9.64

1.4

1.5

394.77

508.50

pmol/l

0.53

237

1594

Hypoglycaemia, other or unspecified

320

2.28

9.63

1.3

1.4

222.75

367.44

pmol/l

2.03

272

Special screening examination for other diseases and disorders

116

615

1.90

9.62

1.3

307.25

287.13

pmol/l

0.18

519

Acute sinusitis

497

3336

1.36

9.62

1.4

726.75

348.91

pmol/l

0.71

426

2883

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

250

1611

1.54

9.62

1.4

1.5

332.29

475.29

pmol/l

1.32

212

1416

516

3421

1.35

9.61

1.3

1.4

312.79

385.08

pmol/l

0.89

424

2919

Pre-eclampsia

188

1149

1.65

9.57

1.5

1.4

989.36

415.08

pmol/l

0.55

168

1002

Personal history of other diseases and conditions

109

565

1.94

9.56

1.4

370.01

567.32

pmol/l

0.55

499

Early onset COPD

212

1335

1.60

9.56

1.2

1.3

235.53

382.58

pmol/l

1.21

167

1126

Benign neoplasm of meninges

108

562

1.94

9.54

1.6

1.3

320.25

304.81

pmol/l

0.18

475

Carbimazole or st.post thyroidectomy, condition for graves disease

210

1321

1.60

9.51

1.4

296.95

367.15

pmol/l

1.46

179

1142

Thyrotoxicosis, other and/or unspecified

194

1197

1.63

9.51

1.3

309.90

333.24

pmol/l

0.32

167

1029

Cluster headache, strict

139

3.00

9.50

1.5

1.3

316.29

343.07

pmol/l

0.18

116

Other problems related to primary support group, including family circumstances

111

567

1.92

9.47

1.4

375.44

378.98

pmol/l

0.02

503

Injuries to the ankle and foot

693

4590

1.29

9.40

1.4

299.73

387.07

pmol/l

1.94

575

3994

Diabetes mellitus in pregnancy

280

1177

1.52

9.39

1.4

1.5

698.74

446.42

pmol/l

0.31

241

1058

Gonarthrosis, primary, with knee surgery

527

3060

1.35

9.35

1.3

283.49

295.05

pmol/l

0.35

455

2581

Pacemaker

308

1957

1.47

9.35

1.3

310.95

341.67

pmol/l

0.22

261

1610

Hypogonadotropic hypogonadism

146

2.94

9.34

1.4

1.5

314.75

330.44

pmol/l

0.12

128

Other diseases of pleura

385

2380

1.41

9.32

1.2

1.3

330.99

344.70

pmol/l

0.09

333

1966

Other disorders of white blood cells

244

2.46

9.32

1.4

400.02

320.23

pmol/l

0.62

208

540

3527

1.34

9.30

1.3

1.4

362.35

377.19

pmol/l

0.08

445

3010

Isolated proteinuria

120

3.15

9.28

1.3

1.4

356.58

350.86

pmol/l

0.03

105

Excessive, frequent and irregular menstruation

334

1218

1.47

9.26

1.4

361.68

339.61

pmol/l

0.44

289

1074

Sequelae of cerebrovascular disease

310

1814

1.47

9.21

1.3

280.73

347.64

pmol/l

0.57

260

1522

Aneurysms, operations, SAH

157

926

1.71

9.18

1.3

341.04

328.47

pmol/l

0.11

130

792

Intestinal malabsorption

228

2.50

9.16

1.6

1.4

248.39

344.35

pmol/l

2.23

197

Cerebral palsy and other paralytic syndromes

108

570

1.91

9.15

1.4

1.3

288.89

340.26

pmol/l

0.81

487

Abnormal weight loss

501

1.98

9.14

1.3

300.30

312.45

pmol/l

0.11

428

Hypertrichosis

3.49

9.11

1.3

1.5

361.15

469.84

pmol/l

0.54

Oxicams

195

674

1.65

9.10

1.3

1.4

420.92

362.68

pmol/l

0.22

162

569

Status epilepticus

111

3.20

9.08

1.3

3522.22

309.98

pmol/l

0.49

Mental and behavioural disorders due to alcohol, excluding acute intoxication

392

2796

1.40

9.06

1.3

1.4

307.60

387.09

pmol/l

0.80

317

2383

Disorders of vitreous body

479

3384

1.35

9.03

1.3

267.17

330.65

pmol/l

1.22

407

2881

Benign neoplasm: Colon, unspecified

238

1561

1.54

8.99

1.3

333.01

376.54

pmol/l

0.26

199

1306

Necrosis of pulp, including avohilmo

556

4175

1.32

8.99

1.5

1.4

299.81

394.06

pmol/l

1.86

467

3612

Weight loss

104

547

1.92

8.93

1.3

1.4

314.80

312.75

pmol/l

0.02

465

Other disorders of glucose regulation and pancreatic internal secretion

403

2.08

8.92

1.2

1.4

222.52

349.60

pmol/l

2.17

340

Post-traumatic stress disorder

383

2.11

8.91

1.5

1.4

355.87

629.89

pmol/l

0.53

342

Nontraumatic intracranial haemmorrhage

175

1070

1.65

8.91

1.4

1.3

294.16

307.56

pmol/l

0.14

148

900

Gingivitis and periodontal diseases

909

3754

1.25

8.87

1.4

389.42

338.95

pmol/l

0.46

765

3222

Cluster headache, wide,, including avohilmo

256

2.38

8.87

1.4

330.40

380.07

pmol/l

0.46

220

Cellulitis

214

1377

1.56

8.82

1.4

1.3

319.87

400.98

pmol/l

0.49

176

1166

Nonorganic sleeping disorders

206

1314

1.58

8.82

1.6

1.4

397.36

456.49

pmol/l

0.28

185

1142

Collagenous colitis

494

1.97

8.80

1.4

1.3

314.12

323.66

pmol/l

0.08

421

Noninfectious colitis NAS

131

744

1.78

8.78

1.3

428.34

359.03

pmol/l

0.47

118

640

Aortic valve malfunction, age under 60 years

516

1.94

8.75

1.2

1.4

312.49

509.33

pmol/l

0.50

447

Candidiasis, including avohilmo

287

1967

1.47

8.75

1.4

359.64

367.42

pmol/l

0.09

239

1681

Diseases of male genital organs

415

1501

1.40

8.68

1.4

275.04

352.43

pmol/l

0.57

338

1267

Disorders of vitreous body and globe

486

3442

1.34

8.68

1.3

266.91

329.76

pmol/l

1.23

413

2927

Urolithiasis

280

1913

1.47

8.67

1.4

1.3

310.65

366.18

pmol/l

0.46

239

1593

Solid cancers

772

3571

1.27

8.66

1.4

363.46

351.08

pmol/l

0.09

664

3065

Inflammatory diseases of female pelvic organs

591

3096

1.31

8.63

1.4

554.14

354.43

pmol/l

0.57

511

2731

Pain and other conditions associated with female genital organs and menstrual cycle

183

948

1.62

8.60

1.5

1.4

664.77

363.29

pmol/l

1.02

158

839

Mycoses, including avohilmo

865

5294

1.25

8.59

1.3

1.4

575.68

327.36

pmol/l

0.86

741

4565

Left ventricular outflow tract obstruction (LVOTO), broad definition

104

555

1.90

8.56

1.2

1.4

315.09

509.76

pmol/l

0.54

484

Speech and linguistic disorders

411

2.03

8.55

1.4

1.5

362.15

387.87

pmol/l

0.19

360

Restless leg syndrome

141

825

1.72

8.53

1.6

1.3

343.27

346.91

pmol/l

0.03

123

700

Psychotic depression

280

2.28

8.47

1.2

1.3

239.87

304.78

pmol/l

1.08

247

Malignant neoplasm of thyroid gland

365

2.11

8.46

1.5

1.3

318.68

346.91

pmol/l

0.43

318

Non-allergic asthma (mode)

167

1015

1.64

8.41

1.3

1.4

336.38

323.17

pmol/l

0.16

146

876

Coxibs

223

748

1.57

8.41

1.4

804.51

365.10

pmol/l

0.45

187

635

Blepharochalasis

274

1878

1.47

8.39

1.3

289.53

311.59

pmol/l

0.50

237

1607

Leiomyoma of uterus

585

2508

1.31

8.38

1.5

1.3

330.17

348.52

pmol/l

0.39

509

2208

Mental and behavioural disorders due to tobacco

490

1.94

8.33

1.3

1.4

387.70

312.95

pmol/l

0.92

423

Smoking dependency

491

1.94

8.28

1.3

1.4

387.70

319.16

pmol/l

0.81

425

Atopic dermatitis, strict definition

264

1759

1.47

8.28

1.4

1.5

730.73

411.72

pmol/l

0.38

226

1538

Other disorders of bone

188

1194

1.59

8.25

1.4

313.55

351.12

pmol/l

0.60

151

1033

Gastroduodenal ulcer

219

1434

1.53

8.24

1.3

334.11

369.40

pmol/l

0.19

180

1197

Diseases of the myoneural junction and muscle

119

672

1.79

8.18

1.3

321.03

297.20

pmol/l

0.29

566

Malignant neoplasm of thyroid gland, including Hilmo

397

2.04

8.16

1.5

1.3

319.26

341.99

pmol/l

0.34

347

Polyarthrosis

202

1173

1.56

8.16

1.3

287.46

295.37

pmol/l

0.15

181

993

Disease of hard tissues of teeth, NOS

491

1920

1.34

8.15

1.4

1.3

322.15

347.01

pmol/l

0.18

419

1637

Chronic sinusitis

391

2863

1.37

8.13

1.3

1.4

880.07

335.08

pmol/l

0.85

337

2470

DVT of lower extremities and pulmonary embolism

362

2610

1.39

8.12

1.4

1.3

341.88

340.03

pmol/l

0.01

308

2189

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

154

906

1.66

8.11

1.3

1.4

399.43

366.54

pmol/l

0.27

132

783

Transport accidents

431

2661

1.35

8.09

1.3

1.4

329.63

376.82

pmol/l

0.37

373

2319

Nephrotic syndrome

125

2.94

8.06

1.3

516.85

339.90

pmol/l

0.82

112

Ovarian dysfunction

299

2.20

8.06

1.5

1.3

517.25

413.23

pmol/l

0.64

264

Haemorrhoids and perianal venous thrombosis

290

2012

1.44

8.00

1.3

1.4

338.79

299.29

pmol/l

1.07

249

1723

Other congenital malformations, including avohilmo

120

684

1.77

7.98

1.6

1.4

370.57

356.36

pmol/l

0.13

109

593

Enlarged lymph nodes

138

818

1.70

7.97

1.4

1010.74

334.23

pmol/l

0.46

120

702

Thyrotoxicosis

238

1604

1.49

7.96

1.3

315.55

347.46

pmol/l

0.47

206

1377

Other shoulder lesions

519

1.89

7.95

1.4

314.73

332.64

pmol/l

0.17

457

Other cataract

394

2144

1.37

7.94

1.3

578.06

349.49

pmol/l

0.38

322

1839

Diplopia

127

739

1.73

7.88

1.4

1.3

342.99

302.63

pmol/l

0.60

106

624

Umbilical hernia

247

1681

1.48

7.87

1.2

1.4

335.84

331.06

pmol/l

0.05

202

1416

Injuries to the head

1038

5076

1.22

7.86

1.4

423.70

351.37

pmol/l

0.32

880

4390

Fungal Sepsis

178

2.57

7.86

1.4

1.3

336.16

321.87

pmol/l

0.08

152

Other arthrosis

480

2424

1.33

7.86

1.3

1.4

319.23

310.78

pmol/l

0.08

420

2066

Other diseases of stomach and duodenum

316

2.15

7.84

1.3

235.02

309.03

pmol/l

1.14

274

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

161

970

1.62

7.78

1.3

1.4

390.66

360.62

pmol/l

0.26

139

840

Disorders of refraction and accommodation

265

1825

1.45

7.77

1.4

355.40

490.63

pmol/l

0.96

220

1581

Retention of urine

278

1559

1.45

7.77

1.4

1.3

275.92

352.55

pmol/l

0.56

232

1266

Disorders of ocular muscles, binocular movement, accommodation and refraction

438

3265

1.33

7.72

1.4

351.80

418.68

pmol/l

0.71

363

2818

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

841

5316

1.23

7.71

1.4

554.02

331.68

pmol/l

0.72

727

4581

Astigmatism

305

2.15

7.68

1.4

1.5

351.43

366.39

pmol/l

0.12

261

Diseases of pulp and periapical tissues and dental caries

563

2218

1.31

7.67

1.4

1.3

294.59

321.68

pmol/l

0.74

466

1911

Later onset COPD, excluding more controls

180

870

1.59

7.65

1.2

1.3

402.63

252.42

pmol/l

0.43

138

726

Caries of dentine, including avohilmo

685

2763

1.27

7.57

1.4

1.3

308.78

321.45

pmol/l

0.30

566

2391

Acute pharyngitis

139

829

1.67

7.57

1.5

1.4

311.44

340.70

pmol/l

0.55

124

719

Sequelae of injuries, of poisoning and of other consequences of external causes

218

1459

1.50

7.57

1.4

763.50

333.66

pmol/l

0.44

184

1246

Complications of internal orthopaedic prosthetic devices, implants and grafts

206

1363

1.52

7.56

1.4

1.3

271.81

305.62

pmol/l

0.66

175

1149

Excessive vomiting in pregnancy

388

2.01

7.55

1.6

1.4

374.06

375.76

pmol/l

0.01

339

COPD, hospital admission 2, with asthma infections

265

1581

1.45

7.53

1.2

1.3

230.03

349.84

pmol/l

1.12

205

1315

N06DA Anticholinesterases

121

1565

0.59

7.51

1.1

1.3

238.93

269.70

pmol/l

0.72

1292

Use of anticholinesterases

121

1565

0.59

7.51

1.1

1.3

238.93

269.70

pmol/l

0.72

1292

Viral pneumonia

122

712

1.73

7.51

1.3

363.25

313.50

pmol/l

0.61

102

603

Hypercalcemia

213

2.39

7.49

1.4

1.3

2302.01

305.19

pmol/l

0.49

187

Dermatographic urticaria

336

2.08

7.44

1.4

1784.03

350.60

pmol/l

0.49

299

Other disorders of eye and adnexa

137

827

1.67

7.44

1.5

1.3

358.35

365.22

pmol/l

0.05

124

720

Fenamates

127

502

1.73

7.43

1.3

1.4

346.00

392.79

pmol/l

0.28

107

429

Calculus of kidney and ureter

257

1785

1.45

7.39

1.5

1.3

308.99

374.90

pmol/l

0.53

220

1488

Benign neoplasm: Kidney

160

2.61

7.39

1.5

1.4

236.15

325.21

pmol/l

1.41

139

Other pleural conditions

489

1.88

7.39

1.2

1.4

388.10

292.74

pmol/l

0.33

399

Benign neoplasm: Cerebral meninges

518

1.85

7.39

1.5

1.3

336.87

305.19

pmol/l

0.39

442

Tinnitus

222

1500

1.49

7.38

1.4

1.3

270.95

390.57

pmol/l

1.01

193

1276

Implicit fungal Sepsis

166

2.57

7.37

1.4

1.3

346.73

336.72

pmol/l

0.05

141

Persistent mood disorders

173

1108

1.57

7.37

1.5

1.3

366.17

429.19

pmol/l

0.28

149

953

Cluster headache, strict, including avohilmo

240

2.28

7.34

1.4

340.09

386.16

pmol/l

0.38

208

Benign neoplasm: Caecum

106

599

1.79

7.33

1.3

318.91

297.10

pmol/l

0.22

504

Other and unspecified injuries of lower leg

379

2.00

7.31

1.5

1.4

333.78

336.41

pmol/l

0.02

336

Other diseases of pericardium

203

2.40

7.30

1.2

1.3

327.15

296.06

pmol/l

0.19

169

Mental disorders, not otherwise specified

428

1.94

7.29

1.3

1.4

349.94

337.58

pmol/l

0.13

374

Other enthesopathies

268

1881

1.43

7.27

1.3

1.4

743.81

320.20

pmol/l

0.58

231

1626

Acute pancreatitis

172

1104

1.57

7.27

1.3

304.71

413.63

pmol/l

0.55

146

923

Algoneurodystrophy

162

2.58

7.22

1.2

1.4

300.88

408.40

pmol/l

1.23

140

conjunctival haemorrhage

402

1.96

7.21

1.4

1.3

351.35

309.63

pmol/l

0.37

345

Idiopathic gout

472

1.88

7.21

1.2

1.4

338.98

281.95

pmol/l

0.64

385

Other and unspecified disorders of white blood cells

180

2.49

7.20

1.4

441.06

337.64

pmol/l

0.66

155

IgA nephropathy (IgA glomerulonephritis)

106

2.99

7.18

1.3

1.4

337.20

390.41

pmol/l

0.26

Other inflammation of eyelid

137

836

1.65

7.16

1.4

1.3

273.76

338.06

pmol/l

1.03

119

719

Dystonia

282

2.16

7.13

1.3

1.4

277.80

337.09

pmol/l

1.13

245

Melanocytic naevi

288

2057

1.41

7.11

1.5

1.4

346.00

468.24

pmol/l

0.97

254

1752

Dislocation, sprain and strain of joints and ligaments of knee

566

4023

1.28

7.09

1.3

1.4

305.87

392.61

pmol/l

1.58

502

3499

Coxarthrosis [arthrosis of hip](FG)

474

2494

1.31

7.09

1.3

288.11

301.47

pmol/l

0.34

419

2103

Symptoms and signs involving speech and voice

303

2185

1.39

7.07

1.3

304.90

338.63

pmol/l

0.69

256

1857

Heartburn

105

598

1.77

7.07

1.2

1.4

310.01

351.92

pmol/l

0.57

519

Other inflammation of eyelid, including avohilmo

408

3082

1.33

7.04

1.4

312.97

425.78

pmol/l

1.59

355

2671

Hypermobility syndrome

251

2.22

7.03

1.6

1.4

347.90

378.63

pmol/l

0.24

224

Other complications of surgical and medical care, not elsewhere classified

520

1.82

6.99

1.4

1.3

357.58

394.30

pmol/l

0.22

453

Other bacterial intestinal infections

159

1012

1.58

6.99

1.4

1.3

433.69

331.45

pmol/l

0.62

133

856

Migraine, single triptan purchase ok & required. ICD-code if available is included

711

3881

1.24

6.93

1.4

511.45

363.63

pmol/l

0.51

636

3365

Triptan medication for migraine, single purchase ok

711

3881

1.24

6.93

1.4

511.45

363.63

pmol/l

0.51

636

3365

Ptosis of eyelid

107

617

1.75

6.92

1.6

1.3

301.05

296.54

pmol/l

0.05

529

Mental and behavioural disorders due to sedatives or hypnotics

339

2.03

6.92

1.2

1.5

290.84

339.33

pmol/l

0.56

288

AV-block

141

742

1.63

6.91

1.2

1.3

305.18

268.12

pmol/l

0.60

124

604

Other diseases of biliary tract

436

1.90

6.91

1.2

1.3

306.17

298.33

pmol/l

0.04

368

Sulfonylureas

246

1357

1.45

6.88

1.2

1.3

275.54

287.77

pmol/l

0.15

195

1118

Dissociative [conversion] disorders

166

2.51

6.87

1.2

1.4

564.50

367.59

pmol/l

0.75

147

Postprocedural musculoskeletal disorders, not elsewhere classified

361

1.99

6.84

1.2

1.3

299.28

310.98

pmol/l

0.13

309

Other and unspecified urticaria

179

1176

1.53

6.84

1.3

1.4

346.02

357.12

pmol/l

0.12

157

1019

Benign neoplasm of urinary organs

222

2.29

6.83

1.4

234.74

309.81

pmol/l

1.45

190

Other diseases of hard tissues of teeth

488

1938

1.31

6.83

1.3

314.03

353.07

pmol/l

0.31

411

1653

Misadventures to patients during surgical and medical care

133

816

1.64

6.83

1.3

325.55

336.87

pmol/l

0.09

113

697

Alcohol use disorder, ICD-based

352

2616

1.35

6.81

1.3

1.4

307.68

353.82

pmol/l

0.51

284

2236

Rosacea

121

726

1.68

6.78

1.4

1.3

330.26

354.72

pmol/l

0.23

104

632

Other diseases of lip and oral mucosa

394

2980

1.33

6.78

1.4

1.3

338.36

400.90

pmol/l

0.63

337

2563

Viral hepatitis, IBD co-morbidity

155

2.54

6.76

1.4

1.5

307.19

383.21

pmol/l

0.58

140

Charcot foot

3.57

6.76

1.4

1.3

157.00

346.71

pmol/l

2.90

Injury, poisoning and certain other consequences of external causes

465

1777

1.32

6.75

1.4

361.04

319.60

pmol/l

0.72

395

1548

Disorders of continuity of bone

548

1.79

6.74

1.3

1314.71

376.20

pmol/l

0.45

476

Cardiomyopathy

139

865

1.62

6.71

1.2

1.4

325.94

437.30

pmol/l

0.41

117

717

Acetic acid derivatives and related substances

213

735

1.50

6.70

1.3

1.4

321.73

364.43

pmol/l

0.43

181

624

Internal derangement of knee

333

2435

1.36

6.70

1.3

1.4

302.59

323.34

pmol/l

0.50

288

2082

Female infertility, associated with anovulation

330

2.02

6.65

1.6

1.5

2171.91

406.24

pmol/l

0.60

302

Other and/or unspecified nontoxic goitre

464

1.85

6.64

1.3

589.22

310.87

pmol/l

0.45

396

Other diseases of intestine

142

893

1.60

6.60

1.2

1.3

274.69

317.18

pmol/l

0.98

120

756

Spontaneous rupture of synovium and tendon

436

1.88

6.60

1.3

588.31

299.38

pmol/l

0.42

385

Other peripheral vertigo

501

1.81

6.59

1.4

1.3

263.90

309.63

pmol/l

0.94

430

Other diseases of the respiratory system

168

1099

1.54

6.57

1.3

324.68

325.30

pmol/l

0.01

143

908

Other respiratory disorders and diseases

168

1099

1.54

6.57

1.3

324.68

325.30

pmol/l

0.01

143

908

Other and unspecified rosacea

488

1.82

6.53

1.3

1.4

306.89

325.07

pmol/l

0.27

425

Dental operations

524

2099

1.29

6.53

1.4

1.3

296.55

418.59

pmol/l

1.04

445

1791

Budesonide

130

804

1.63

6.48

1.4

311.38

324.50

pmol/l

0.18

114

688

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

505

3800

1.28

6.47

1.4

321.76

347.18

pmol/l

0.69

438

3303

Other diseases of the digestive system

258

1840

1.41

6.46

1.3

337.01

363.60

pmol/l

0.16

215

1532

Type 1 diabetes, strict definition

354

1.96

6.44

1.4

1.5

342.63

397.20

pmol/l

0.43

316

Unspecified fall

449

3417

1.29

6.42

1.3

523.92

364.77

pmol/l

0.30

370

2920

Reimbursement for rheumatic diseases

511

4004

1.27

6.40

1.3

1.4

533.43

351.46

pmol/l

0.44

449

3434

Artrosis, including avohilmo

725

3223

1.23

6.40

1.4

478.71

336.64

pmol/l

0.51

633

2764

Unspecific neurodegenerative disorder

179

1818

0.67

6.40

1.1

1.3

241.21

271.01

pmol/l

1.06

141

1499

KRA_PSY_EATING, excluding more controls

318

2.01

6.39

1.5

1.4

512.69

750.10

pmol/l

0.34

281

Diseases of peritoneum

528

1.78

6.39

1.3

342.48

310.46

pmol/l

0.42

449

Papillary adenocarcinoma of thyroid gland

275

2.10

6.38

1.5

1.3

302.66

361.72

pmol/l

0.91

241

COPD-related respiratory insufficiency

573

1.74

6.35

1.2

1.3

262.99

283.53

pmol/l

0.23

480

Injuries to the shoulder and upper arm

779

4947

1.22

6.35

1.3

1.4

293.91

364.16

pmol/l

1.49

670

4250

GI-bleeding

256

1829

1.41

6.35

1.3

344.30

363.76

pmol/l

0.11

213

1524

Other disorders of conjunctiva

129

801

1.62

6.35

1.5

1.3

339.56

334.10

pmol/l

0.04

109

675

Disorders of sclera, cornea, iris and ciliary body

490

3850

1.28

6.34

1.4

312.04

385.29

pmol/l

1.12

422

3298

Arthropathies in other diseases classified elsewhere

167

2.43

6.31

1.4

1.3

250.87

346.85

pmol/l

1.03

140

Vascular diseases of the intestine

149

2.52

6.29

1.1

1.3

300.18

299.12

pmol/l

0.00

128

Superficial injury of lower leg

234

1650

1.43

6.28

1.5

1.4

314.53

476.57

pmol/l

1.07

201

1420

Myeloproliferative diseases

415

1.87

6.28

1.2

1.4

279.95

316.23

pmol/l

0.57

355

Other disorders of nervous system

338

1.98

6.27

1.5

1.4

316.36

319.03

pmol/l

0.02

289

Diseases of oral cavity, salivary glands and jaws

485

1939

1.29

6.25

1.3

298.04

352.92

pmol/l

0.50

408

1654

Fracture of lower leg, including ankle

494

3820

1.27

6.24

1.3

1.4

315.93

377.69

pmol/l

0.77

402

3309

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

244

1079

1.43

6.23

1.5

491.83

520.99

pmol/l

0.09

213

966

Trigeminal neuralgia

291

2.05

6.22

1.3

348.90

335.79

pmol/l

0.11

256

Anaemia in chronic diseases classified elsewhere

2.96

6.20

1.2

1.3

296.10

318.19

pmol/l

0.12

Bipolar affective disorders

161

1058

1.53

6.19

1.3

1.4

492.40

570.87

pmol/l

0.22

141

933

Other local infections of skin and subcutaneous tissue

541

1.75

6.17

1.2

1.3

343.99

327.91

pmol/l

0.11

464

Voice disturbances

242

1723

1.41

6.17

1.4

1.3

304.22

334.44

pmol/l

0.52

206

1470

Type 1 diabetes, strict definition, subgroup 1

332

1.97

6.17

1.4

1.5

353.00

395.49

pmol/l

0.29

295

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

341

2531

1.33

6.13

1.4

314.84

456.18

pmol/l

1.70

282

2206

Open wound of forearm

476

1.80

6.12

1.3

1.4

289.40

327.28

pmol/l

0.60

393

Other bacterial intestinal infections, including avohilmo

202

1394

1.46

6.11

1.4

1.3

390.43

339.24

pmol/l

0.35

174

1186

Perforation of tympanic membrane

506

1.77

6.10

1.3

303.88

321.01

pmol/l

0.21

428

Periapical abscess

422

3273

1.29

6.09

1.4

278.72

395.01

pmol/l

1.83

345

2805

Cholangitis (primary sclerosing, PSC)

280

2.06

6.08

1.2

1.4

352.42

313.51

pmol/l

0.16

242

Benign lipomatous neoplasm

263

1905

1.39

6.06

1.4

1.3

383.01

370.97

pmol/l

0.04

240

1605

Conjunctivitis (acute, non atopic), including avohilmo

925

4680

1.20

6.04

1.3

1.4

580.04

321.10

pmol/l

1.00

801

4026

Unspecified mental disorder

346

2614

1.33

6.04

1.3

1.4

405.24

425.52

pmol/l

0.12

277

2248

Postmenopausal osteoporosis with pathological fracture

357

1.93

6.03

1.2

233.25

283.96

pmol/l

1.05

303

Gestational diabetes (for exclusion)

294

1479

1.37

6.03

1.4

1.5

666.51

447.58

pmol/l

0.28

258

1320

Ocular pain

457

1.81

6.02

1.5

1.3

381.52

342.35

pmol/l

0.42

397

Coxarthrosis

437

2182

1.30

6.02

1.3

288.50

294.24

pmol/l

0.15

385

1838

Adenomyosis (Endometriosis of uterus)

120

743

1.62

5.95

1.4

1.3

335.99

312.55

pmol/l

0.33

103

648

Hypertrophic cardiomyopathy

178

2.34

5.95

1.2

1.3

292.00

312.25

pmol/l

0.16

160

Other gastritis (incl. Duodenitis)

193

1328

1.46

5.95

1.2

1.3

428.45

376.24

pmol/l

0.12

154

1112

Fissure and fistula of anal and rectal regions

202

1402

1.45

5.94

1.4

374.43

319.04

pmol/l

0.44

183

1195

Diabetic retinopathy, excluding more controls

296

1210

1.38

5.94

1.3

282.01

308.20

pmol/l

0.55

239

1038

Seropositive rheumatoid arthritis

210

1460

1.44

5.93

1.3

326.94

322.33

pmol/l

0.06

183

1241

Endometriosis

276

1160

1.39

5.91

1.4

400.46

332.34

pmol/l

0.49

243

1024

Traumatic subarachnoid haemorrhage

124

2.61

5.90

1.1

1.3

281.66

267.47

pmol/l

0.12

105

Emotional disorders and disorders of social functioning with onset specific to childhood

193

2.25

5.89

1.6

1.5

695.76

434.10

pmol/l

1.14

172

171

1072

1.50

5.88

1.2

260.99

269.23

pmol/l

0.19

139

887

Fibroblastic disorders

189

1298

1.46

5.88

1.2

1.4

272.24

306.59

pmol/l

0.82

163

1097

Poisoning by drugs, medicaments and biological substances

206

1439

1.44

5.86

1.4

362.51

439.18

pmol/l

0.45

169

1259

Other and unspecified local infections of skin and subcutaneous tissue

505

1.76

5.86

1.2

1.3

344.38

334.80

pmol/l

0.06

428

Other and unspecified visual disturbances

580

1.70

5.85

1.4

1.3

282.04

302.82

pmol/l

0.38

495

Other/unspecified enthesopathies of lower limb, excluding foot

354

1.91

5.83

1.3

257.72

330.13

pmol/l

1.24

311

Diseases of appendix

665

4873

1.22

5.82

1.4

347.48

367.91

pmol/l

0.16

580

4196

Hyperkinetic disorders

115

692

1.63

5.80

1.6

1.5

397.62

566.10

pmol/l

0.57

608

Other obstetric conditions, not elsewhere classified

248

1118

1.40

5.78

1.5

495.90

518.17

pmol/l

0.07

216

1003

Appendicitis, broad definition

659

4846

1.22

5.78

1.4

348.21

368.72

pmol/l

0.16

575

4174

Malnutrition

2.96

5.77

1.2

1.3

1468.00

287.22

pmol/l

0.50

Chronic laryngitis and laryngotracheitis

127

806

1.59

5.75

1.3

291.42

350.95

pmol/l

0.65

100

677

Other and unspecified diseases of blood and blood-forming organs

126

2.59

5.75

1.6

1.3

376.67

294.19

pmol/l

0.45

111

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

524

1.73

5.71

1.4

1.3

404.91

312.54

pmol/l

0.46

447

Temporomandibular joint disorders, including avohilmo

398

2992

1.29

5.70

1.5

1.4

409.43

429.86

pmol/l

0.10

341

2617

Trigger finger

133

855

1.57

5.70

1.2

1.3

263.26

323.13

pmol/l

1.94

111

736

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

581

1.69

5.68

1.4

507.92

362.32

pmol/l

1.39

508

Disturbance of activity and attention

108

644

1.65

5.68

1.6

1.5

410.15

569.39

pmol/l

0.48

566

Sequelae of other external causes

281

2.02

5.67

1.2

1.4

721.88

324.79

pmol/l

0.42

239

Acute appendicitis, no complications

485

3839

1.26

5.65

1.4

374.36

391.27

pmol/l

0.10

426

3315

Oter anti-inflammatory and antirheumatic agents, non-steroids

168

612

1.51

5.63

1.3

271.03

343.16

pmol/l

0.83

142

518

Acute pancreatitis (for exclusion)

172

1171

1.48

5.63

1.3

304.71

414.23

pmol/l

0.60

146

978

Fracture of foot, except ankle

221

1576

1.41

5.62

1.4

304.12

492.24

pmol/l

1.29

171

1364

L04AC Interleukin inhibitors

352

1.90

5.61

1.5

1.4

297.15

336.31

pmol/l

0.31

303

Lesion of ulnar nerve

122

772

1.59

5.60

1.3

280.50

444.17

pmol/l

0.65

658

Gastric ulcer

145

955

1.53

5.57

1.2

1.3

317.69

284.80

pmol/l

0.48

116

792

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

248

1806

1.38

5.57

1.4

1.5

360.82

502.54

pmol/l

0.96

205

1569

Viral infections of the central nervous system

360

1.88

5.56

1.4

1.3

1810.28

368.45

pmol/l

0.46

311

D07AA Corticosteroids, weak (group I)

129

827

1.57

5.56

1.2

1.4

362.18

357.56

pmol/l

0.04

115

715

Volvulus

2.77

5.55

1.4

318.95

323.14

pmol/l

0.02

Postprocedural disorders of nervous system

368

1.87

5.52

1.5

1.4

341.84

370.13

pmol/l

0.26

325

Sarcoidosis

119

752

1.59

5.51

1.3

398.10

345.08

pmol/l

0.20

644

Viral infections of the central nervous system, including avohilmo

397

1.83

5.51

1.4

1.3

1684.10

358.13

pmol/l

0.46

342

Other and unspecified disorders of vitreous body

388

2951

1.29

5.51

1.4

1.3

263.24

336.00

pmol/l

1.30

336

2527

Pain associated with micturition

106

652

1.64

5.48

1.4

1.3

371.67

331.65

pmol/l

0.45

557

Acute appendicitis

617

4692

1.22

5.47

1.4

354.43

371.41

pmol/l

0.12

540

4039

Impingement syndrome of shoulder

201

1417

1.43

5.47

1.4

310.06

308.62

pmol/l

0.02

169

1212

Mycoses

247

1804

1.38

5.46

1.4

1.3

771.24

388.70

pmol/l

0.43

210

1532

Dislocation, sprain and strain of joints and ligaments at neck level

132

856

1.55

5.46

1.4

438.35

464.89

pmol/l

0.05

111

742

COPD, hospital admissions 1, only main diagnosis

268

1698

1.36

5.46

1.2

1.3

337.71

347.64

pmol/l

0.03

208

1411

Conductive and sensorineural hearing loss

691

3787

1.21

5.44

1.3

1.4

296.41

340.24

pmol/l

0.72

582

3256

Obsessive-compulsive disorder

306

1.94

5.43

1.7

1.5

477.80

364.97

pmol/l

0.60

268

Methotrexate

123

787

1.57

5.40

1.4

1.3

1147.17

313.04

pmol/l

0.51

109

670

Emotional disorders starting during childhood or adolecense, excluding more controls

161

2.31

5.40

1.6

1.4

700.00

411.85

pmol/l

1.16

145

Fracture of lumbar spine and pelvis

187

1301

1.44

5.40

1.2

1.3

266.28

310.59

pmol/l

0.96

152

1082

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

232

2.10

5.40

1.3

262.17

309.27

pmol/l

0.56

196

Poisoning by medicine

183

1272

1.45

5.39

1.4

370.83

451.56

pmol/l

0.41

151

1119

Allergic conjunctivitis

522

4054

1.24

5.39

1.4

321.32

396.90

pmol/l

1.23

452

3532

Melanocytic naevi, other sites/unspecified

437

1.78

5.37

1.7

1.3

304.49

329.10

pmol/l

0.34

376

Liquid cancers

240

1654

1.38

5.36

1.3

317.44

357.13

pmol/l

0.25

204

1371

Other disorders of the musculoskeletal system and connective tissue

132

861

1.54

5.34

1.2

1.3

294.97

336.27

pmol/l

0.54

117

732

Second line medication for Crohn's disease

514

4146

1.24

5.33

1.4

335.86

384.11

pmol/l

0.65

446

3579

Bacterial intestinal infections, IBD co-morbidities

154

1038

1.49

5.32

1.4

1.3

439.41

333.60

pmol/l

0.62

129

877

Decubitus ulcer and pressure area

274

1.99

5.32

1.1

1.3

267.09

294.94

pmol/l

0.21

233

Hypertrophy of breast in women and men

173

1194

1.46

5.31

1.4

322.70

368.73

pmol/l

0.67

143

1044

Other female pelvic inflammatory diseases

143

951

1.51

5.29

1.4

1.3

535.55

323.25

pmol/l

0.61

127

827

Bruxism

2.88

5.29

1.3

355.37

398.49

pmol/l

0.23

Otalgia

439

1.77

5.28

1.3

1.4

277.11

351.77

pmol/l

0.96

376

Dental caries, including avohilmo

616

2571

1.23

5.28

1.4

1.3

303.57

321.71

pmol/l

0.48

514

2221

Inflammatory disease of uterus

124

800

1.56

5.27

1.6

1.4

328.46

415.21

pmol/l

1.07

107

702

Liquid cancers, including Hilmo

294

1951

1.33

5.25

1.3

318.99

348.55

pmol/l

0.22

252

1627

Emotionally unstable personality disorder

101

621

1.64

5.25

1.3

1.4

420.34

531.84

pmol/l

0.28

543

Other noninflammatory disorders of uterus, except cervix

187

866

1.45

5.23

1.3

347.80

288.79

pmol/l

1.40

162

762

Social phobias

418

1.78

5.23

1.5

1.4

378.24

362.75

pmol/l

0.12

371

Hyperplasia of prostate

262

1080

1.37

5.23

1.4

1.3

276.31

378.21

pmol/l

0.51

214

882

Other postsurgical states

332

1.89

5.22

1.3

501.07

354.09

pmol/l

0.35

286

Injuries to the neck

199

1415

1.41

5.19

1.3

1.4

898.85

422.41

pmol/l

0.43

166

1209

Benign neoplasm: Stomach

532

1.69

5.18

1.2

1.3

276.32

303.61

pmol/l

0.51

452

Enterocolitis due to Clostridium difficile

540

1.68

5.15

1.4

1.3

338.65

325.54

pmol/l

0.10

454

COPD, hospital admissions 3, with asthma pneumonia sepsis

204

1246

1.41

5.13

1.2

1.3

231.16

287.50

pmol/l

2.28

153

1031

Localized swelling, mass and lump of skin and subcutaneous tissue

280

2108

1.33

5.11

1.4

1.3

317.66

392.60

pmol/l

0.75

250

1775

Infective dermatitis

100

618

1.63

5.11

1.2

1.3

328.60

354.06

pmol/l

0.17

525

Sensorineural hearing loss

651

3587

1.21

5.10

1.3

299.10

335.32

pmol/l

0.52

547

3080

Biological medication for rheuma

155

1056

1.48

5.10

1.5

1.4

307.59

357.59

pmol/l

0.69

140

921

Atopic dermatitis

518

3342

1.24

5.07

1.4

534.70

389.45

pmol/l

0.33

447

2894

Benign neoplasm: Rectum, anus and anal canal

174

1215

1.44

5.04

1.3

255.02

313.60

pmol/l

1.29

149

1013

Unspecified misadventure during surgical and medical care

273

1.96

5.03

1.3

1.4

360.38

335.30

pmol/l

0.17

235

Melanocytic naevi of trunk

108

683

1.59

5.03

1.4

345.13

315.73

pmol/l

0.52

582

L04AX Other immunosuppressants

496

4016

1.24

5.02

1.4

333.49

386.68

pmol/l

0.71

429

3462

Sequelae of injuries of neck and trunk

135

2.41

5.01

1.6

1.4

289.30

350.85

pmol/l

0.54

117

Vitreous haemorrhage

545

1.66

4.99

1.3

302.87

312.51

pmol/l

0.06

464

Degeneration of macula and posterior pole

393

2385

1.28

4.99

1.3

293.74

336.08

pmol/l

0.43

329

2004

Other necrotizing vasculopathies (FG)

260

1.98

4.98

1.2

1.3

496.90

317.79

pmol/l

0.94

213

Any prescribed medicine buy

+∞

4.98

1.3

0.0

157.17

—

pmol/l

—

Type1 diabetes, definitions combined, early onset

315

1.88

4.97

1.5

352.78

381.13

pmol/l

0.16

272

Other benign neoplasms of skin

317

2440

1.30

4.95

1.3

319.69

374.59

pmol/l

0.58

278

2062

Arterial embolism and thrombosis

213

2.08

4.94

1.3

321.49

308.62

pmol/l

0.05

179

Calcific aortic valvular stenosis

216

1511

1.38

4.93

1.2

1.3

243.60

278.44

pmol/l

1.04

185

1230

Calcific aortic valvular stenosis, operated

216

1511

1.38

4.93

1.2

1.3

243.60

278.44

pmol/l

1.04

185

1230

Benign neoplasm: Rectum

157

1082

1.46

4.90

1.3

263.02

321.57

pmol/l

1.10

133

903

Other and unspecified myopathies

428

1.74

4.87

1.2

1.3

298.51

305.32

pmol/l

0.08

361

Benign neoplasm: Descending colon

370

1.80

4.84

1.2

1.3

335.72

294.02

pmol/l

0.31

317

Osteomyelitis

284

1.92

4.83

1.1

1.4

261.56

330.52

pmol/l

0.74

236

Retinal vascular disorders

612

1.61

4.82

1.4

1.3

292.49

288.41

pmol/l

0.04

506

Use of donepezil

1000

0.56

4.81

1.0

1.2

193.85

263.89

pmol/l

1.46

816

Chronic hepatitis, not elsewhere classified

163

2.24

4.81

1.3

1.4

283.77

340.49

pmol/l

0.64

147

Use of pramipexole

187

1336

1.41

4.79

1.4

1.3

381.07

325.16

pmol/l

0.67

156

1124

227

1435

1.36

4.75

1.2

1.3

298.17

290.91

pmol/l

0.09

189

1184

Impotence

265

1.94

4.74

1.5

1.3

284.40

291.56

pmol/l

0.05

219

Alzheimer disease, including avohilmo

149

1488

0.69

4.73

1.1

1.3

232.12

273.27

pmol/l

1.74

115

1222

Artificial joint re-operation

373

1.79

4.73

1.3

305.17

293.91

pmol/l

0.13

315

Parkinson's disease, excluding more controls

543

1.62

4.71

1.1

1.4

240.63

292.80

pmol/l

1.08

458

Other abnormal uterine and vaginal bleeding

187

955

1.41

4.70

1.3

371.85

313.29

pmol/l

1.19

159

841

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

191

2.12

4.69

1.3

1.5

192.89

398.92

pmol/l

5.41

170

Other specified/unspecified soft tissue disorders

211

2.06

4.69

1.3

247.32

348.57

pmol/l

1.63

188

Invasive ventilation

345

1.81

4.67

1.5

1.3

2127.98

309.16

pmol/l

0.51

289

Benign neoplasm: Transverse colon

602

1.61

4.67

1.3

338.14

296.23

pmol/l

0.33

509

Operations 2 for CAVS

214

1510

1.37

4.66

1.2

1.3

239.23

278.31

pmol/l

1.25

183

1229

Calcific aortic valvular stenosis, diagnosis (helper)

214

1510

1.37

4.66

1.2

1.3

239.23

278.31

pmol/l

1.25

183

1229

Traumatic subdural haemorrhage

525

1.63

4.66

1.3

1.4

278.51

272.61

pmol/l

0.06

436

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

254

1914

1.33

4.65

1.4

304.07

463.06

pmol/l

1.36

219

1651

Alzheimer disease

121

1292

0.67

4.64

1.1

1.3

232.02

272.82

pmol/l

1.43

1055

Injuries to the wrist and hand

910

5180

1.17

4.63

1.4

338.36

365.50

pmol/l

0.28

774

4474

Achilles tendinitis

580

1.62

4.62

1.2

1.3

426.42

534.13

pmol/l

0.20

498

All influenza (not pneumonia)

122

810

1.51

4.60

1.3

1.4

326.15

299.39

pmol/l

0.27

103

693

Glaucoma

470

3244

1.23

4.57

1.3

297.43

328.60

pmol/l

0.40

407

2743

Open wound of lower leg

129

868

1.49

4.57

1.4

1.3

331.36

319.98

pmol/l

0.13

111

739

Brain meningioma

262

1.93

4.56

1.5

1.4

315.60

326.48

pmol/l

0.08

233

Intestinal adhesions without obstruction

407

1.73

4.55

1.4

250.83

305.11

pmol/l

0.78

345

Calcific aortic valvular stenosis, including rheumatic fever

214

1515

1.36

4.54

1.2

1.3

239.23

277.95

pmol/l

1.23

183

1234

Spasmodic torticollis

161

2.21

4.52

1.3

1.4

300.30

335.75

pmol/l

0.37

139

Schizophrenia or delusion, excluding more controls

237

1753

1.34

4.52

1.3

1.4

389.93

456.27

pmol/l

0.32

182

1505

Alzheimer’s disease, strict definition

1075

0.62

4.51

1.1

1.2

216.73

266.55

pmol/l

1.70

868

Speech therapy

221

1640

1.35

4.51

1.3

318.79

326.54

pmol/l

0.11

200

1375

Other/unspecified soft tissue disorders related to use, overuse and pressure

142

2.29

4.50

1.1

1.3

347.81

346.56

pmol/l

0.01

127

Retinal vascular occlusion

608

1.59

4.49

1.4

1.3

289.86

288.48

pmol/l

0.01

502

Rheumatoid arthritis

266

1793

1.32

4.47

1.3

1.4

341.16

314.86

pmol/l

0.50

233

1513

Benign neoplasm of middle ear and respiratory system

387

1.75

4.47

1.4

250.45

340.24

pmol/l

1.43

330

Brain meningioma, including Hilmo

271

1.90

4.47

1.5

1.4

313.88

325.73

pmol/l

0.09

238

Other necrotizing vasculopathies

343

1.79

4.46

1.2

1.3

461.22

296.76

pmol/l

1.13

294

Radial styloid tenosynovitis [de Quervain]

300

1.85

4.44

1.3

281.76

352.07

pmol/l

0.99

273

Other disorders starting during childhood or adolecense, excluding more controls

173

2.11

4.42

1.4

257.65

445.15

pmol/l

1.84

156

Polycystic ovarian syndrome

223

1.99

4.41

1.6

1.3

563.97

449.88

pmol/l

0.55

195

Tonsillectomy and adenotomy

475

2693

1.23

4.40

1.5

1.4

767.70

379.07

pmol/l

0.71

414

2360

Sequelae of injuries of upper limb

541

1.62

4.40

1.3

246.56

318.00

pmol/l

1.96

466

Zoster [herpes zoster], including avohilmo

449

3527

1.23

4.39

1.4

1.3

298.07

318.97

pmol/l

0.59

389

2996

Abdominal aortic aneurysm (AAA)

334

1.79

4.39

1.3

206.60

268.44

pmol/l

1.71

272

Hypertrophy of breast

151

1057

1.44

4.38

1.4

325.49

377.21

pmol/l

0.69

124

930

Hemiplegia

210

2.02

4.37

1.2

1.4

278.00

350.93

pmol/l

1.02

184

Impetigo

197

2.05

4.34

1.4

373.74

438.71

pmol/l

0.29

172

Flat foot [pes planus] (acquired)

543

1.61

4.34

1.6

1.3

303.41

322.19

pmol/l

0.19

463

Other disorders of optic [2nd] nerve and visual pathways

288

1.86

4.33

1.4

256.84

334.36

pmol/l

1.27

247

Vasomotor and allergic rhinitis

316

2423

1.28

4.29

1.3

1.4

337.31

357.61

pmol/l

0.37

268

2093

Disorders of breast

433

3096

1.23

4.28

1.4

367.33

381.74

pmol/l

0.08

383

2720

Herpesviral [herpes simplex] infections

632

1.56

4.26

1.3

333.45

329.44

pmol/l

0.04

543

Allergic urticaria

438

1.68

4.26

1.4

276.26

337.63

pmol/l

1.33

381

Thyrotoxicosis with toxic multinodular goitre

319

1.81

4.26

1.3

329.69

315.45

pmol/l

0.10

268

Mixed and other personality disorders

416

1.70

4.23

1.4

392.16

342.91

pmol/l

0.50

362

Other diseases of arteries and capillaries

432

1.68

4.20

1.2

1.4

271.52

321.19

pmol/l

0.66

375

Neuralgia and neuritis, unspecified

256

1.89

4.17

1.3

345.07

328.08

pmol/l

0.12

226

Papulosquamous disorders

338

2686

1.26

4.17

1.4

1.3

298.30

352.74

pmol/l

0.70

297

2294

Presence of cardiac and vascular implants and grafts

336

1952

1.27

4.17

1.2

1.3

295.19

340.49

pmol/l

0.36

285

1630

Degenerative diseases of the nervous system

150

1515

0.71

4.15

1.1

1.3

240.40

274.31

pmol/l

0.87

118

1251

Separation of retinal layers (serosa)

201

2.01

4.14

1.3

1.4

239.59

344.85

pmol/l

1.61

179

Disorders of muscles

542

1.60

4.14

1.3

1.4

290.82

334.06

pmol/l

0.60

474

Other coagulation defects

359

1.74

4.13

1.4

1.3

318.27

372.07

pmol/l

0.54

310

Injury of unspecified body region

389

1.71

4.12

1.4

288.12

315.48

pmol/l

0.24

332

Thyrotropin deficiency

3.16

4.12

1.8

1.3

419.56

422.80

pmol/l

0.01

Paracetamol or NSAID medication

114

376

1.53

4.12

1.4

1.5

352.11

389.10

pmol/l

0.18

102

316

Pilonidal cyst

427

1.67

4.11

1.4

283.81

338.69

pmol/l

0.94

368

Maltreatment syndromes

229

1.94

4.11

1.4

523.18

396.23

pmol/l

0.41

196

Myeloproliferative diseases (CML excluded)

367

1.73

4.11

1.2

1.3

289.16

316.03

pmol/l

0.33

316

Fall on same level involving ice and snow

504

4186

1.21

4.06

1.4

290.27

377.83

pmol/l

1.65

436

3589

Vitamin B12 deficiency anaemia

490

1.62

4.06

1.3

434.95

295.93

pmol/l

0.40

410

Colectomy operation

137

957

1.44

4.06

1.3

342.36

322.99

pmol/l

0.17

124

796

Viral infections characterized by skin and mucous membrane lesions

359

2880

1.25

4.06

1.4

899.62

343.33

pmol/l

0.78

308

2450

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

317

1.78

4.04

1.4

272.55

315.94

pmol/l

0.54

270

Myeloid leukaemia

111

2.38

4.02

1.1

1.4

215.90

308.61

pmol/l

1.45

Other and unspecified glaucoma

325

1.77

4.01

1.4

1.3

322.63

286.76

pmol/l

0.32

268

Injuries to unspecified part of trunk, limb or body region

547

1.58

4.00

1.4

301.83

317.99

pmol/l

0.16

460

Deficiency of other B group vitamins

2.57

3.99

1.2

954.25

339.07

pmol/l

0.46

Chondropathies

124

853

1.46

3.99

1.3

1.4

328.97

330.22

pmol/l

0.01

102

736

Abnormal findings on diagnostic imaging of central nervous system

225

1.93

3.97

1.7

1.4

409.72

364.71

pmol/l

0.25

188

Cholecystitis

106

707

1.51

3.97

1.3

318.16

330.81

pmol/l

0.09

586

Other skin changes

167

1214

1.38

3.94

1.3

327.20

323.97

pmol/l

0.03

146

1008

Disorder of the sleep-wake schedule

2.68

3.92

1.4

287.20

472.99

pmol/l

0.66

Anorexia (incl.atypical)

247

1.88

3.92

1.3

1.4

510.24

406.81

pmol/l

0.80

220

Emotional disorders starting during childhood or adolescence

196

1.99

3.92

1.6

1.5

694.21

395.24

pmol/l

1.29

173

Panniculitis affecting regions of neck and back

151

2.14

3.91

1.3

293.33

335.81

pmol/l

0.35

131

Exposure to other specified factors

710

5225

1.17

3.91

1.4

317.12

372.99

pmol/l

1.08

613

4509

Other disorders of patella

144

1023

1.41

3.90

1.4

310.27

356.28

pmol/l

0.71

120

876

Fracture of shoulder and upper arm

302

2390

1.27

3.85

1.4

1.3

296.18

356.58

pmol/l

0.65

256

2023

Other condition

120

827

1.46

3.84

1.4

268.84

316.92

pmol/l

1.31

109

716

Eating disorders

481

1.61

3.84

1.4

481.48

638.86

pmol/l

0.33

425

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

337

1.73

3.84

1.4

314.31

324.93

pmol/l

0.10

288

Noninflammatory disorders of female genital tract

310

1222

1.28

3.82

1.3

1.4

375.23

339.85

pmol/l

0.69

262

1078

Other and unspecified vascular occlusions

460

1.62

3.80

1.5

1.3

319.38

294.66

pmol/l

0.25

383

Other eating disorders

201

1.95

3.77

1.5

1.4

463.86

474.27

pmol/l

0.04

180

Iron deficiency anaemia secondary to blood loss (chronic)

121

839

1.45

3.75

1.3

347.00

349.34

pmol/l

0.02

708

Paralytic ileus

134

2.19

3.74

1.5

1.4

153.39

339.93

pmol/l

3.99

113

Uterine polyps

229

1017

1.32

3.74

1.4

1.3

319.00

306.17

pmol/l

0.24

199

894

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

302

1.76

3.73

1.3

314.17

300.23

pmol/l

0.09

256

Dementia in Alzheimer disease

732

0.58

3.73

1.1

1.2

243.00

254.59

pmol/l

0.16

593

Other and unspecified paralytic syndromes

2.84

3.72

1.1

1.3

415.00

363.73

pmol/l

0.15

Supervision of normal pregnancy

791

0.66

3.71

1.4

1.5

346.29

375.56

pmol/l

0.38

710

Fracture of neck

267

1.81

3.70

1.3

2374.12

308.71

pmol/l

0.46

226

Redundant prepuce, phimosis and paraphimosis

157

1125

1.38

3.68

1.5

1.4

280.34

378.61

pmol/l

0.53

127

959

Other bursopathies

108

736

1.48

3.68

1.3

276.79

324.12

pmol/l

0.83

630

Overexertion and strenuous or repetitive movements

543

1.56

3.68

1.4

275.87

328.35

pmol/l

0.92

465

Vasculitis limited to skin, not elsewhere classified

116

2.27

3.66

1.2

1.4

356.55

334.37

pmol/l

0.07

106

Any death

399

3390

0.82

3.66

1.4

1.3

321.40

321.51

pmol/l

0.00

322

2886

Heterophoria

403

1.65

3.65

1.3

1.4

271.80

377.72

pmol/l

2.02

350

Unspecified acute lower respiratory infection

124

869

1.43

3.65

1.5

1.3

324.99

428.26

pmol/l

0.41

101

740

Psoriatic and enteropathic arthropathies

648

1.51

3.65

1.6

1.3

339.08

373.82

pmol/l

0.27

545

Gluteal tendinitis

218

1.90

3.65

1.3

266.24

434.50

pmol/l

0.76

194

Preparatory care for dialysis

190

1.97

3.64

1.2

1.4

460.19

332.06

pmol/l

0.71

164

Somnolence, stupor and coma

183

1.99

3.64

1.4

318.19

343.79

pmol/l

0.15

156

Bulimia nervosa (incl. atypical)

136

2.15

3.62

1.5

1.4

389.09

461.50

pmol/l

0.50

119

Problems related to lifestyle

561

1.54

3.61

1.5

1.4

348.64

319.60

pmol/l

0.28

489

Other medical care

397

2734

1.22

3.61

1.4

1.3

559.22

354.65

pmol/l

0.35

335

2319

Other/unspecified enthesopathies, not elsewhere classified

420

1.63

3.61

1.3

526.94

312.21

pmol/l

0.34

372

Assault

110

756

1.46

3.60

1.3

1.4

344.97

341.09

pmol/l

0.02

666

Giant cell arteritis

184

1.98

3.59

1.2

1.3

454.29

286.15

pmol/l

0.63

162

Iridocyclitis

187

1406

1.34

3.59

1.4

1.3

305.54

411.82

pmol/l

0.75

164

1185

Fall involving bed

130

2.18

3.59

1.2

1.3

248.06

270.07

pmol/l

0.24

109

Visual impairment including blindness (binocular or monocular)

314

1.73

3.59

1.4

1.3

2424.62

297.25

pmol/l

0.52

266

Fall on and from stairs and steps

219

1684

1.31

3.58

1.3

301.54

459.89

pmol/l

1.04

180

1426

Anterior Iridocyclitis

163

1201

1.36

3.58

1.4

1.3

309.68

421.77

pmol/l

0.66

145

1020

Striking against or struck by other objects

274

2164

1.27

3.58

1.4

313.02

444.08

pmol/l

1.18

225

1853

Myasthenia gravis

2.62

3.58

1.2

1.3

510.93

328.81

pmol/l

0.46

Explicit bacterial Sepsis

499

1.57

3.57

1.2

1.3

327.41

296.48

pmol/l

0.19

417

Any dementia

181

1664

0.75

3.57

1.1

1.3

269.74

270.64

pmol/l

0.02

148

1369

Superficial injury of ankle and foot

101

684

1.48

3.56

1.4

292.00

497.83

pmol/l

0.76

600

Unspecified/other endometriosis

443

1.60

3.55

1.5

578.77

373.53

pmol/l

0.38

400

Candidiasis

118

824

1.44

3.55

1.3

392.93

362.81

pmol/l

0.21

712

Haemorrhage in early pregnancy

222

1662

1.30

3.55

1.4

438.77

397.16

pmol/l

0.20

196

1466

Otitis externa

189

1427

1.33

3.53

1.5

1.4

301.49

419.39

pmol/l

0.88

165

1210

Glaucoma suspect

296

2366

1.25

3.53

1.3

307.22

352.48

pmol/l

0.45

259

1997

Superficial injury of abdomen, lower back and pelvis

126

892

1.42

3.52

1.4

353.19

355.94

pmol/l

0.02

105

759

Parkinson's disease, strict definition, excluding more controls

511

1.54

3.50

1.2

1.4

239.19

273.05

pmol/l

0.72

432

Chronic conjunctivitis

145

2.10

3.49

1.4

318.44

352.75

pmol/l

0.16

126

Eating disorder

392

1.64

3.49

1.5

1.4

512.69

719.37

pmol/l

0.36

345

Herpesviral [herpes simplex] infections, including avohilmo

216

1665

1.30

3.48

1.4

324.29

389.58

pmol/l

1.31

186

1432

Emphysema

332

1.70

3.48

1.2

1.4

716.99

271.68

pmol/l

0.44

281

Crohn disease

103

704

1.47

3.48

1.6

1.4

391.64

314.58

pmol/l

0.69

608

Other and unspecified mood [affective] disorders

333

1.69

3.45

1.4

469.18

336.94

pmol/l

0.95

297

Alzheimer’s disease (Late onset)

976

0.66

3.42

1.1

1.2

219.48

255.40

pmol/l

1.01

784

Bronchitis, not specified as acute or chronic

426

1.61

3.42

1.3

1.4

284.60

287.29

pmol/l

0.03

364

Other and unspecified trigeminal disorders

2.70

3.42

1.0

1.4

352.41

355.64

pmol/l

0.01

Other congenital malformations of skin, including avohilmo

411

1.62

3.41

1.5

1.3

374.98

366.94

pmol/l

0.05

355

Abscess of anal and rectal regions

450

1.59

3.41

1.2

1.4

246.78

322.73

pmol/l

1.79

388

Delirium, not induced by alcohol and other psychoactive substances

600

1.50

3.40

1.3

315.42

281.50

pmol/l

0.38

496

Otitis externa, unspecified

635

1.49

3.38

1.5

1.4

311.62

321.70

pmol/l

0.13

546

Dentofacial anomalies [including malocclusion]

623

4187

1.17

3.38

1.4

365.97

386.78

pmol/l

0.16

546

3639

Dermatophytosis

112

783

1.44

3.38

1.4

1.3

1201.30

303.23

pmol/l

0.49

660

Car occupant injured in other and unspecified transport accidents

148

1086

1.37

3.36

1.4

437.97

429.63

pmol/l

0.02

125

935

Covid-19 suspected case

174

1309

1.33

3.36

1.2

1.4

318.00

473.81

pmol/l

1.15

158

1148

Haemangioma, any site

452

1.58

3.35

1.4

1.3

359.44

340.61

pmol/l

0.14

395

Encephalitis

134

2.12

3.35

1.4

1.5

4148.36

361.43

pmol/l

0.47

119

Diagnoses used for exclusion with ILD

196

1500

1.31

3.35

1.3

878.78

322.05

pmol/l

0.55

167

1260

Peripheral artery operations in Hilmo

563

1.52

3.35

1.2

1.3

256.97

281.71

pmol/l

0.31

469

Other disorders of pigmentation

225

1.84

3.34

1.2

1.3

326.29

322.96

pmol/l

0.03

193

Other noninflammatory disorders of vulva and perineum

492

1.55

3.34

1.3

1.4

399.51

345.28

pmol/l

0.49

432

Poor fetal growth

645

1.48

3.33

1.4

1.5

463.11

624.67

pmol/l

0.44

573

Hypermetropia

359

1.65

3.33

1.4

364.28

381.57

pmol/l

0.12

314

Polymyalgia rheumatica

100

686

1.47

3.33

1.2

1.3

311.64

286.55

pmol/l

0.33

574

Diabetic retinopathy, strict definition

180

1208

1.33

3.33

1.3

254.81

323.45

pmol/l

1.34

139

1023

Female genital prolapse

230

989

1.30

3.33

1.3

485.34

302.69

pmol/l

0.77

190

868

Follicular cysts of skin and subcutaneous tissue

151

1114

1.36

3.32

1.3

468.51

422.12

pmol/l

0.10

133

955

Small fibre neuropathy

135

2.10

3.30

1.5

1.3

303.32

351.90

pmol/l

0.33

119

Other hearing loss

212

1592

1.29

3.28

1.3

293.44

304.44

pmol/l

0.15

178

1334

Chronic ulcer of skin, not elsewhere classified

323

1.68

3.27

1.3

310.80

310.18

pmol/l

0.00

274

Amputation of toe

324

1.68

3.24

1.1

1.3

248.02

292.22

pmol/l

0.43

275

Medial epicondylitis

206

1.86

3.23

1.4

1.3

252.44

330.20

pmol/l

1.13

186

Tuberculosis of other organs

2.53

3.23

1.2

323.62

282.23

pmol/l

0.15

Familial hypercholesterolemia, with ischemic heart disease

425

1.59

3.23

1.2

1.3

271.44

276.79

pmol/l

0.05

357

Effects of other external causes

123

2.14

3.21

1.2

1.4

238.16

352.38

pmol/l

1.68

105

Preterm labour and delivery

212

1650

1.29

3.21

1.3

1.4

322.36

389.58

pmol/l

1.32

180

1456

Meralgia paraesthetica

157

2.00

3.21

1.4

275.54

358.00

pmol/l

0.87

138

Malignant neoplasm of skin, including Hilmo

429

2400

1.20

3.21

1.3

290.86

338.71

pmol/l

0.55

387

2027

Endometriosis of pelvic peritoneum

124

809

1.40

3.20

1.5

1.4

468.22

340.89

pmol/l

0.43

114

716

Zoster [herpes zoster]

148

1096

1.36

3.19

1.3

310.02

318.83

pmol/l

0.09

126

916

Other inflammatory liver diseases

318

1.68

3.19

1.6

1.4

339.93

339.71

pmol/l

0.00

275

Acute laryngitis and tracheitis

601

1.48

3.18

1.4

345.08

355.84

pmol/l

0.11

527

Explicit bacterial Sepsis, including avohilmo

514

1.52

3.17

1.2

1.3

327.41

294.88

pmol/l

0.20

429

Other and unspecified injuries of ankle and foot

215

1.83

3.15

1.4

1.5

260.34

377.17

pmol/l

1.76

181

Salpingitis and oophoritis

147

1092

1.35

3.12

1.5

1.3

1029.97

318.23

pmol/l

0.50

126

955

Ulcerative colitis

194

1499

1.30

3.12

1.4

400.42

396.81

pmol/l

0.02

170

1286

Specific development disorders of speech and language

257

1.74

3.12

1.4

340.00

386.93

pmol/l

0.24

226

Other viral diseases, including avohilmo

306

2471

1.23

3.10

1.4

354.63

459.08

pmol/l

0.99

265

2133

Scoliosis

406

1.59

3.09

1.3

389.65

343.81

pmol/l

0.37

352

Seborrhoeic dermatitis

558

1.50

3.09

1.6

1.3

339.34

320.95

pmol/l

0.15

475

Acute nasopharyngitis (common cold)

676

1.45

3.07

1.2

1.4

301.05

296.62

pmol/l

0.06

576

Congenital malformations of the circulatory system

115

799

1.40

3.07

1.4

373.40

341.97

pmol/l

0.27

685

Propionic acid derivatives

202

780

1.31

3.06

1.4

329.80

361.84

pmol/l

0.29

171

666

Other/unspecified synovitis and tenosynovitis

625

1.46

3.05

1.2

1.3

258.52

331.35

pmol/l

1.70

549

Inflammatory bowel disease

257

2062

1.25

3.05

1.4

381.58

453.03

pmol/l

0.42

226

1763

Other encephalitis

126

2.09

3.04

1.4

4522.49

360.96

pmol/l

0.47

111

Acute and subacute iridocyclitis

152

1140

1.34

3.04

1.5

1.3

313.01

427.49

pmol/l

0.64

134

973

Dementia

221

1912

0.79

3.04

1.1

1.3

267.51

287.06

pmol/l

0.39

174

1586

439

0.48

3.04

1.2

1.3

291.63

282.98

pmol/l

0.04

372

Dermatophytosis, including avohilmo

554

4675

1.16

3.03

1.3

1.4

697.30

328.36

pmol/l

0.81

478

4002

Erosion of teeth , including avohilmo

221

1744

1.27

3.02

1.4

329.00

496.24

pmol/l

1.22

195

1506

Peritonsillar abscess

163

1236

1.32

3.02

1.4

260.62

373.88

pmol/l

2.90

142

1071

Myopia

101

709

1.43

3.02

1.4

344.64

503.34

pmol/l

0.55

621

Cystic fibrosis

10.47

3.01

1.0

1.2

301.00

199.00

pmol/l

—

Lichen simplex chronicus and prurigo

339

1.64

3.01

1.4

1.3

368.80

317.97

pmol/l

0.42

290

Amiodarone users

505

1.51

3.01

1.2

1.3

300.24

283.46

pmol/l

0.18

420

Use of antiglaucoma preparations and miotics

370

1.60

3.00

1.4

1.2

298.61

284.37

pmol/l

0.12

304

Ulcerative colitis, NAS

107

760

1.41

3.00

1.4

431.05

305.98

pmol/l

1.25

663

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

127

929

1.37

2.99

1.4

375.21

480.65

pmol/l

0.40

101

813

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

819

4567

1.13

2.99

1.3

1.4

352.04

360.10

pmol/l

0.07

698

3931

Congenital malformations and deformations of the musculoskeletal system

447

1.54

2.98

1.5

1.4

569.47

382.97

pmol/l

1.36

386

Carrier of infectious disease

107

2.18

2.98

1.7

1.4

332.33

381.19

pmol/l

0.30

Respiratory insufficiency

354

1.61

2.98

1.2

1.3

264.31

267.80

pmol/l

0.03

298

Benign neoplasm: Ascending colon

116

837

1.39

2.98

1.2

1.3

315.52

323.51

pmol/l

0.06

705

Otitis media, unspecified

517

1.48

2.97

1.5

1.4

335.70

393.42

pmol/l

0.58

449

Other diseases of peritoneum

227

1.78

2.96

1.4

273.55

326.67

pmol/l

0.64

196

Autoimmune hyperthyroidism

302

1.67

2.96

1.4

1.3

341.30

318.48

pmol/l

0.15

266

Other degenerative diseases of the nervous system

186

1044

1.30

2.96

1.2

1.3

267.49

321.53

pmol/l

0.97

150

897

Tumor necrosis factor alpha inhibitors

129

949

1.37

2.94

1.4

308.72

362.06

pmol/l

0.62

116

824

Malignant melanoma

120

873

1.38

2.93

1.4

1.3

316.25

299.04

pmol/l

0.22

102

721

Other viral diseases, not elsewhere classified

142

1057

1.34

2.93

1.4

373.58

367.22

pmol/l

0.06

118

913

Polycystic ovarian syndrome, broad definition

516

1.50

2.93

1.6

1.5

719.02

484.27

pmol/l

0.46

455

Cramp and spasm

213

1.80

2.93

1.5

1.4

396.50

362.81

pmol/l

0.15

184

Bicuspidal aortic valve syndrome

170

1.90

2.91

1.2

1.4

414.16

337.76

pmol/l

0.26

152

Allergic colitis

2.34

2.91

1.7

1.4

254.36

496.24

pmol/l

1.08

Spermatocele

342

1.62

2.91

1.3

224.80

313.54

pmol/l

1.92

276

Temporal arteritis

149

1.97

2.91

1.2

1.3

509.68

293.52

pmol/l

0.65

131

Single delivery by forceps and vacuum extractor

556

0.64

2.91

1.3

1.5

347.67

420.91

pmol/l

1.01

496

Spondylopathies (FG)

104

740

1.41

2.90

1.4

228.47

371.04

pmol/l

3.10

632

Thyrotoxicosis with diffuse goitre

110

791

1.40

2.89

1.3

310.27

353.91

pmol/l

0.46

681

Psoriasis

236

1889

1.25

2.88

1.5

1.3

291.35

379.07

pmol/l

0.85

206

1592

Retinal detachments and breaks

273

2221

1.23

2.87

1.4

1.3

271.72

349.99

pmol/l

0.91

230

1864

Pyogenic arthritis

320

1.64

2.87

1.3

362.60

318.51

pmol/l

0.24

260

Cardiomyopathy, other and unspecified

367

1.59

2.86

1.2

1.3

341.48

269.50

pmol/l

0.77

308

Suicide or other Intentional self-harm

192

1501

1.28

2.86

1.3

1.4

329.17

484.20

pmol/l

0.88

154

1306

Allergic rhinitis

241

1911

1.25

2.85

1.4

346.96

446.83

pmol/l

1.00

207

1667

Acute lymphadenitis

275

1.68

2.84

1.2

1.4

329.70

342.66

pmol/l

0.12

236

Adhesive capsulitis of shoulder

130

964

1.35

2.83

1.4

1.3

299.36

316.82

pmol/l

0.24

107

827

Seropositive rheumatoid arthritis, wide

210

1663

1.27

2.82

1.3

326.94

321.70

pmol/l

0.07

183

1412

Retinal haemorrhage

103

2.16

2.82

1.4

1.3

314.94

284.43

pmol/l

0.14

Childhood asthma (age<16), excluding more controls

448

1.47

2.82

1.6

1.5

418.67

397.32

pmol/l

0.15

399

Coagulation defects, purpura and other haemorrhagic conditions

150

1137

1.32

2.82

1.4

1.3

390.41

346.61

pmol/l

0.22

131

956

Other neurotic disorders

216

1.77

2.81

1.3

1.4

275.45

318.61

pmol/l

0.38

190

Diseases of external ear

287

2354

1.22

2.80

1.4

1.3

292.81

379.43

pmol/l

1.06

247

1993

Nontoxic single thyroid nodule

401

1.56

2.80

1.6

1.3

312.92

305.46

pmol/l

0.06

349

Fibrosis and cirrhosis of liver

401

1.56

2.80

1.2

1.4

340.64

310.10

pmol/l

0.21

339

Polyp of the female genital tract

231

1039

1.26

2.78

1.4

1.3

295.79

311.46

pmol/l

0.37

200

916

Other respiratory diseases principally affecting the interstitium

129

959

1.35

2.77

1.2

1.3

296.34

290.95

pmol/l

0.06

112

791

Other maternal disorders predominantly related to pregnancy

466

2488

1.17

2.76

1.4

600.60

370.85

pmol/l

0.53

411

2204

Other diseases of gallbladder

210

1.78

2.75

1.4

334.29

309.99

pmol/l

0.15

181

Other viral diseases, not elsewhere classified, including avohilmo

215

1702

1.26

2.75

1.4

352.49

498.47

pmol/l

0.98

184

1479

Chondrocostal junction syndrome [Tietze]

181

1.84

2.75

1.3

1.4

296.32

351.24

pmol/l

0.76

160

Spondyloarthritis

130

969

1.35

2.74

1.4

1.3

231.20

445.33

pmol/l

1.30

114

829

Seronegative rheumatoid arthritis

623

1.44

2.74

1.4

1.3

409.40

355.18

pmol/l

0.38

533

Other disorders of penis

491

1.49

2.74

1.5

1.3

243.92

513.89

pmol/l

0.69

408

Pediculosis, acariasis and other infestations, including avohilmo

134

1004

1.34

2.73

1.3

1.4

408.86

351.50

pmol/l

0.59

121

867

Alcohol-induced chronic pancreatitis

325

1.61

2.72

1.2

1.4

279.63

311.10

pmol/l

0.24

280

Rheumatoid arthritis, including avohilmo

305

2526

1.21

2.72

1.3

337.32

366.62

pmol/l

0.27

267

2153

Acute posthaemorrhagic anaemia

132

1.99

2.71

2.1

1.3

405.08

303.54

pmol/l

0.61

117

Haemangioma and lymphangioma, any site

485

1.49

2.71

1.4

1.3

374.37

337.83

pmol/l

0.30

422

Palmar fascial fibromatosis [Dupuytren]

105

760

1.39

2.68

1.2

1.3

268.95

292.94

pmol/l

0.43

637

Keratitis

292

2412

1.21

2.68

1.4

324.73

427.97

pmol/l

0.95

251

2055

Kela-code for severe mental illness

286

2358

1.22

2.67

1.3

1.4

415.31

431.50

pmol/l

0.08

225

2027

Haemolytic anaemias

154

1.90

2.67

1.3

1.4

375.55

321.39

pmol/l

0.46

135

Malignant melanoma of skin, including Hilmo

110

804

1.37

2.65

1.4

1.3

316.56

294.49

pmol/l

0.28

663

Stomatitis and related lesions

160

1236

1.30

2.64

1.5

1.4

369.53

342.97

pmol/l

0.23

143

1055

Sulfasalazine

220

1767

1.25

2.64

1.4

1.3

750.43

394.49

pmol/l

0.37

201

1507

Acute suppurative otitis media

196

1446

1.27

2.64

1.5

860.21

398.68

pmol/l

0.43

173

1255

Hydronephrosis

562

1.45

2.63

1.8

1.4

501.72

300.28

pmol/l

0.76

471

Malignant melanoma, including Hilmo

132

994

1.33

2.63

1.4

1.3

312.24

294.78

pmol/l

0.25

112

827

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

205

1636

1.26

2.61

1.3

324.92

322.98

pmol/l

0.03

181

1389

Use of rivastigmine

753

0.63

2.60

1.1

1.3

275.57

255.28

pmol/l

0.27

611

Other disorders starting during childhood or adolescence

219

1.73

2.60

1.4

1.5

257.65

434.87

pmol/l

2.11

189

Other/unspecified seropositive rheumatoid arthritis

206

1648

1.25

2.58

1.3

324.92

322.34

pmol/l

0.03

181

1401

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

232

1.70

2.58

1.4

1.5

262.41

429.58

pmol/l

2.08

202

Juvenile arthritis (FINNGEN)

185

1.80

2.57

1.5

1.4

3715.19

419.71

pmol/l

0.49

160

Androgenic alopecia

2.92

2.57

1.3

287.75

427.49

pmol/l

0.64

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

434

1.51

2.57

1.3

715.60

319.47

pmol/l

0.52

373

Oesophagitis

245

1.69

2.57

1.3

1.4

471.86

336.15

pmol/l

0.42

212

Essential (haemorrhagic) thrombocythaemia

178

1.82

2.57

1.1

1.4

255.70

316.45

pmol/l

0.74

157

Other infectious diseases

354

1.56

2.56

1.2

1.3

322.35

323.01

pmol/l

0.00

295

Mental and behavioural disorders due to opioids

171

1.83

2.55

1.3

1.5

287.04

407.58

pmol/l

0.69

144

Special screening examination for neoplasms

323

1.59

2.55

1.5

1.2

305.42

281.49

pmol/l

0.21

279

Injuries to the elbow and forearm

606

4562

1.14

2.55

1.4

358.77

374.85

pmol/l

0.11

512

3943

Other and unspecified coagulation defects

246

1.68

2.54

1.5

1.4

298.53

421.39

pmol/l

1.24

215

Giant cell arteritis with polymyalgia rheumatica

157

1.86

2.53

1.2

1.3

509.68

285.58

pmol/l

0.68

137

Chronic diseases of tonsils and adenoids

665

3698

1.14

2.53

1.4

485.39

336.18

pmol/l

0.48

568

3206

Other diseases of oesophagus

485

1.47

2.51

1.4

1.3

245.38

318.14

pmol/l

1.30

405

Malignant neoplasm of skin

398

2293

1.18

2.50

1.3

287.12

338.94

pmol/l

0.57

356

1934

Scabies, including avohilmo

114

847

1.35

2.49

1.3

1.4

422.77

357.74

pmol/l

0.57

101

744

Hypertrophic disorders of skin

278

1.63

2.49

1.5

1.3

387.03

339.47

pmol/l

0.38

242

Superficial injury of wrist and hand

164

1283

1.28

2.48

1.4

326.88

500.08

pmol/l

0.89

147

1122

Tuberculosis of other organs, strict

2.22

2.48

1.2

1.3

323.62

280.26

pmol/l

0.16

Tuberculosis of other organs, strict, including avohilmo

2.22

2.48

1.2

1.3

323.62

280.26

pmol/l

0.16

Ganglion

159

1239

1.29

2.48

1.3

1.4

338.63

422.02

pmol/l

0.47

141

1077

Colonic or urogenital fistula

213

1719

1.24

2.48

1.4

1.3

384.32

388.68

pmol/l

0.02

193

1451

Female infertility

214

1027

1.25

2.48

1.4

915.86

343.26

pmol/l

0.61

182

914

Childhood asthma (age<16)

461

1.43

2.47

1.6

1.5

418.67

392.69

pmol/l

0.19

408

Malignant melanoma of skin

670

1.39

2.47

1.4

1.3

319.24

299.38

pmol/l

0.21

556

Benign neoplasm: Cranial nerves

137

1.92

2.47

1.4

231.10

332.12

pmol/l

1.60

120

Duodenal ulcer

528

1.45

2.47

1.4

1.3

347.65

307.59

pmol/l

0.37

437

Urethral stricture

248

1.66

2.46

1.5

1.3

354.49

272.51

pmol/l

0.88

205

Procreative management

280

1910

1.21

2.46

1.5

1.4

411.66

401.02

pmol/l

0.04

245

1678

Later onset COPD

187

1191

1.26

2.46

1.1

1.3

389.14

261.49

pmol/l

0.37

145

972

Benign neoplasm: Skin of trunk

188

1.77

2.46

1.2

1.4

257.14

339.77

pmol/l

1.26

163

Bell's palsy

621

1.41

2.44

1.3

614.49

321.82

pmol/l

0.45

534

Attention to artificial openings

196

1.75

2.44

1.2

1.4

377.25

309.07

pmol/l

0.24

169

Other osteochondropathies

335

1.56

2.43

1.4

348.24

350.23

pmol/l

0.01

292

Graves disease, strict definition

547

1.43

2.42

1.4

271.97

379.20

pmol/l

1.33

479

Other juvenile arthritis

167

1.81

2.41

1.5

1.4

3997.24

415.86

pmol/l

0.49

143

Dementia, including avohilmo

249

2060

0.82

2.40

1.1

1.3

281.41

291.31

pmol/l

0.17

196

1712

5-aminosalicylic acid

162

1272

1.28

2.40

1.4

336.17

414.30

pmol/l

0.44

139

1089

Pericarditis

153

1.85

2.39

1.3

1.4

279.91

290.80

pmol/l

0.06

124

Cervical polyps

532

1.44

2.39

1.4

1.3

281.88

310.90

pmol/l

0.47

460

Adalimumab

557

1.43

2.39

1.7

1.4

314.82

340.57

pmol/l

0.21

485

Benign neoplasm of ovary

138

1063

1.30

2.38

1.4

1.3

337.16

338.59

pmol/l

0.01

121

917

308

2328

1.19

2.36

1.3

300.15

291.86

pmol/l

0.15

270

1929

Pleural plaque

386

1.51

2.35

1.2

1.3

231.71

263.35

pmol/l

0.46

300

Psoriatic arthropathies

576

1.41

2.34

1.6

1.3

348.16

333.49

pmol/l

0.14

477

Other viral diseases

224

1824

1.23

2.34

1.4

370.33

489.15

pmol/l

0.78

191

1579

Congenital deformities of feet, including avohilmo

184

1.75

2.32

1.3

1.5

611.65

362.89

pmol/l

1.33

157

Synovial cyst of popliteal space [Baker]

363

1.52

2.32

1.3

225.43

311.80

pmol/l

1.33

321

Plantar fascial fibromatosis

552

1.42

2.32

1.3

1.4

270.61

344.52

pmol/l

1.00

491

Superficial injury of head

184

1472

1.25

2.31

1.3

327.20

332.03

pmol/l

0.04

160

1253

Injury of muscle and tendon at shoulder and upper arm level

279

2333

1.20

2.31

1.3

284.10

350.05

pmol/l

0.73

243

1947

Vestibular neuronitis

478

1.45

2.31

1.4

1.3

339.18

303.86

pmol/l

0.31

410

Fall on and from ladder

380

1.51

2.30

1.4

256.49

295.86

pmol/l

0.72

317

Unspecified privation

578

1.41

2.30

1.3

317.49

312.21

pmol/l

0.05

493

Perineal laceration during delivery

785

0.70

2.30

1.4

1.6

420.38

518.77

pmol/l

0.81

705

Benign lipomatous neoplasm of other sites/unspecified

429

1.48

2.30

1.3

302.22

307.61

pmol/l

0.06

358

Other symptoms and signs involving general sensations and perceptions

185

1.74

2.29

1.4

300.52

321.46

pmol/l

0.19

161

Pollen allergy

139

1063

1.29

2.27

1.4

1.5

340.02

526.97

pmol/l

1.10

118

938

Skin changes due to chronic exposure to nonionizing radiation

289

2195

1.19

2.27

1.3

298.19

291.97

pmol/l

0.10

253

1815

Speech disturbances, not elsewhere classified

463

1.45

2.27

1.2

1.3

282.41

304.18

pmol/l

0.21

389

Rash and other nonspecific skin eruption

505

1.43

2.26

1.3

308.81

304.22

pmol/l

0.04

427

Other psoriatic arthropathies

564

1.41

2.25

1.6

1.4

345.80

317.01

pmol/l

0.34

490

Other disorders of breast

108

811

1.34

2.25

1.4

1.3

595.07

369.75

pmol/l

0.46

705

Vulvovaginal ulceration/inflammation in other diseases

358

1.52

2.25

1.5

1.4

395.21

377.03

pmol/l

0.10

315

Ectropion of eyelid

149

1.82

2.25

1.2

182.94

242.04

pmol/l

1.17

123

Tobacco use

255

1.62

2.24

1.5

1.4

297.58

350.30

pmol/l

0.55

222

Hallux rigidus

112

846

1.33

2.24

1.2

1.3

293.05

308.69

pmol/l

0.23

703

Acne

511

1.43

2.24

1.4

1.5

388.75

614.82

pmol/l

0.57

445

Pedal cyclist injured in other and unspecified transport accidents

632

1.38

2.24

1.3

1.4

319.71

321.82

pmol/l

0.02

544

Bitten or struck by other mammals

615

1.39

2.24

1.4

340.83

357.57

pmol/l

0.15

534

Other fall from one level to another

169

1346

1.26

2.24

1.5

1.3

330.24

426.23

pmol/l

0.56

138

1140

Other specified and unspecified personality disorders

473

1.45

2.23

1.4

411.18

339.11

pmol/l

0.57

413

Acute alcohol intoxication

186

1499

1.24

2.23

1.3

1.4

297.68

386.58

pmol/l

0.62

145

1270

Use of other anti-dementia drugs

108

1149

0.75

2.23

1.1

1.2

257.22

262.57

pmol/l

0.09

932

Use of memantine

108

1149

0.75

2.23

1.1

1.2

257.22

262.57

pmol/l

0.09

932

Other mental disorders due to brain damage and dysfunction and to physical disease

633

1.38

2.22

1.2

1.3

280.23

289.02

pmol/l

0.10

524

Demyelinating diseases of the central nervous system

449

1.46

2.22

1.4

315.00

353.67

pmol/l

0.32

392

Other disorders of iris and ciliary body

121

1.92

2.22

1.7

1.3

254.14

313.48

pmol/l

0.43

110

Amputation

457

1.45

2.21

1.2

1.3

239.19

281.51

pmol/l

0.49

378

Other infectious diseases, including avohilmo

441

1.46

2.21

1.2

1.4

321.44

322.01

pmol/l

0.00

371

Psoriatic arthropathies, ICD10

583

1.40

2.21

1.6

1.4

348.16

318.29

pmol/l

0.37

507

Pleural effusion

107

805

1.33

2.20

1.2

1.3

460.53

295.92

pmol/l

0.74

656

Inflammatory diseases of the central nervous system

425

1.47

2.20

1.4

2026.80

314.33

pmol/l

0.51

365

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

484

3288

1.14

2.20

1.5

1.4

416.82

376.92

pmol/l

0.25

420

2848

Other puerperal infections

368

1.50

2.20

1.5

407.56

730.97

pmol/l

0.61

328

Arthropathic psoriasis

626

1.38

2.19

1.6

1.3

332.38

319.20

pmol/l

0.14

539

Family history of malignant neoplasm

643

1.37

2.19

1.2

1.4

321.01

377.05

pmol/l

0.44

568

Other complications of labour and delivery, not elsewhere classified

556

0.63

2.19

1.5

1.6

281.77

523.13

pmol/l

3.72

501

Deviated nasal septum

246

2043

1.21

2.18

1.5

1.4

292.41

314.50

pmol/l

0.43

217

1720

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

119

911

1.31

2.17

1.2

1.3

405.51

315.59

pmol/l

0.47

107

775

Lateral epicondylitis

103

774

1.34

2.15

1.3

1.4

335.28

335.22

pmol/l

0.00

676

Drug-induced osteoporosis with pathological fracture

2.13

2.14

1.6

1.3

445.75

259.88

pmol/l

1.37

Event of undetermined intent

314

1.54

2.14

1.4

1.5

418.00

346.08

pmol/l

0.26

264

Hypertrophic scar

251

1.60

2.13

1.5

1.4

337.46

347.28

pmol/l

0.07

216

Congenital malformations of aortic and mitral valves

197

1.69

2.13

1.3

1.5

401.89

337.21

pmol/l

0.22

174

Atrophic disorders of skin

125

967

1.30

2.12

1.5

1.3

317.55

348.89

pmol/l

0.37

110

839

Amblyopia ex anopsia

182

1.72

2.12

1.5

1.4

280.32

384.96

pmol/l

0.78

158

Crohn's disease of small intestine

347

1.51

2.12

1.7

1.4

289.41

319.23

pmol/l

0.33

295

Lesion of plantar nerve

323

1.53

2.12

1.4

1.3

319.35

314.80

pmol/l

0.04

283

Hereditary lymphedema

5.34

2.11

2.6

1.0

678.60

233.60

pmol/l

—

Mucosal proctocolitis

699

1.35

2.11

1.5

1.4

375.83

313.56

pmol/l

0.58

608

Labour and delivery complicated by fetal stress [distress]

107

915

0.76

2.11

1.7

1.5

382.63

463.23

pmol/l

0.96

823

Antenatal screening

112

819

0.76

2.08

1.3

1.5

382.75

377.43

pmol/l

0.05

734

Assault by bodily force

423

1.45

2.06

1.4

337.94

365.54

pmol/l

0.10

366

Lesion of lateral popliteal nerve

222

1.63

2.06

1.2

1.4

320.00

328.05

pmol/l

0.05

190

Simple and mucopurulent chronic bronchitis

161

1.75

2.06

1.3

1.4

359.63

344.50

pmol/l

0.04

141

Lyme disease, including avohilmo

193

2349

0.82

2.05

1.3

297.69

373.76

pmol/l

0.81

175

2002

Lyme disease

193

2349

0.82

2.05

1.3

297.69

373.76

pmol/l

0.81

175

2002

Disorders of optic nerve and visual pathways

482

1.42

2.04

1.3

1.4

251.58

338.26

pmol/l

2.30

420

Benign neoplasm: Sigmoid colon

146

1159

1.26

2.04

1.2

1.3

318.84

315.41

pmol/l

0.03

120

968

Hypersomnia

2.25

2.02

2.1

1.5

308.86

381.63

pmol/l

0.46

Other and unspecified psoriasis

343

1.50

2.02

1.5

1.4

223.18

326.15

pmol/l

2.66

298

Fracture of skull and facial bones

167

1348

1.24

2.01

1.3

1.4

926.30

331.75

pmol/l

0.49

143

1154

Alcohol dependence

194

1591

1.22

2.01

1.3

1.4

325.73

374.09

pmol/l

0.30

154

1355

Female infertility, cervical, vaginal, other or unspecified origin

194

1011

1.23

2.01

1.4

977.53

345.10

pmol/l

0.62

167

899

In situ neoplasms

303

2588

1.17

2.01

1.3

351.15

373.15

pmol/l

0.11

265

2188

Suppurative and unspecified otitis media

270

2020

1.19

2.00

1.5

1.4

715.95

436.08

pmol/l

0.33

232

1748

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

139

1100

1.27

1.99

1.5

1.4

338.66

412.80

pmol/l

1.18

124

959

Unspecified lump in breast

123

959

1.29

1.99

1.4

1.3

266.65

328.16

pmol/l

2.33

112

833

Medical abortion

506

2414

1.14

1.99

1.3

1.4

372.14

388.06

pmol/l

0.10

435

2142

Spirochaetal infections, other/unspecified, including avohilmo

196

2372

0.82

1.97

1.3

295.06

372.75

pmol/l

0.85

178

2025

Hypothalamic dysfunction, including iatrogenic, not elsewhere classified

4.79

1.97

1.8

1.0

797.40

229.36

pmol/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

105

803

1.31

1.97

1.4

1.3

273.34

346.77

pmol/l

1.16

692

Labour and delivery complicated by umbilical cord complications

241

1.59

1.96

1.4

406.91

353.38

pmol/l

0.30

222

Other spirochaetal diseases

196

2369

0.83

1.95

1.3

294.78

372.75

pmol/l

0.86

178

2022

Alcohol abuse, main dg, excluding more controls

105

804

1.31

1.95

1.4

1.3

293.98

432.49

pmol/l

0.54

688

Male infertility

210

1.63

1.95

1.6

1.5

239.38

340.83

pmol/l

1.25

184

Presbycusis

623

1.35

1.95

1.2

253.17

248.77

pmol/l

0.06

508

Open wound of head

428

3530

1.14

1.93

1.3

1.4

329.48

350.61

pmol/l

0.20

351

3018

Herpesviral keratitis and keratoconjunctivitis

203

1.64

1.93

1.2

1.3

442.93

332.50

pmol/l

0.87

179

Primary_lymphoid and hematopoietic malignant neoplasms

173

1410

1.23

1.92

1.3

322.18

392.21

pmol/l

0.40

149

1168

Other enthesopathy of foot (+metatarsalgia)

590

1.36

1.92

1.3

1593.03

345.21

pmol/l

0.48

524

Benign neoplasm: Choroid

347

1.48

1.92

1.5

1.3

289.81

315.21

pmol/l

0.31

297

Other spirochaetal diseases, including avohilmo

200

2408

0.83

1.92

1.3

291.97

371.91

pmol/l

0.91

182

2055

Disorders of speech understanding and production

184

1.66

1.92

1.6

1.4

402.54

380.32

pmol/l

0.07

164

Anogenital herpesviral [herpes simplex] infection

323

1.49

1.91

1.5

1.4

389.55

374.29

pmol/l

0.10

280

Psoriasis vulgaris

140

1116

1.26

1.91

1.4

1.3

293.46

425.82

pmol/l

0.76

120

948

Other demyelinating diseases of the central nervous system

173

1.69

1.90

1.5

1.4

292.60

389.78

pmol/l

0.58

150

Early lumbar disc prolapse, operated

498

1.39

1.89

1.3

1.4

352.52

584.36

pmol/l

0.58

441

Osteonecrosis

324

1.49

1.89

1.3

1.4

321.47

330.88

pmol/l

0.06

283

Pregnancy with abortive outcome

526

2430

1.13

1.88

1.3

1.4

427.92

389.45

pmol/l

0.21

448

2155

Coeliac disease

661

1.34

1.88

1.5

1.4

1475.57

357.78

pmol/l

0.46

573

Other and unspecified mononeuropathies of upper limb

136

1.78

1.88

1.3

1.4

187.84

368.26

pmol/l

3.63

120

Metatarsalgia

533

1.38

1.88

1.2

1.3

1724.08

345.53

pmol/l

0.49

472

Convergent concomitant strabismus

276

1.53

1.87

1.3

1.4

308.09

398.59

pmol/l

0.92

236

Crowding of teeth, including avohilmo

349

1.43

1.87

1.6

1.5

435.96

405.63

pmol/l

0.19

303

Postmenopausal bleeding

204

880

1.22

1.86

1.3

305.69

285.10

pmol/l

0.39

179

769

Hereditary lymphedema, including avohilmo

4.38

1.85

2.6

1.1

678.60

231.33

pmol/l

—

Other cranial nerve disorders in other disorders

4.33

1.84

2.2

1.0

388.80

243.67

pmol/l

—

Contusion of other and unspecified parts of foot

269

1.53

1.84

1.4

295.74

362.23

pmol/l

0.81

234

Paralytic strabismus

334

1.47

1.84

1.3

321.18

316.35

pmol/l

0.03

286

Benign neoplasm: Skin of eyelid, including canthus

116

909

1.28

1.83

1.3

304.86

330.41

pmol/l

0.30

102

772

Other interstitial pulmonary diseases

104

804

1.30

1.83

1.2

1.3

305.47

283.34

pmol/l

0.28

658

Other maltreatment syndromes

145

1.74

1.82

1.2

1.5

338.68

390.97

pmol/l

0.28

123

ILD, hospital admissions

103

796

1.30

1.81

1.2

1.3

302.54

284.61

pmol/l

0.21

654

Anti-inflammatory and antirheumatic products, non-steroids

189

780

1.22

1.80

1.4

317.09

361.84

pmol/l

0.48

161

666

Interstitial lung disease

104

806

1.29

1.80

1.2

1.3

305.47

284.04

pmol/l

0.27

661

Interstitial lung disease endpoints

104

806

1.29

1.80

1.2

1.3

305.47

284.04

pmol/l

0.27

661

Suppurative and necrotic conditions of lower respiratory tract

247

1.55

1.79

1.5

1.4

268.89

321.23

pmol/l

0.54

211

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

231

1954

1.18

1.77

1.3

1.4

302.44

378.30

pmol/l

0.72

207

1652

Outcome of delivery

618

0.74

1.76

1.3

1.5

440.87

390.80

pmol/l

0.39

557

Acute nephritic syndrome

1.95

1.76

1.2

1.4

231.83

350.51

pmol/l

0.48

IBD patients in KELA-register

170

1399

1.22

1.75

1.4

362.23

474.46

pmol/l

0.53

151

1213

Endometriosis of rectovaginal septum and vagina

371

1.44

1.75

1.4

1.3

326.53

320.61

pmol/l

0.05

326

Benign neoplasm of mouth and pharynx

583

1.34

1.75

1.2

1.3

283.23

311.99

pmol/l

0.47

496

Endometriosis diagnosis and infertility diagnosis occurring together

583

1.34

1.75

1.5

1.4

556.04

396.00

pmol/l

0.29

519

Dislocation, sprain and strain of joints and ligaments of thorax

147

1.71

1.74

1.2

1.4

334.57

368.47

pmol/l

0.17

129

Open wound of wrist and hand

350

2956

1.15

1.74

1.4

319.98

406.98

pmol/l

0.96

278

2534

Acne vulgaris

396

1.42

1.73

1.5

343.46

665.34

pmol/l

0.66

345

Left ventricular outflow tract obstruction, narrow definition

233

1.55

1.73

1.3

1.5

403.04

377.55

pmol/l

0.08

204

Actinic keratosis

273

2132

1.17

1.72

1.3

293.34

292.70

pmol/l

0.01

237

1760

Diabetic retinopathy

347

1876

1.15

1.72

1.3

284.76

307.45

pmol/l

0.50

279

1596

Other congenital malformations of the digestive system, including avohilmo

248

1.53

1.71

1.4

1.5

362.26

379.46

pmol/l

0.09

214

Pedal cyclist injured in transport accident

169

1395

1.21

1.70

1.3

1.4

307.36

412.77

pmol/l

0.74

146

1197

Corns and callosities

332

1.45

1.70

1.3

1.4

345.93

318.73

pmol/l

0.18

294

Excessive earwax

512

4158

1.12

1.69

1.4

1.3

301.38

363.37

pmol/l

0.95

440

3536

Benign neoplasm: Skin of other and unspecified parts of face

561

1.34

1.69

1.2

1.3

330.57

304.32

pmol/l

0.20

472

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

391

1.41

1.68

1.3

304.89

318.19

pmol/l

0.08

336

Ankylosing hyperostosis [Forestier]

2.21

1.68

1.2

259.42

353.96

pmol/l

0.51

Endovascular or surgical operations to intracerebral aneurysms

292

1.48

1.67

1.1

1.4

247.07

323.21

pmol/l

1.60

257

Pneumonitis due to solids and liquids

342

1.44

1.66

1.3

1.4

2307.23

296.64

pmol/l

0.49

292

Bullous disorders

252

1.52

1.65

1.3

273.06

315.31

pmol/l

0.37

217

Malignant neoplasm of bone and articular cartilage, including Hilmo

1.95

1.65

1.4

587.09

364.67

pmol/l

0.41

Sequelae of injuries of head

236

1.53

1.65

1.6

1.4

3117.61

343.28

pmol/l

0.49

203

Abnormal spermatozoa

650

1.31

1.65

1.4

1.3

236.96

281.60

pmol/l

1.06

529

Intermittent heterotropia

276

1.49

1.65

1.1

1.4

389.94

403.78

pmol/l

0.04

235

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

478

1.37

1.64

1.3

272.48

390.70

pmol/l

1.31

418

Atypical facial pain

269

1.50

1.64

1.3

277.49

333.96

pmol/l

0.49

237

Benign neoplasm of eye and adnexa

573

1.33

1.63

1.5

1.3

290.13

309.08

pmol/l

0.28

495

Schizophrenia or delusion

237

2026

1.17

1.63

1.3

1.4

389.93

455.18

pmol/l

0.35

182

1749

Nail disorders

445

1.38

1.62

1.4

297.55

338.43

pmol/l

0.55

374

Other Crohn's disease

344

1.43

1.62

1.2

1.4

288.75

326.57

pmol/l

0.47

293

Superficial injury of thorax

109

864

1.27

1.61

1.3

227.49

313.02

pmol/l

4.47

735

Superficial injury of forearm

531

1.34

1.61

1.4

365.88

346.14

pmol/l

0.15

460

Schizophrenia, schizotypal and delusional disorders

238

2038

1.17

1.61

1.3

1.4

389.15

453.78

pmol/l

0.35

183

1760

Congenital malformations of heart and great arteries

684

1.29

1.60

1.4

333.24

350.81

pmol/l

0.13

587

Contusion of ankle

198

1.58

1.60

1.5

1.4

290.59

362.29

pmol/l

0.67

169

Renal agenesis and other reduction defects of kidney, including avohilmo

3.06

1.59

1.7

1.3

437.17

652.65

pmol/l

—

Leiomyosarcoma, including Hilmo

2.24

1.58

1.1

1.3

572.73

356.66

pmol/l

0.39

Presence of other devices

166

1357

1.21

1.58

1.2

1.3

373.18

308.20

pmol/l

0.87

134

1131

Other benign neoplasms of uterus

255

1.50

1.58

1.2

1.3

304.32

302.73

pmol/l

0.01

216

Recurrent aphthous stomatitis , including avohilmo

106

840

1.27

1.58

1.4

1.3

388.76

344.84

pmol/l

0.28

714

Diseases of middle ear and mastoid

446

3253

1.12

1.57

1.4

553.35

393.22

pmol/l

0.31

387

2794

Other otitis externa (chronic)

347

1.42

1.55

1.2

1.4

302.10

334.67

pmol/l

0.20

301

Other appendicitis

432

1.37

1.54

1.3

227.29

323.92

pmol/l

2.46

369

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

128

1039

1.23

1.54

1.2

1.3

402.03

344.13

pmol/l

0.27

113

878

Coxarthrosis, primary

461

3433

1.12

1.52

1.2

1.3

273.70

325.81

pmol/l

0.92

403

2895

Viral warts

528

1.33

1.52

1.4

357.79

345.90

pmol/l

0.11

453

Other and unspecified injuries of head

357

1.41

1.52

1.4

1.3

289.45

324.11

pmol/l

0.40

303

Female infertility, tubal origin

233

1.51

1.52

1.7

1.4

359.86

352.62

pmol/l

0.03

207

Diabetic maculopathy

121

924

1.24

1.52

1.3

1.4

267.11

324.23

pmol/l

0.74

773

Monoarthritis, not elsewhere classified

193

1.56

1.51

1.7

1.4

333.76

357.30

pmol/l

0.13

167

Any dementia, excluding more controls

177

1445

0.84

1.51

1.1

1.3

270.03

270.09

pmol/l

0.00

144

1195

Benign leiomyoma with endometriosis

121

980

1.24

1.51

1.3

329.23

341.93

pmol/l

0.13

106

846

Hallux valgus (acquired)

257

1587

1.16

1.51

1.4

1.3

400.68

321.41

pmol/l

0.35

225

1362

MS-disease / Multiple Sclerosis

375

1.39

1.50

1.4

294.52

365.40

pmol/l

0.75

325

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

361

2153

1.13

1.50

1.3

279.49

338.78

pmol/l

0.64

327

1820

Other specified and unspecified disorders of eye and adnexa

170

1.60

1.49

1.7

1.3

370.94

344.20

pmol/l

0.11

149

Allergic contact dermatitis

767

1.27

1.49

1.2

1.4

328.56

379.19

pmol/l

0.52

666

Purpura and other haemorrhagic conditions

732

1.27

1.48

1.4

1.3

440.24

304.30

pmol/l

0.53

615

Degenerative macular diseases

609

1.30

1.48

1.3

266.53

292.50

pmol/l

0.43

507

Excessive attrition of teeth

500

4472

1.11

1.48

1.4

310.55

390.27

pmol/l

1.54

438

3859

Parkinson's disease, including avohilmo

105

840

1.25

1.46

1.1

1.3

238.95

281.20

pmol/l

1.15

695

Complications predominantly related to the puerperium

190

1613

1.18

1.46

1.4

388.91

473.55

pmol/l

0.59

172

1414

Phlebitis and thrombophlebitis (not including DVT)

171

1439

1.19

1.45

1.3

303.19

404.25

pmol/l

0.71

146

1208

Macular cyst

140

1.66

1.45

1.2

1.3

320.25

274.16

pmol/l

0.18

117

Streptococcal septicaemia

437

1.36

1.45

1.2

1.3

319.94

302.88

pmol/l

0.07

365

Inflammatory bowel disease, strict (require KELA)

170

1430

1.19

1.45

1.4

362.23

476.88

pmol/l

0.56

151

1236

Fracture at wrist and hand level

267

2320

1.15

1.45

1.4

274.94

420.43

pmol/l

1.60

230

1990

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

175

1430

1.19

1.45

1.8

1.3

300.35

359.01

pmol/l

0.29

152

1185

Strabismus

194

1646

1.18

1.45

1.3

1.4

352.37

369.54

pmol/l

0.14

162

1408

Injury of blood vessels at abdomen, lower back and pelvis level

2.79

1.45

1.3

1.2

285.50

287.32

pmol/l

—

Open wound of ankle and foot

550

1.31

1.44

1.3

1.4

245.41

322.37

pmol/l

1.79

466

Progressive vascular leukoencephalopathy

148

1.63

1.44

1.3

1.2

279.68

234.93

pmol/l

0.38

125

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

2.77

1.44

1.2

1.1

592.83

262.14

pmol/l

—

Sequelae of injuries of lower limb

507

1.33

1.44

1.2

1.4

244.81

321.97

pmol/l

2.15

431

Other hammer toe(s) (acquired)

130

969

1.22

1.44

1.2

1.3

275.08

293.11

pmol/l

0.36

112

816

Nummular dermatitis

438

1.35

1.44

1.4

1.3

278.67

302.52

pmol/l

0.28

371

Varicose veins

481

3277

1.11

1.43

1.2

1.3

289.43

331.33

pmol/l

0.64

403

2803

Other and unspecified nonorganic psychotic disorders

137

1131

1.21

1.43

1.3

1.4

446.97

416.67

pmol/l

0.10

110

996

Pyothorax

188

1.55

1.43

1.7

1.3

270.14

325.74

pmol/l

0.44

163

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

328

1.41

1.43

1.3

1.5

344.44

361.38

pmol/l

0.16

280

Vasomotor rhinitis (mode)

379

1.38

1.42

1.2

1.4

279.37

330.17

pmol/l

0.66

324

Ulcer of oesophagus

303

1.43

1.42

1.1

1.4

223.69

297.00

pmol/l

1.02

261

Subarachnoid haemorrhage

517

1.32

1.42

1.4

1.3

296.09

342.95

pmol/l

0.29

446

Etanercept

354

1.39

1.41

1.3

1.4

326.84

344.05

pmol/l

0.09

306

Drug-induced obesity

2.28

1.41

1.7

1.4

355.33

451.69

pmol/l

—

Fitting and adjustment of other devices

264

2028

1.15

1.41

1.2

1.3

300.86

297.08

pmol/l

0.05

221

1695

Cardiomyopathies, Primary/intrinsic

570

1.30

1.41

1.1

1.4

314.27

470.80

pmol/l

0.39

468

Childhood allergy (age < 16)

548

1.28

1.40

1.6

1.5

424.63

625.55

pmol/l

0.52

479

Contact with nonpowered hand tool

189

1.54

1.40

1.7

1.4

355.57

355.16

pmol/l

0.00

161

Benign neoplasm of bone and articular cartilage

432

1.35

1.39

1.2

1.4

897.86

325.32

pmol/l

0.66

377

Eustachian salpingitis and obstruction

415

1.35

1.39

1.2

1.5

298.53

359.78

pmol/l

0.84

363

Failure and rejection of transplanted organs and tissues

2.02

1.39

1.0

1.5

370.83

395.39

pmol/l

0.11

Patellar tendinitis

2.02

1.38

1.8

1.3

259.50

445.70

pmol/l

1.10

Infections specific to the perinatal period

2.22

1.37

1.4

1.6

480.78

315.72

pmol/l

—

L02BA Anti-estrogens

1061

0.79

1.37

1.4

1.3

416.14

352.14

pmol/l

0.18

920

Other strabismus

156

1305

1.19

1.37

1.3

1.4

357.58

379.28

pmol/l

0.15

132

1131

Acute alcohol intoxication, ICD10

146

1219

1.20

1.37

1.3

1.4

298.94

422.67

pmol/l

0.74

114

1031

Other noninflammatory disorders of vagina

399

1.36

1.37

1.3

341.25

339.25

pmol/l

0.01

347

Idiopathic urticaria

112

1.71

1.36

1.5

1.4

341.74

407.01

pmol/l

0.58

100

Malignant neoplasm of bladder, including Hilmo

531

1.30

1.36

1.1

1.3

269.25

271.64

pmol/l

0.03

431

Abnormal findings in nipple discharge synovial fluid wound secretions

1.89

1.35

1.4

1.3

347.56

330.13

pmol/l

—

Paranoid personality disorder

1.88

1.35

1.5

497.00

482.84

pmol/l

—

Hidradenitis suppurativa

159

1.58

1.35

1.2

1.3

278.88

394.11

pmol/l

1.54

136

Ehlers-Danlos syndrome

2.16

1.34

1.1

1.4

332.10

474.14

pmol/l

—

Inflammatory disorders of male genital organs, not elsewhere classified

2.15

1.34

1.3

210.60

268.49

pmol/l

—

Corneal ulcer

135

1122

1.21

1.34

1.4

1.3

306.39

342.80

pmol/l

0.55

115

965

Malignant neoplasm of oropharynx

1.93

1.34

1.2

1.5

255.46

364.72

pmol/l

1.08

Sudden idiopathic hearing loss

558

1.30

1.33

1.4

1.3

263.57

288.74

pmol/l

0.43

475

Sixth [abducent] nerve palsy

144

1.61

1.32

1.1

1.3

362.81

342.20

pmol/l

0.07

125

Melanocytic naevi of other and unspecified parts of face

300

1.41

1.31

1.5

1.4

295.19

323.50

pmol/l

0.31

258

Inflammatory disease of cervix uteri

317

1.39

1.31

1.1

1.3

283.03

311.55

pmol/l

0.28

274

Congenital malformations of cardiac septa

315

1.39

1.31

1.5

1.4

311.94

382.89

pmol/l

0.67

270

Carcinoma in situ of other and unspecified digestive organs

209

1.49

1.30

1.7

1.3

284.54

302.60

pmol/l

0.14

181

Congenital malformations of eye, ear, face and neck

309

1.40

1.30

1.5

1.4

285.81

412.56

pmol/l

1.46

259

Renal agenesis and other reduction defects of kidney

2.83

1.29

1.8

1.2

496.40

707.06

pmol/l

—

Examination and encounter for administrative purposes

412

1.34

1.29

1.3

297.81

261.02

pmol/l

0.27

333

Focal brain injury

234

1.46

1.29

1.1

1.3

275.00

273.43

pmol/l

0.01

195

Malignant neoplasm of digestive organs, including Hilmo

311

2028

1.13

1.28

1.2

1.3

334.37

340.94

pmol/l

0.04

265

1694

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

491

1.31

1.28

1.2

1.3

307.91

315.84

pmol/l

0.09

423

Streptococcal septicaemia, including avohilmo

448

1.32

1.27

1.2

1.3

319.94

302.79

pmol/l

0.07

375

Ectopic pregnancy

129

1075

1.20

1.26

1.5

1.4

727.06

455.11

pmol/l

0.49

108

948

Conductive hearing loss, unspecified

432

1.32

1.25

1.3

1.4

264.87

310.26

pmol/l

0.51

372

Basal cell carcinoma, including Hilmo

345

2088

1.12

1.25

1.3

267.56

337.53

pmol/l

0.78

314

1762

Septal defects

297

1.39

1.24

1.5

1.4

319.48

386.21

pmol/l

0.56

255

Single spontaneous delivery

251

1510

0.88

1.24

1.3

342.84

363.31

pmol/l

0.29

218

1313

Viral haemorrhagic fevers, not elsewhere classified/unspecified

398

1.34

1.24

1.4

1.3

328.64

317.32

pmol/l

0.07

339

Endometriosis ASRM stages 1,2

128

1069

1.20

1.23

1.5

1.4

460.63

499.23

pmol/l

0.09

118

938

Liposarcoma, including Hilmo

2.07

1.23

1.2

1.4

224.10

372.34

pmol/l

—

Endometriosis of ovary

115

895

1.21

1.22

1.4

1.3

443.99

328.80

pmol/l

0.35

106

786

Postpartum haemorrhage

130

1278

0.84

1.22

1.5

347.81

447.22

pmol/l

1.68

117

1145

Pneumonia due to Streptococcus pneumoniae

172

1.52

1.20

1.3

1.4

683.88

339.81

pmol/l

0.88

152

Open wound of abdomen, lower back and pelvis

140

1.58

1.20

1.3

1.4

722.82

345.61

pmol/l

0.75

126

Cardiomyopathy (excluding other)

594

1.27

1.19

1.1

1.4

314.27

469.94

pmol/l

0.40

484

Acute and transient psychotic disorders

648

1.25

1.19

1.3

1.4

408.98

371.38

pmol/l

0.16

565

Thyroiditis

384

1.33

1.18

1.5

1.4

343.65

328.44

pmol/l

0.13

336

Injuries to the hip and thigh

359

2900

1.11

1.18

1.3

288.09

339.99

pmol/l

0.65

296

2454

malignant neoplasm of male genital organs

184

953

1.16

1.18

1.7

1.3

256.40

391.76

pmol/l

0.63

149

765

Dysplasia of cervi uteri

159

953

1.18

1.17

1.5

1.4

668.99

350.52

pmol/l

1.03

135

845

Carcinoma in situ of skin

437

1.31

1.17

1.4

1.3

235.46

277.99

pmol/l

0.92

362

Macular pucker

113

940

1.21

1.15

1.2

1.3

270.86

318.63

pmol/l

0.57

785

Benign mammary dysplasia

102

840

1.22

1.15

1.5

1.2

271.56

316.90

pmol/l

0.96

721

Nasal polyp

133

1124

1.19

1.14

1.4

1.3

1036.84

333.75

pmol/l

0.46

120

945

Viral hepatitis

352

1.34

1.14

1.4

294.67

365.80

pmol/l

0.95

303

Superficial injury of shoulder and upper arm

661

1.24

1.14

1.1

1.4

251.07

320.47

pmol/l

1.85

566

Mixed connective tissue disease

1.77

1.13

1.2

1.4

415.50

361.96

pmol/l

0.17

Other malignant neoplasms of skin (=non-melanoma skin cancer)

340

2075

1.11

1.13

1.3

273.41

339.29

pmol/l

0.71

305

1751

Epiphora

103

1.66

1.13

1.2

1.3

342.06

294.00

pmol/l

0.24

Suggestive for eosinophilic asthma

475

1.29

1.12

1.5

1.3

1937.58

284.14

pmol/l

0.50

408

Ascites

370

1.33

1.12

1.2

1.3

595.17

316.05

pmol/l

0.91

320

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

113

943

1.20

1.12

1.4

379.13

325.26

pmol/l

0.86

816

Tubulo-interstitial nephritis, not specified as acute or chronic

284

1.38

1.12

1.3

405.79

336.84

pmol/l

0.32

243

Benign neoplasm: Tongue

127

1.59

1.12

1.3

1.4

327.77

339.73

pmol/l

0.05

113

Malignant neoplasm of oropharynx, including Hilmo

1.72

1.12

1.2

1.5

233.20

332.61

pmol/l

1.15

Contusion of toe(s) without damage to nail

127

1.58

1.12

1.5

1.4

287.20

411.27

pmol/l

0.79

104

Other viral hepatitis

293

1.37

1.11

1.3

1.4

288.79

383.05

pmol/l

1.20

252

Pleural plaque with presence of asbestos

293

1.37

1.11

1.1

1.3

253.28

253.15

pmol/l

0.00

224

Benign neoplasm: Peripheral nerves and autonomic nervous system

1.80

1.11

1.6

1.3

383.23

332.18

pmol/l

0.34

Inflammatory diseases of prostate (prostatitis)

609

1.25

1.11

1.4

1.3

313.36

465.52

pmol/l

0.41

499

Patent foramen ovale

1.68

1.10

1.1

1.4

347.89

513.17

pmol/l

—

malignant neoplasm of male genital organs, including Hilmo

188

979

1.15

1.10

1.7

1.3

254.78

388.09

pmol/l

0.64

151

787

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

328

1.35

1.10

1.3

1.5

440.53

348.05

pmol/l

0.50

282

Tongue abnormality

311

1.36

1.10

1.3

337.41

322.68

pmol/l

0.08

265

Viral warts, including avohilmo

158

1360

1.16

1.10

1.4

340.31

361.40

pmol/l

0.26

136

1171

Other specified/unspecified hearing loss

468

1.29

1.10

1.3

384.44

308.93

pmol/l

0.58

396

Malignant neoplasm of prostate, including Hilmo

181

924

1.16

1.09

1.7

1.3

250.16

393.77

pmol/l

0.66

145

747

Anogenital herpesviral [herpes simplex] infection, including avohilmo

584

1.25

1.09

1.3

1.4

360.30

553.30

pmol/l

0.56

516

Diseases of tongue

320

1.35

1.09

1.3

332.12

300.39

pmol/l

0.19

273

Colorectal cancer, including Hilmo

183

1485

1.15

1.08

1.2

1.3

336.13

356.58

pmol/l

0.08

161

1233

ILD, hospital admissions 1, main diag only

711

1.23

1.08

1.2

1.3

313.71

287.76

pmol/l

0.29

582

Glaucoma-related operations

278

1.37

1.08

1.8

1.3

343.45

298.99

pmol/l

0.31

231

malignant neoplasm of female genital organs, including Hilmo

127

1025

1.18

1.07

1.2

1.3

465.82

302.95

pmol/l

0.82

114

884

Other disorders of veins

321

2851

1.11

1.07

1.3

410.23

358.78

pmol/l

0.26

265

2454

Other keratitis

631

1.24

1.06

1.4

395.90

319.47

pmol/l

1.14

542

Malignant neoplasm of prostate

176

902

1.16

1.06

1.7

1.3

251.78

396.49

pmol/l

0.64

143

726

Viral hepatitis, including avohilmo

383

1.31

1.05

1.4

307.27

361.74

pmol/l

0.68

326

Fracture of femur

178

1397

1.15

1.05

1.3

238.96

305.46

pmol/l

1.74

142

1166

Ulcerative colitis (strict definition, require KELA)

117

987

1.19

1.05

1.4

378.55

324.76

pmol/l

0.89

103

851

Congenital malformations of breast

1.80

1.05

1.4

331.67

444.34

pmol/l

0.55

Delivery

256

1514

0.89

1.04

1.3

347.99

364.64

pmol/l

0.23

224

1316

Basal cell carcinoma

328

2019

1.11

1.04

1.3

267.21

338.61

pmol/l

0.76

297

1701

Maternal care for known or suspected abnormality of pelvic organs

178

1045

1.15

1.04

1.6

1.5

1064.05

410.35

pmol/l

0.60

159

935

Injury of muscle and tendon at hip and thigh level

589

1.24

1.03

1.5

1.4

332.30

317.33

pmol/l

0.12

506

Wet age-related macular degeneration

105

848

1.20

1.02

1.2

325.84

259.67

pmol/l

1.08

694

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

1.90

1.02

2.3

1.2

446.90

241.00

pmol/l

—

Other and unspecified injuries of wrist and hand

197

1.43

1.00

1.1

1.4

251.65

355.76

pmol/l

1.33

169

Sequelae of infectious and parasitic diseases, including avohilmo

352

1.31

0.99

1.3

1.4

312.21

331.31

pmol/l

0.14

304

Acute epiglottitis

1.82

0.99

1.4

341.09

381.16

pmol/l

0.14

Arthropod-borne viral fevers and viral haemorrhagic fevers

494

1.26

0.98

1.3

329.98

313.49

pmol/l

0.13

414

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

355

1.31

0.98

1.6

1.4

2519.77

432.40

pmol/l

0.47

305

Malignant neoplasm of pancreas, including Hilmo

432

1.28

0.98

1.4

1.3

278.72

293.43

pmol/l

0.16

367

Other menopausal disorders

196

960

1.14

0.97

1.4

1.3

348.28

301.83

pmol/l

0.84

179

846

Disorders of acoustic nerve

132

1.53

0.97

1.5

1.4

238.27

331.36

pmol/l

1.23

114

Other or ill-defined heart diseases

232

1.38

0.97

1.2

1.4

295.96

300.16

pmol/l

0.02

192

Other congenital malformations of intestine, including avohilmo

1.82

0.97

1.8

1.3

450.33

577.70

pmol/l

—

Malignant neoplasm of colon, including Hilmo

121

1028

1.17

0.97

1.1

1.3

375.74

284.55

pmol/l

0.44

108

852

Superficial injuries involving multiple body regions

116

1.56

0.97

1.2

1.4

131.77

375.09

pmol/l

4.96

103

Obstructed labour due to malposition and malpresentation of fetus

117

1269

0.85

0.96

1.3

1.5

408.63

448.69

pmol/l

0.28

106

1136

Secondary and unspecified malignant neoplasm of lymph nodes

425

1.27

0.95

1.4

1.3

327.16

306.36

pmol/l

0.20

355

Bacterial, viral and other infectious agents

435

1.27

0.94

1.2

1.4

310.64

340.51

pmol/l

0.36

372

Abrasion of teeth

281

2542

1.11

0.94

1.4

1.3

318.13

381.26

pmol/l

0.74

246

2181

Use of disulfiram, acamprosate or naltrexone

480

1.25

0.93

1.5

1.4

729.24

335.91

pmol/l

0.46

412

Memory loss

472

1.25

0.92

1.4

1.3

343.27

296.14

pmol/l

0.68

394

Other degenerative diseases of the basal ganglia

1.68

0.92

1.2

1.3

214.50

267.28

pmol/l

—

Other embolism and thrombosis

744

1.20

0.92

1.3

340.19

305.76

pmol/l

0.48

626

Other obstructed labour

401

1.28

0.92

1.1

1.4

270.86

432.96

pmol/l

1.46

364

Other viral hepatitis, including avohilmo

314

1.31

0.90

1.3

1.5

291.94

380.12

pmol/l

1.15

268

Other (seronegative) rheumatoid arthritis, wide

131

1134

1.16

0.90

1.4

1.3

367.10

331.26

pmol/l

0.37

114

970

Reactive arthropathies

474

1.25

0.89

1.2

1.4

332.94

314.91

pmol/l

0.18

399

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

123

1060

1.16

0.89

1.4

371.56

347.48

pmol/l

0.25

107

917

Lichen sclerosus et atrophicus

719

1.20

0.89

1.5

1.3

318.83

356.16

pmol/l

0.34

621

Entropion and trichiasis of eyelid

385

1.28

0.89

1.1

1.3

235.35

273.47

pmol/l

0.72

322

Congenital malformations of breast, including avohilmo

1.70

0.89

1.4

331.67

446.98

pmol/l

0.59

Complications of labour and delivery

430

2586

0.92

0.89

1.4

583.76

367.88

pmol/l

0.43

370

2290

Other peripheral vascular diseases

394

1.27

0.89

1.2

1.4

235.76

341.34

pmol/l

2.36

340

Contact with heat and hot substances

254

1.34

0.88

1.4

455.79

355.79

pmol/l

0.29

219

Lichen planus

766

1.19

0.88

1.3

301.77

338.77

pmol/l

0.36

655

Congenital malformations of genital organs

490

1.24

0.88

1.6

1.4

285.13

362.36

pmol/l

1.89

434

Special screening examination for infectious and parasitic diseases

152

969

1.15

0.87

1.6

1.4

378.42

322.07

pmol/l

0.96

130

848

Acute appendicitis, with complications

132

1146

1.15

0.87

1.3

279.96

404.53

pmol/l

0.76

114

968

Colorectal adenocarcinoma

133

1140

1.15

0.87

1.2

1.3

281.19

368.78

pmol/l

0.44

116

944

Seborrhoeic keratosis

182

1615

1.13

0.87

1.6

1.3

306.46

316.45

pmol/l

0.16

164

1365

Melanocytic naevi of lower limb, including hip

229

1.36

0.87

1.5

1.4

421.31

336.33

pmol/l

0.50

198

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

357

0.73

0.86

1.5

1.4

470.81

663.19

pmol/l

0.28

316

Ulcerative colitis (strict definition, all Crohn cases excluded)

823

1.18

0.86

1.3

1.4

388.91

324.32

pmol/l

0.96

715

Early lumbar disc prolapse operation

585

1.22

0.86

1.3

1.4

345.95

353.03

pmol/l

0.05

512

Other specified/unspecified bacterial intestinal infections

334

1.29

0.86

1.3

1.4

386.05

331.45

pmol/l

0.37

285

Alcohol abuse, main dg

105

897

1.17

0.86

1.4

293.98

432.50

pmol/l

0.62

764

Maternal care for other conditions predominantly related to pregnancy

131

1110

1.15

0.85

1.4

1.5

358.78

445.36

pmol/l

1.18

111

995

Myocardial infarction, with ST-elevation

102

870

1.17

0.85

1.2

1.3

192.60

282.96

pmol/l

4.83

714

Spontaneous abortion

346

2124

1.09

0.85

1.4

356.28

403.81

pmol/l

0.29

306

1896

Schizoaffective disorder

397

1.26

0.85

1.2

1.4

544.70

346.57

pmol/l

0.80

347

Acute poliomyelitis

1.77

0.84

1.3

1.2

145.90

336.90

pmol/l

—

Acute poliomyelitis, including avohilmo

1.77

0.84

1.3

1.2

145.90

336.90

pmol/l

—

Postpartum hemorraghe, all women as controls

130

1453

0.87

0.84

1.5

347.81

506.67

pmol/l

1.34

117

1289

Seropositive rheumatoid arthritis, strict definition

106

909

1.17

0.84

1.2

1.3

299.63

358.65

pmol/l

0.85

775

Acute alcohol intoxication ICD-9

129

1.48

0.83

1.4

1.5

304.43

327.37

pmol/l

0.12

112

Additional codes for the location of defect, injury or illness

283

1.31

0.83

1.2

1.4

235.56

336.89

pmol/l

1.59

243

Parkinson's disease

808

1.18

0.83

1.1

1.3

240.63

277.52

pmol/l

0.85

669

Long labour

131

1271

0.87

0.83

1.6

1.5

337.18

442.07

pmol/l

1.92

121

1137

Valvular operations

670

1.20

0.83

1.2

1.4

308.89

431.09

pmol/l

0.34

547

Ulcerative rectosigmoiditis

417

1.25

0.82

1.4

537.26

310.50

pmol/l

1.14

360

Follow-up examination after treatment for malignant neoplasms

498

1.23

0.82

1.2

296.70

271.98

pmol/l

0.25

412

Maternal care related to the fetus and amniotic cavity and possible delivery problems

275

1770

0.91

0.81

1.4

381.22

389.69

pmol/l

0.10

241

1581

Left bundle-branch block

346

1.28

0.81

1.3

243.82

273.32

pmol/l

0.39

289

Medicines for HER+ breast cancer

236

2425

0.90

0.81

1.3

331.12

322.33

pmol/l

0.06

209

2119

Pigmented purpuric dermatosis

1.72

0.81

1.4

1.2

300.63

345.93

pmol/l

—

Presbyopia

436

1.24

0.80

1.5

1.4

291.80

328.47

pmol/l

0.58

383

463

1.23

0.80

1.5

1.6

315.73

732.85

pmol/l

1.17

412

Primary open-angle glaucoma

210

1818

1.11

0.80

1.3

264.37

300.02

pmol/l

0.82

182

1509

Bacterial pneumoniae

285

2285

1.10

0.80

1.3

310.84

354.48

pmol/l

0.41

239

1950

Diabetic neuropathy

845

1.17

0.79

1.2

1.3

299.81

307.05

pmol/l

0.06

688

Carcinoma in situ of skin of trunk

139

1.45

0.79

1.3

243.65

248.59

pmol/l

0.04

116

Embedded and impacted teeth

138

1273

0.88

0.79

1.3

1.5

373.62

479.20

pmol/l

0.62

123

1113

Fracture of forearm

438

3661

1.08

0.79

1.4

1.3

377.38

378.80

pmol/l

0.01

375

3170

Neuroendocrine tumor and carcinoma of small intestine

1.68

0.79

1.4

1.5

304.00

356.12

pmol/l

0.26

Injuries involving multiple body regions

173

1.39

0.79

1.3

1.4

159.44

382.34

pmol/l

4.01

151

Agranulocytosis

620

1.20

0.78

1.3

535.17

361.75

pmol/l

0.47

533

Nonsuppurative otitis media, including avohilmo

222

1735

1.11

0.78

1.4

823.47

381.57

pmol/l

0.49

200

1501

Hepatocellular carcinoma, including Hilmo

123

1.47

0.77

1.0

1.4

444.28

309.40

pmol/l

0.39

102

Acne, including avohilmo

137

974

1.14

0.77

1.4

1.5

380.27

528.70

pmol/l

0.73

124

849

Abnormal findings in secretions and smears from cervix uteri vagina vulva

378

2575

1.08

0.77

1.5

1.4

456.55

400.14

pmol/l

0.29

336

2274

Nonsuppurative otitis media

148

1135

1.13

0.77

1.4

1029.79

371.61

pmol/l

0.48

132

980

Non-small cell lung cancer

522

0.79

0.77

1.0

1.3

311.97

286.40

pmol/l

0.28

436

Chalazion

603

1.20

0.76

1.5

1.3

330.89

313.23

pmol/l

0.16

523

Erythema multiforme

107

1.50

0.76

1.8

1.4

240.09

361.81

pmol/l

0.84

Convalescence

270

1.30

0.76

1.7

1.4

383.35

359.81

pmol/l

0.18

230

Other pulmonary heart/vessel disease

183

1.37

0.76

1.2

1.3

206.65

278.16

pmol/l

1.10

155

Drug-induced neutropenia

386

1.25

0.75

1.4

1.3

717.29

321.22

pmol/l

0.81

329

Other disorders of skin and subcutaneous tissue, not elsewhere classified

798

1.17

0.75

1.3

296.14

338.73

pmol/l

0.37

683

Disorders of tooth development and eruption

111

784

1.15

0.75

1.4

280.28

467.93

pmol/l

0.80

667

Congenital malformations of uterus and cervix

1.57

0.75

1.1

1.4

224.92

474.23

pmol/l

3.76

Exposure to other and unspecified inanimate mechanical forces

396

1.24

0.74

1.3

1.4

263.97

339.47

pmol/l

1.34

341

Raynaud syndrome

487

1.21

0.73

1.3

1.4

296.82

339.78

pmol/l

0.50

425

Effects of foreign body entering through natural orifice

166

1485

1.12

0.73

1.3

1.4

286.52

406.00

pmol/l

0.92

146

1262

Certain zoonotic bacterial diseases, including avohilmo

133

0.60

0.73

1.6

1.4

302.50

342.31

pmol/l

—

121

Superficial injury of hip and thigh

837

1.16

0.73

1.2

1.3

320.36

303.15

pmol/l

0.11

706

Colon adenocarcinoma

643

1.18

0.73

1.1

1.3

258.22

284.20

pmol/l

0.44

535

Deep endometriosis

524

1.21

0.73

1.4

1.3

341.49

340.12

pmol/l

0.01

453

Other disorders of the genitourinary system

764

1.17

0.72

1.3

294.29

343.84

pmol/l

0.51

649

Intrahepatic Cholestasis of Pregnancy (ICP)

345

0.75

0.72

1.5

1.4

470.81

385.39

pmol/l

0.31

306

Other congenital malformations of peripheral vascular system

1.68

0.72

1.8

1.3

363.50

516.22

pmol/l

—

Inguinal hernia, bilateral

545

0.81

0.72

1.3

1.4

2472.56

289.61

pmol/l

0.48

450

Leiomyosarcoma

1.77

0.72

1.0

1.3

439.43

374.29

pmol/l

—

Bacterial pneumonia, not elsewhere classified

264

2125

1.09

0.71

1.3

291.94

359.61

pmol/l

0.69

225

1804

Primary open-angle glaucoma, strict

172

1541

1.11

0.71

1.3

262.53

304.38

pmol/l

0.87

147

1285

Benign neoplasm: Connective and other soft tissue, unspecified

1.59

0.71

1.2

126.78

367.50

pmol/l

—

Postmenopausal atrophic vaginitis

184

900

1.12

0.71

1.2

1.3

270.81

290.45

pmol/l

0.32

165

788

Benign neoplasm: Vagina

1.59

0.71

1.3

1.2

292.11

348.46

pmol/l

—

Inguinal or femoral hernia, bilateral

555

0.81

0.71

1.3

1.4

2416.67

289.56

pmol/l

0.48

459

Scar conditions and fibrosis of skin

203

1.34

0.71

1.3

346.45

343.94

pmol/l

0.01

180

Orchitis and epididymitis

444

1.22

0.70

1.8

1.3

298.48

302.96

pmol/l

0.04

366

severe traumatic brain injury, does not include concussion

139

1235

1.13

0.70

1.3

284.35

377.88

pmol/l

0.53

111

1016

L02BG Aromatase inhibitors

191

2081

0.90

0.70

1.3

340.84

314.47

pmol/l

0.17

169

1816

Tuberculosis, IBD comorbidity

292

1.27

0.69

1.3

252.00

308.58

pmol/l

0.54

248

Reactive arthropathies, FINNGEN

337

1.25

0.69

1.2

1.4

347.39

335.25

pmol/l

0.09

288

Malignant neoplasm of gallbladder

1.87

0.69

1.6

1.1

349.20

285.00

pmol/l

—

Osteomalacia

1.68

0.69

1.3

490.71

385.86

pmol/l

—

Disorders of male genital organs in diseases classified elsewhere

1.87

0.69

1.0

1.2

190.60

266.64

pmol/l

—

Abscess of external ear

1.53

0.68

2.6

1.3

219.44

372.13

pmol/l

—

Hydrocele

528

1.20

0.68

1.6

1.3

261.95

496.51

pmol/l

0.61

430

Postpartum hemorraghe, parous women as controls

130

1224

0.89

0.68

1.5

1.4

347.81

501.49

pmol/l

1.05

117

1085

Atypical virus infections of central nervous system

1.64

0.67

1.3

121.86

383.63

pmol/l

—

Atypical virus infections of central nervous system, including avohilmo

1.64

0.67

1.3

121.86

383.63

pmol/l

—

Carcinoma in situ of skin of ear and external auricular canal

1.64

0.67

1.0

1.2

307.29

215.29

pmol/l

—

Non-small cell lung cancer, squamous, helper endpoint

191

0.68

0.66

1.0

1.3

336.38

255.46

pmol/l

—

157

Tuberculosis, wide

294

1.26

0.66

1.3

252.00

306.56

pmol/l

0.51

250

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

570

1.18

0.66

1.2

1.3

315.96

283.03

pmol/l

0.33

463

Pedal cyclist injured in noncollision transport accidents

660

1.17

0.66

1.2

1.4

292.88

319.74

pmol/l

0.29

568

Stenosis and insufficiency of lacrimal passages

485

1.20

0.65

1.3

287.92

369.34

pmol/l

0.71

418

Malignant neoplasm of head and neck

412

1.22

0.65

1.2

1.3

321.50

306.81

pmol/l

0.11

352

Malignant neoplasm of head and neck, including Hilmo

513

1.19

0.65

1.2

1.3

348.27

298.85

pmol/l

0.35

430

Other epidermal thickening

207

1.31

0.63

1.1

1.3

320.40

327.56

pmol/l

0.03

180

Other orthopaedic follow-up care

287

1.26

0.63

1.2

1.4

310.13

349.03

pmol/l

0.33

245

Injury of other and unspecified intrathoracic organs

296

1.25

0.63

1.3

237.87

324.60

pmol/l

1.25

245

malignant neoplasm of female genital organs

107

922

1.14

0.63

1.1

1.2

511.72

298.76

pmol/l

0.95

788

Maternal care for other known or suspected fetal problems

156

879

1.11

0.63

1.4

1.5

1053.31

432.26

pmol/l

0.46

134

790

Malignant neoplasm of bronchus and lung

880

0.87

0.63

1.3

262.78

278.98

pmol/l

0.29

726

Pedal cyclist injured in collision with motor vehicle

153

0.65

0.63

1.3

1.4

364.70

371.12

pmol/l

—

134

LSIL lesion of the cervix uteri, vagina or vulva

822

1.15

0.63

1.6

1.4

405.80

563.12

pmol/l

0.60

727

Deep bite

533

1.17

0.62

1.6

1.4

391.87

355.12

pmol/l

0.28

464

Pedestrian injured in transport accident

333

1.23

0.62

1.1

1.4

278.22

328.90

pmol/l

0.35

282

Malignant neoplasm of tonsil

1.60

0.62

1.2

1.4

275.90

356.53

pmol/l

—

Bacterial pneumonia (organism specified)

299

2516

1.08

0.61

1.3

317.36

353.87

pmol/l

0.35

252

2117

Ethmoidectomy

749

1.15

0.61

1.3

1.4

1504.36

321.83

pmol/l

0.49

635

Hypertrophy of (infrapatellar) fat pad

1.58

0.60

1.1

1.2

171.13

320.78

pmol/l

—

Other papulosquamous disorders

1.58

0.60

1.4

1.2

87.62

282.48

pmol/l

—

Typhoid and paratyphoid fevers

0.00

0.60

0.0

1.3

—

229.48

—

Infections with a predominantly sexual mode of transmission

206

1885

1.09

0.60

1.4

1.5

453.25

439.59

pmol/l

0.05

175

1651

Premature rupture of membranes

112

897

0.89

0.60

1.4

1.5

405.62

429.77

pmol/l

0.21

803

Foreign body or object entering through skin

299

1.24

0.59

1.3

1.4

261.09

351.09

pmol/l

1.24

256

Other disorders of choroid

1.57

0.59

1.5

1.3

468.60

263.86

pmol/l

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

846

1.14

0.58

1.1

1.3

443.13

422.50

pmol/l

0.05

704

Normotensive glaucoma

464

1.19

0.58

1.3

263.67

279.23

pmol/l

0.22

381

Puerperal sepsis

790

1.14

0.58

1.3

366.65

355.82

pmol/l

0.07

694

Lung diseases due to external agents

659

1.15

0.58

1.3

1598.82

287.18

pmol/l

0.51

547

Alcoholic liver disease

557

1.17

0.58

1.2

1.3

442.75

306.85

pmol/l

1.16

473

Other disorders of amniotic fluid and membranes

745

1.14

0.57

1.6

1.5

359.40

430.11

pmol/l

0.73

671

Nonischemic cardiomyopathy

511

1.18

0.57

1.2

1.4

268.78

290.95

pmol/l

0.22

435

FESS (DNB20)

718

1.14

0.56

1.3

1.4

1576.46

322.97

pmol/l

0.49

608

All dysplastic lesions of the cervix uteri, vagina or vulva

200

1795

1.09

0.55

1.6

1.4

582.05

444.00

pmol/l

0.42

175

1583

Unspecified urinary incontinence

467

1.18

0.55

1.2

401.53

307.04

pmol/l

0.61

393

Cysts of oral region, not elsewhere classified

293

1.23

0.55

1.2

1.4

257.41

333.20

pmol/l

1.21

251

Malignant neoplasm of breast, ER-negative, including Hilmo

151

1283

1.10

0.55

1.3

453.76

310.67

pmol/l

0.38

131

1120

Bacterial, viral and other infectious agents, including avohilmo

477

1.18

0.54

1.2

1.4

311.73

338.77

pmol/l

0.33

408

Benign neoplasm: Vulva

1.42

0.54

2.2

1.3

367.30

357.27

pmol/l

0.04

Placenta praevia

239

0.75

0.54

1.2

1.5

342.67

468.09

pmol/l

0.52

212

Tuberculosis, wide, including avohilmo

303

1.22

0.54

1.3

252.00

309.48

pmol/l

0.55

259

Parkinson's disease, strict definition

739

1.14

0.54

1.2

1.3

239.19

274.31

pmol/l

0.79

614

Toxic effects of substances chiefly nonmedicinal as to source

608

1.15

0.54

1.2

1.4

346.36

328.14

pmol/l

0.09

521

Malignant neoplasm of respiratory system and intrathoracic organs

110

1018

0.89

0.54

1.2

1.3

257.93

276.78

pmol/l

0.41

836

Secondary uncertain malignant neoplasm

721

1.14

0.53

1.4

1.3

352.32

291.79

pmol/l

0.77

595

False labour

201

1148

1.09

0.53

1.5

469.94

429.86

pmol/l

0.16

176

1028

Colon adenocarcinoma, helper endpoint

665

1.14

0.53

1.1

1.3

258.22

279.11

pmol/l

0.34

557

Organic, including symptomatic, mental disorders

327

2448

0.94

0.53

1.2

1.3

289.97

295.42

pmol/l

0.10

257

2046

Injury of eye and orbit

835

1.13

0.52

1.5

1.4

307.63

315.65

pmol/l

0.09

726

Personal history of malignant neoplasm

507

1.17

0.52

1.3

301.04

375.84

pmol/l

0.62

442

Other sexually transmitted chlamydial diseases, including avohilmo

490

0.84

0.52

1.5

463.69

620.33

pmol/l

0.32

428

1.45

0.52

1.4

323.33

407.20

pmol/l

0.36

Noise effects on inner ear

170

1.30

0.51

1.2

1.4

259.47

311.10

pmol/l

0.31

147

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

127

1150

1.11

0.51

1.4

1.3

348.23

285.85

pmol/l

0.45

112

962

Lichen planus, including avohilmo

136

1236

1.10

0.51

1.3

304.62

328.64

pmol/l

0.33

122

1054

Malignant neoplasm of digestive organs

264

1884

1.07

0.51

1.3

294.74

345.04

pmol/l

0.40

224

1567

Lung cancer and mesothelioma

115

878

1.11

0.51

1.3

263.22

266.63

pmol/l

0.05

737

Viral conjunctivitis

101

1.39

0.49

1.3

1.4

365.00

391.70

pmol/l

0.16

Endometriosis ASRM stages 3,4

154

1412

1.09

0.49

1.4

422.29

451.70

pmol/l

0.08

141

1230

Colorectal cancer

155

1363

1.09

0.49

1.2

1.3

278.71

361.11

pmol/l

0.51

135

1137

Anomalies of dental arch relationship, including avohilmo

130

1069

1.10

0.48

1.5

1.4

388.07

459.03

pmol/l

0.28

111

937

Malignant neoplasm of oral cavity, including Hilmo

208

1.25

0.48

1.3

1.4

442.33

326.91

pmol/l

0.36

178

Other specified and unspecified strabismus

1.50

0.47

1.0

1.2

357.86

366.60

pmol/l

—

HSIL lesion of the cervix uteri, vagina or vulva

127

1156

1.10

0.47

1.5

667.62

495.44

pmol/l

0.32

112

1027

Undescended testicle

1.49

0.47

1.1

1.3

222.71

250.70

pmol/l

—

Adenocarcinoma and papilloma adenocarcinoma of rectum

522

1.15

0.47

1.3

310.91

295.93

pmol/l

0.08

439

Struck by thrown, projected or falling objec

245

1.23

0.47

1.5

1.4

362.79

359.91

pmol/l

0.02

209

Foreign body entering into or through eye or natural orifice

402

1.17

0.46

1.4

454.40

319.19

pmol/l

0.52

341

Other/unspecified reactive arthropathies

319

1.19

0.46

1.2

1.4

363.09

341.97

pmol/l

0.15

274

Retinal detachment with retinal break

731

1.12

0.45

1.5

1.3

281.92

303.68

pmol/l

0.29

606

Use of levodopa decarboxylase inhibitor

731

1.12

0.45

1.2

1.3

230.41

278.75

pmol/l

1.19

604

Malignant neoplasm of stomach, including Hilmo

255

1.22

0.45

1.1

1.3

320.58

315.13

pmol/l

0.03

216

Use of teriflunomide

1.41

0.45

2.1

1.5

243.57

462.52

pmol/l

—

Malignant neoplasm of stomach

219

1.24

0.45

1.0

1.4

333.10

322.93

pmol/l

0.04

187

Malignant neoplasm of pancreas

339

1.18

0.44

1.5

1.3

284.91

302.37

pmol/l

0.15

288

Glucosamine medication

331

2502

1.06

0.43

1.3

271.65

298.13

pmol/l

0.81

273

2138

Supervision of high-risk pregnancy

118

778

0.91

0.43

1.3

1.5

378.01

406.54

pmol/l

0.25

106

698

Family history of other specific disorders

1.41

0.42

1.1

1.2

413.50

408.89

pmol/l

—

Non-allergic asthma

443

1.15

0.42

1.3

359.15

332.62

pmol/l

0.18

376

Non-small cell lung cancer, squamous

173

0.75

0.42

1.0

1.3

336.38

256.57

pmol/l

—

142

Other osteochondrodysplasias, including avohilmo

1.39

0.41

1.3

1.2

673.75

303.58

pmol/l

—

Epileptic seizures related to drugs

0.00

0.41

0.0

1.1

—

353.07

—

Fibrosarcoma

1.52

0.41

1.6

1.5

202.80

276.59

pmol/l

—

Malignant neoplasm of rectum, including Hilmo

652

1.12

0.41

1.3

308.93

291.16

pmol/l

0.12

542

Other disorders of cornea

549

1.13

0.40

1.2

1.3

311.26

313.11

pmol/l

0.02

475

Malignant neoplasm of tonsil and base of tongue

1.37

0.40

1.2

1.5

250.33

378.33

pmol/l

1.06

Acute bronchiolitis

234

1.20

0.39

1.8

1.5

327.26

424.04

pmol/l

0.78

211

Lichen ruber planus, wide definition including periferal and oral lichen planus

160

1488

1.08

0.39

1.3

299.65

323.86

pmol/l

0.40

144

1263

Myocardial infarction, unclassifiable

112

916

1.09

0.39

1.2

1.3

293.76

288.09

pmol/l

0.05

753

Maxillary hypoplasia

0.00

0.39

0.0

1.2

—

234.21

—

Down's syndrome

0.00

0.39

0.0

1.3

—

712.37

—

Retrobulbar neuritis in diseases classified elsewhere

0.00

0.39

0.0

1.3

—

406.00

—

Contraceptive management

282

2079

0.95

0.39

1.4

362.91

393.40

pmol/l

0.23

236

1837

Sequelae of infectious and parasitic diseases

344

1.16

0.38

1.3

1.4

319.87

335.17

pmol/l

0.10

296

Infections of genitourinary tract in pregnancy

495

1.13

0.38

1.3

1.4

437.12

417.09

pmol/l

0.08

436

Other specified disorders of external ear

170

1.24

0.37

1.2

1.3

265.00

319.82

pmol/l

0.48

145

Pemphigoid

116

1.30

0.37

1.1

1.4

198.80

280.51

pmol/l

—

100

Medical treatment for female infertility

127

1165

1.08

0.36

1.4

1.5

488.33

532.94

pmol/l

0.13

107

1047

Diseases caused by chlamydiae, including avohilmo

1.27

0.36

2.1

1.4

386.11

419.89

pmol/l

—

Other specified congenital malformation syndromes affecting multiple systems

1.27

0.36

1.2

1.3

242.33

493.62

pmol/l

—

Personal history of certain other diseases

1.27

0.36

1.6

1.4

318.56

407.05

pmol/l

—

Benign neoplasm: Scapula and long bones of upper limb

1.40

0.35

1.2

263.33

234.92

pmol/l

—

Maternal care for known or suspected malpresentation of fetus

100

776

0.92

0.34

1.5

471.02

442.48

pmol/l

0.21

700

Malignant neoplasm of tonsil, including Hilmo

1.38

0.34

1.2

1.4

275.90

350.63

pmol/l

—

Mental and behavioural disorders of puerperium, not classified elsewhere

1.37

0.34

2.0

1.3

330.50

472.00

pmol/l

—

Malignant neoplasm of colon

833

1.09

0.34

1.1

1.3

251.67

286.00

pmol/l

0.79

687

Delivery, wide proxy

209

1175

0.94

0.34

1.3

1.4

355.89

371.54

pmol/l

0.17

179

1015

Oral lichen planus, including avohilmo , including avohilmo

405

1.14

0.34

1.3

286.91

386.35

pmol/l

0.73

348

Acquired absence of limb

1.34

0.34

1.8

1.4

263.83

313.88

pmol/l

—

Malignant neoplasm of tonsil and base of tongue, including Hilmo

100

1.30

0.33

1.2

1.5

238.31

368.74

pmol/l

1.22

Carcinoma in situ of skin of other and unspecified parts of face

415

1.13

0.33

1.3

214.95

263.69

pmol/l

1.11

337

Transient global amnesia

529

1.12

0.33

1.6

1.3

293.54

350.48

pmol/l

0.47

448

HSIL lesion of the cervix uteri

112

1037

1.08

0.33

1.5

728.61

502.50

pmol/l

0.38

922

Glaucoma, exfoliation

510

1.12

0.33

1.2

1.3

277.60

268.40

pmol/l

0.08

411

Malignant neoplasm of renal pelvis, including Hilmo

1.31

0.33

1.0

1.3

235.67

272.72

pmol/l

—

Other abnormal products of conception

210

1302

1.06

0.33

1.5

394.04

482.33

pmol/l

0.43

183

1179

Burns and corrosions

778

1.09

0.33

1.3

1.4

288.01

322.29

pmol/l

0.24

665

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

903

1.09

0.33

1.3

340.78

298.76

pmol/l

0.60

752

Infectious mononucleosis, including avohilmo

408

1.13

0.31

1.3

1.5

357.02

400.62

pmol/l

0.46

358

Infectious mononucleosis

408

1.13

0.31

1.3

1.5

357.02

400.62

pmol/l

0.46

358

Mixed conductive and sensorineural hearing loss

666

1.10

0.31

1.3

239.89

330.63

pmol/l

1.16

565

Malignant neoplasm of bronchus and lung, including Hilmo

114

1021

0.93

0.31

1.3

262.92

275.35

pmol/l

0.22

838

Recurrent dislocation and subluxation of joint

352

1.14

0.30

1.2

1.4

263.00

344.66

pmol/l

1.60

305

LSIL lesion of the cervix uteri

628

1.10

0.30

1.5

1.4

401.48

624.03

pmol/l

0.68

562

Multiple myeloma and malignant plasma cell neoplasms

203

1.18

0.30

1.4

1.3

322.62

298.13

pmol/l

0.13

168

Exclusion endpoint for clefts

1.31

0.29

1.3

1.4

257.36

482.32

pmol/l

1.01

Persistent delusional disorders

377

0.87

0.29

1.4

294.15

336.72

pmol/l

0.38

322

Alzheimer’s disease (Late onset), excluding more controls

457

0.91

0.29

1.0

1.4

230.78

263.41

pmol/l

0.67

388

Erectile dysfunction

355

0.87

0.28

1.7

1.3

248.22

269.29

pmol/l

0.24

289

Shoulder region

1.29

0.28

1.0

1.4

198.88

363.46

pmol/l

—

Malignant neoplasm of rectum

527

1.10

0.27

1.3

333.30

293.43

pmol/l

0.24

445

Motorcycle rider injured in noncollision transport accidents

140

1.22

0.27

1.1

1.5

168.88

377.11

pmol/l

4.84

121

Malignant neoplasm of bladder

261

1.15

0.27

1.1

1.3

252.30

282.07

pmol/l

0.22

211

Other diseases caused by chlamydiae, including avohilmo

1.30

0.26

2.0

1.4

358.50

409.32

pmol/l

—

Other superficial mycoses, including avohilmo

587

1.09

0.26

1.3

1.4

315.19

346.99

pmol/l

0.31

509

Malignant neoplasm of breast, HER-negative

134

1215

1.06

0.25

1.2

1.3

468.43

307.47

pmol/l

0.38

116

1056

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

549

1.09

0.25

1.3

310.91

292.71

pmol/l

0.10

461

Maternal care for known or suspected fetal abnormality and damage

756

0.93

0.25

1.6

1.5

465.97

436.85

pmol/l

0.16

681

Atrial septal defect, secundum type

126

0.79

0.25

2.2

1.4

372.10

449.39

pmol/l

—

109

Contact with machinery

589

1.09

0.24

1.3

1.4

288.61

489.34

pmol/l

0.58

489

Failed induction of labour

284

1.13

0.23

1.2

1.5

366.00

440.60

pmol/l

0.38

255

Complications of the puerperium, not elsewhere classified

199

1.16

0.23

1.5

1.4

345.48

402.25

pmol/l

0.38

176

Tooth eruption problems

701

1.07

0.23

1.4

1.5

414.73

548.17

pmol/l

0.41

618

Fibrosarcoma, including Hilmo

1.29

0.23

1.6

1.5

202.80

262.25

pmol/l

—

Injury of urinary and pelvic organs

1.25

0.22

1.6

1.4

238.73

351.72

pmol/l

1.08

Inguinal hernia

406

2619

1.03

0.22

1.3

1.4

527.13

309.35

pmol/l

0.42

348

2215

ILD, hospital admission 2, with pulmonary infections

477

1.09

0.22

1.2

1.3

270.20

269.55

pmol/l

0.01

399

Huntington disease

0.00

0.21

0.0

1.0

—

213.90

—

Folliculitis decalvans

0.00

0.21

0.0

1.0

—

191.30

—

Aortic arch syndrome [Takayasu]

0.00

0.21

0.0

1.1

—

289.60

—

Craniosynostosis EXCLUDE syndromes

0.00

0.21

0.0

1.6

—

232.91

—

Hypospadias with an incomplete glans penis

0.00

0.21

0.0

1.5

—

182.50

—

Other mosquito-borne viral fevers

0.00

0.21

0.0

1.0

—

182.10

—

Severe mental retardation

0.00

0.21

0.0

1.6

—

214.80

—

Unspecified multiple injuries

0.00

0.21

0.0

1.3

—

289.00

—

Female pelvic inflammatory disorders in diseases classified elsewhere

0.00

0.21

0.0

1.6

—

515.91

—

Explosion and rupture of other specified pressurized devices

0.00

0.21

0.0

1.0

—

221.83

—

Central nervous system disorder causing precocious puberty

0.00

0.21

0.0

1.6

—

288.58

—

Squamous cell neoplasms and carcinomas of the skin

449

1.09

0.21

1.2

1.3

281.73

275.14

pmol/l

0.05

367

Trisomy 21 (Down syndrome) due to meiotic nondisjunction

0.00

0.21

0.0

1.4

—

934.69

—

Vitreous prolapse

0.00

0.21

0.0

1.0

—

269.54

—

All dysplastic lesions of the cervix uteri

163

1536

1.04

0.20

1.6

1.5

635.91

466.63

pmol/l

0.42

141

1369

Postpartum care and examination

516

0.94

0.20

1.4

1.5

492.84

404.51

pmol/l

0.66

467

Crossbite

335

1.10

0.20

1.2

1.5

284.61

391.66

pmol/l

1.61

292

Primary coxarthrosis, bilateral

190

1827

1.04

0.20

1.3

300.90

363.50

pmol/l

0.49

164

1516

Venous complications and haemorrhoids in the puerperium

1.23

0.20

1.8

1.2

577.67

361.54

pmol/l

—

Multiple myeloma, including Hilmo

212

1.13

0.19

1.4

1.3

322.62

311.21

pmol/l

0.05

180

L02BB Anti-androgens

385

1.09

0.19

3.4

1.3

218.78

252.89

pmol/l

0.51

305

Diseases caused by chlamydiae

1.13

0.18

2.0

1.4

422.33

449.06

pmol/l

—

Secondary thrombocytopenia

1.13

0.18

1.2

1863.17

271.07

pmol/l

—

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

1.13

0.18

1.5

1.6

356.17

525.20

pmol/l

—

Carcinoma in situ of cervix uteri

511

1.08

0.18

1.5

1.4

736.13

571.98

pmol/l

0.17

452

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

133

1142

0.96

0.18

1.3

259.88

369.55

pmol/l

0.61

108

942

Non-small cell lung cancer, including Hilmo

765

0.94

0.17

1.3

297.80

278.84

pmol/l

0.27

630

Gastrointestinal stromal tumor and sarcoma

1.15

0.17

1.1

1.4

317.57

357.31

pmol/l

—

Other diseases caused by chlamydiae

1.15

0.17

1.9

1.4

377.71

434.13

pmol/l

—

Malignant neoplasm of breast, HER-positive

220

1692

0.97

0.17

1.3

279.96

315.96

pmol/l

0.97

194

1478

Pregnancy examination and test

582

0.95

0.17

1.4

1.5

687.05

398.34

pmol/l

0.58

527

Spirochaetal infections, other/unspecified

494

1.07

0.17

1.3

259.48

320.25

pmol/l

1.27

422

Brain glioblastoma, helper endpoint

0.76

0.17

1.6

1.3

214.20

277.17

pmol/l

—

Evidence of alcohol involvement determined by blood alcohol level

0.76

0.17

1.2

1.3

256.20

354.90

pmol/l

—

Benign neoplasm: Skin of lip

0.74

0.17

2.0

1.3

252.40

300.48

pmol/l

—

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

272

1.10

0.17

1.3

1.4

309.26

366.88

pmol/l

0.56

237

Osteonecrosis due to drugs

1.18

0.16

1.1

1.4

550.25

253.93

pmol/l

—

Malignant neoplasm of breast, ER-positive, including Hilmo

221

1695

0.97

0.16

1.3

279.48

315.95

pmol/l

0.99

195

1481

Undefined dementia

385

1.08

0.16

1.2

275.95

252.84

pmol/l

0.23

312

L02BX Other hormone antagonists and related agents

264

1.10

0.15

4.6

1.3

188.92

244.86

pmol/l

1.01

216

Accidental poisoning by and exposure to alcohol

0.75

0.15

1.5

307.83

359.63

pmol/l

—

Pyogenic granuloma

1.16

0.15

1.3

1.4

321.78

367.70

pmol/l

—

Ankylosing spondylitis, ICD10

472

0.93

0.15

1.3

1.4

208.74

320.42

pmol/l

3.54

400

Hydrocephalus

371

1.08

0.15

1.4

1.3

335.29

298.17

pmol/l

0.19

310

Chronic suppurative otitis media, including avohilmo

352

1.08

0.14

1.4

299.63

368.41

pmol/l

0.58

301

Tularaemia, including avohilmo

0.79

0.14

1.7

1.4

304.71

357.98

pmol/l

—

Other infestations, including avohilmo

0.78

0.14

1.3

302.71

345.33

pmol/l

—

Status post-ami

139

1017

1.04

0.14

1.2

1.4

250.80

271.97

pmol/l

0.46

109

845

Coxarthrosis, primary, with hip surgery

319

2896

1.02

0.13

1.2

1.3

261.65

328.36

pmol/l

1.03

279

2436

Caries of enamel

761

5040

0.99

0.12

1.4

336.27

369.59

pmol/l

0.46

670

4338

Burns and corrosions of external body surface, specified by site

600

1.05

0.12

1.3

1.4

291.85

328.16

pmol/l

0.19

509

Alcohol withdrawal state with delirium

346

1.07

0.12

1.1

1.4

292.97

304.56

pmol/l

0.08

294

DVT of lower extremities

115

1112

1.03

0.11

1.3

295.63

327.16

pmol/l

0.42

926

Schizophrenia

916

1.04

0.11

1.3

1.4

319.26

347.36

pmol/l

0.25

803

Inguinal hernia, unilateral

124

1.13

0.11

1.6

1.3

469.93

300.89

pmol/l

0.40

107

Inguinal of femoral hernia, unilateral

124

1.13

0.11

1.6

1.3

469.93

300.89

pmol/l

0.40

107

Femoral hernia, unilateral

124

1.13

0.11

1.6

1.3

469.93

300.89

pmol/l

0.40

107

Infections with a predominantly sexual mode of transmission, including avohilmo

266

2384

1.02

0.11

1.3

1.4

424.16

465.11

pmol/l

0.18

229

2090

Other/unspecified rheumatoid arthritis

661

1.04

0.11

1.2

1.3

304.61

354.18

pmol/l

0.42

556

Malignant neoplasm of cervix uteri

1.17

0.11

1.3

778.30

396.63

pmol/l

—

Hepatocellular carcinoma

1.16

0.11

1.0

1.3

512.70

269.60

pmol/l

—

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

115

0.87

0.10

1.0

1.4

308.20

358.26

pmol/l

—

102

Small cell lung cancer, helper endpoint

1.15

0.10

1.0

1.3

102.80

260.13

pmol/l

—

Malignant neoplasm of breast

293

1923

0.98

0.10

1.3

370.43

331.97

pmol/l

0.17

255

1684

Unspecified dementia

383

1.05

0.10

1.2

275.95

249.37

pmol/l

0.27

314

Pregnancy, childbirth and the puerperium

181

967

0.98

0.10

1.4

354.25

353.37

pmol/l

0.01

162

839

Sequelae of other and unspecified infectious and parasitic diseases

271

1.07

0.09

1.3

1.4

309.68

366.84

pmol/l

0.53

236

Ductal carcinoma of pancreas

1.09

0.09

1.4

217.80

290.58

pmol/l

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

418

1.05

0.09

1.1

1.4

255.87

334.48

pmol/l

1.76

360

Other mycoses, not elsewhere classified/unspecified, including avohilmo

1.15

0.09

1.2

1.4

378.60

375.18

pmol/l

—

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

122

1187

1.03

0.09

1.4

1.5

482.41

494.23

pmol/l

0.02

105

1044

Foreign body on external eye

852

1.03

0.09

1.5

1.4

221.95

435.06

pmol/l

1.10

724

Aphakia

1.05

0.08

2.5

1.2

224.00

257.80

pmol/l

—

Transitory endocrine and metabolic disorders specific to fetus and newborn

1.05

0.08

1.5

1.6

356.17

514.58

pmol/l

—

Brain glioblastoma

0.77

0.08

1.6

1.4

214.20

295.20

pmol/l

—

Family history of other conditions

0.77

0.08

1.4

604.40

382.14

pmol/l

—

Hypersensitivity pneumonitis due to organic dust

1.09

0.08

1.0

1.2

344.86

338.67

pmol/l

—

Venous complications and haemorrhoids in pregnancy

0.82

0.07

1.2

1.5

552.00

438.55

pmol/l

—

Impacted teeth

105

924

0.97

0.07

1.3

1.5

378.19

510.69

pmol/l

0.58

813

Ankylosing spondylitis

431

1.04

0.07

1.3

1.4

205.51

339.73

pmol/l

4.21

371

Other assisted single delivery

1.07

0.07

1.6

1.5

2293.38

357.45

pmol/l

—

Torsion of testis

1.05

0.07

1.6

1.5

431.11

329.57

pmol/l

—

Malignant neoplasm of breast, HER2-negative

294

1920

0.99

0.06

1.3

369.31

331.92

pmol/l

0.17

256

1681

Use of selegiline

183

0.93

0.06

1.2

1.3

199.09

266.43

pmol/l

0.53

156

Coronary artery bypass grafting

132

959

1.02

0.06

1.2

1.4

253.33

264.89

pmol/l

0.18

110

792

Small cell lung cancer, including Hilmo

1.11

0.06

1.0

1.4

102.80

259.80

pmol/l

—

Small cell lung cancer

1.11

0.06

1.0

1.4

102.80

259.80

pmol/l

—

Aggressive periodontitis

100

0.90

0.06

1.1

1.4

133.56

292.42

pmol/l

—

Impacted cerumen

619

0.97

0.06

1.4

1.3

217.77

299.41

pmol/l

2.52

521

Injury of muscle and tendon at wrist and hand level

810

1.03

0.06

1.4

603.61

441.38

pmol/l

0.20

690

Malignant neoplasm of breast, HER2-negative, including Hilmo

301

1949

0.99

0.05

1.4

1.3

363.92

331.72

pmol/l

0.14

261

1706

Retinal breaks without detachment

100

1021

0.98

0.05

1.5

1.3

273.42

341.63

pmol/l

1.25

867

Other ill-defined and unspecified causes of mortality

405

1.04

0.05

1.2

1.3

231.36

288.58

pmol/l

0.87

338

Malignant neoplasm of breast, including Hilmo

301

1948

0.99

0.05

1.4

1.3

363.92

331.89

pmol/l

0.14

261

1705

Non-follicular lymphoma

485

0.97

0.05

1.2

1.3

280.84

291.63

pmol/l

0.10

410

Non-Hodgkin lymphoma, all, including Hilmo

727

0.98

0.05

1.2

1.3

307.88

291.69

pmol/l

0.19

602

L01XE Protein kinase inhibitors

248

1.05

0.05

1.3

289.05

305.07

pmol/l

0.09

214

Injury of muscle and tendon at ankle and foot level

130

0.92

0.04

1.1

1.4

450.17

387.46

pmol/l

0.26

111

Follow-up care involving plastic surgery

211

0.95

0.04

1.2

1.3

379.86

350.21

pmol/l

0.07

180

Chronic suppurative otitis media

298

1.04

0.04

1.4

288.49

352.22

pmol/l

0.44

253

Mental and behavioural disorders due to use of other stimulants, including caffeine

119

0.92

0.04

1.5

1.6

254.00

404.95

pmol/l

—

104

Retained placenta and membranes, without haemorrhage

724

0.98

0.03

1.4

1768.38

414.91

pmol/l

0.45

646

Alzheimer disease, excluding more controls

560

1.02

0.03

1.1

1.4

258.25

283.25

pmol/l

0.42

477

Dilated cardiomyopathy

612

0.98

0.03

1.1

1.4

323.00

291.54

pmol/l

0.27

508

Normal-pressure hydrocephalus

201

1.05

0.03

1.1

1.3

279.67

267.05

pmol/l

0.09

166

Tuberculosis

239

0.96

0.02

1.4

1.3

184.06

303.91

pmol/l

3.80

204

Persons encountering health services in circumstances related to reproduction

432

2906

1.00

0.02

1.3

1.4

328.99

370.72

pmol/l

0.53

366

2541

Benign neoplasm of breast

710

0.99

0.02

1.2

1.3

304.55

362.33

pmol/l

0.58

611

Use of biperiden

258

0.97

0.02

1.2

1.4

320.67

333.14

pmol/l

0.05

220

Other and unspecified epidermal thickening

127

0.94

0.01

1.1

1.3

301.33

350.54

pmol/l

—

113

Obstructed labour due to maternal pelvic abnormality

949

0.99

0.01

1.2

1.3

303.96

370.93

pmol/l

0.83

840

Other predominantly sexually transmitted diseases, not elsewhere classified

989

0.99

0.01

1.4

1.5

523.05

506.72

pmol/l

0.03

873

Burn and corrosion of hip and lower limb, except ankle and foot

104

1.06

0.01

1.2

1.4

167.06

416.24

pmol/l

3.40

Injury of muscle and tendon at lower leg level

877

1.00

0.00

1.5

1.3

305.65

429.27

pmol/l

0.51

736

Vascular dementia

356

1.00

0.00

1.1

1.3

281.06

238.56

pmol/l

0.50

285

Ill-defined and unknown causes of mortality

452

1.00

0.00

1.2

1.3

219.80

284.44

pmol/l

1.15

379

Contact with other sharp object(s)

345

1.01

0.00

1.2

1.4

347.07

343.76

pmol/l

0.02

293

Chronic viral hepatitis

251

1.00

0.00

1.4

1.5

256.80

379.19

pmol/l

1.71

216

Divergent concomitant strabismus

371

1.00

0.00

1.2

1.4

606.10

362.11

pmol/l

0.61

320

Single delivery by caesarean section

118

670

1.00

0.00

1.5

1281.31

440.02

pmol/l

0.50

106

598

Chromosomal abnormalities, not elsewhere classified

1.02

0.00

1.0

1.3

325.80

483.70

pmol/l

—

Crushed, pushed or stepped on by crowd or human stampede

371

1.00

0.00

1.5

1.4

335.48

388.63

pmol/l

0.38

324

Idiopathic pulmonary fibrosis

347

1.01

0.00

1.2

1.3

284.59

285.58

pmol/l

0.01

288

Thyrotoxicosis from ectopic thyroid tissue

0.00

0.0

1.1

—

192.14

—

Traumatic amputation of part of head

0.00

0.0

1.0

—

244.33

—

Dislocations, sprains and strains involving multiple body regions

0.00

0.0

1.0

—

204.75

—

Pityriasis lichenoides et varioliformis acuta

0.00

0.0

1.0

—

176.17

—

Other congenital malformations of posterior segment of eye (coloboma)

0.00

0.0

1.1

—

1552.71

—

Carcinoma in situ of liver, gallbladder and bile ducts

0.00

0.0

1.0

—

256.00

—

Disorders of multiple cranial nerves

0.00

0.0

1.0

—

162.80

—

Other and unspecified disorders of skin and subcutaneous tissue related to radiation

0.00

0.0

1.0

—

193.20

—

Cutaneous autosensitization

0.00

0.0

1.0

—

237.88

—

Explicit viral Sepsis, including avohilmo

0.00

0.0

1.2

—

245.60

—

Defect, injury or illness of skull

0.00

0.0

1.0

—

193.29

—

Mucinosis of skin

0.00

0.0

1.0

—

229.60

—

Brain mixed glioma, helper endpoint

0.00

0.0

1.1

—

245.43

—

Intentional self-harm by jumping or lying before moving object

0.00

0.0

1.3

—

254.12

—

Ebstein's anomaly

0.00

0.0

1.0

—

208.17

—

Chondrolysis

0.00

-0.00

0.0

1.2

—

230.60

—

Disorders of conjunctiva in diseases classified elsewhere

0.00

-0.00

0.0

1.0

—

227.17

—

Other respiratory conditions originating in the perinatal period

0.00

-0.00

0.0

1.2

—

2043.00

—

Palsy of conjugate gaze

0.00

-0.00

0.0

1.0

—

198.17

—

Alpha thalassaemia

0.00

-0.00

0.0

1.2

—

390.00

—

Convulsions of newborn

0.00

-0.00

0.0

2.2

—

139.20

—

Common variable immunodeficiency with predominant abnormalities of T-cell numbers and function

0.00

-0.00

0.0

1.0

—

215.20

—

Ovarian dysfunction: estrogen excess

0.00

-0.00

0.0

1.2

—

334.67

—

Disorders of olfactory nerve

0.00

-0.00

0.0

1.0

—

191.86

—

Malignant neoplasm of peripheral nerves and autonomic nervous system

0.00

-0.00

0.0

1.0

—

213.13

—

Other abnormal auditory perceptions

0.89

-0.00

1.2

1.4

284.40

410.90

pmol/l

—

Café au lait spots

0.00

-0.00

0.0

1.1

—

212.87

—

Congenital malformation of optic disc

0.00

-0.00

0.0

1.1

—

188.88

—

Induced delusional disorder

0.00

-0.00

0.0

1.0

—

210.40

—

Choroidal detachment

0.00

-0.00

0.0

1.0

—

203.33

—

Unspecified pneumoconiosis

0.00

-0.00

0.0

1.0

—

231.20

—

Crohn's disease (strict) with PSC

0.00

-0.00

0.0

1.0

—

329.22

—

Myxoedema coma

0.00

-0.00

0.0

1.0

—

220.67

—

Pupillary membranes and other adhesions and disruptions of iris and ciliary body

0.00

-0.00

0.0

1.0

—

253.29

—

Sequelae of hyperalimentation

0.00

-0.00

0.0

1.1

—

150.75

—

Drug-induced tics and other tics of organic origin

0.00

-0.00

0.0

1.0

—

131.40

—

Hereditary factor XI deficiency

0.00

-0.00

0.0

1.0

—

277.80

—

Chronic drug-induced interstitial lung disorders

0.00

-0.00

0.0

1.0

—

204.67

—

Methaemoglobinaemia

0.00

-0.00

0.0

1.0

—

266.67

—

Febrile neutrophilic dermatosis [Sweet]

0.00

-0.00

0.0

1.0

—

257.86

—

Other eccrine sweat disorders

0.00

-0.00

0.0

1.2

—

298.60

—

Diaper [napkin] dermatitis

0.00

-0.00

0.0

1.0

—

213.40

—

Pedestrian injured in collision with other nonmotor vehicle

0.00

-0.00

0.0

1.0

—

245.89

—

Macular pucker, drug-induced

0.00

-0.00

0.0

1.0

—

224.40

—

Victim of lightning

0.00

-0.00

0.0

1.2

—

204.50

—

Occupant of railway train or railway vehicle injured in transport accident

0.00

-0.00

0.0

1.0

—

318.14

—

Digeorge syndrome

0.00

-0.00

0.0

1.2

—

1745.17

—

Profound mental retardation

0.00

-0.00

0.0

1.4

—

282.56

—

Anhidrosis

0.00

-0.00

0.0

1.0

—

288.20

—

Haemophagocytic lymphohistiocytosis

0.00

-0.00

0.0

1.1

—

197.00

—

Combined immunodeficiency, unspecified

0.00

-0.00

0.0

1.2

—

239.80

—

Sweet's syndrome

0.00

-0.00

0.0

1.0

—

257.86

—

Beta thalassaemia

0.00

-0.00

0.0

1.0

—

209.83

—

Cicatricial pemphigoid

0.00

-0.00

0.0

1.1

—

221.75

—

Exposure to high-pressure jet

0.00

-0.00

0.0

1.2

—

226.40

—

Other retinal disorders in diseases classified elsewhere

0.00

-0.00

0.0

1.0

—

193.50

—

Flexion deformity

0.00

-0.00

0.0

1.1

—

299.43

—

Chronic postrheumatic arthropathy [Jaccoud]

0.00

-0.00

0.0

1.0

—

328.20

—

Exposure to electric transmission lines

0.00

-0.00

0.0

1.2

—

241.89

—

Traumatic spondylopathy

0.00

-0.00

0.0

1.0

—

257.43

—

Squamous cell neoplasms and carcinoma of rectum

0.00

-0.00

0.0

1.0

—

448.14

—

Kaposi sarcoma, including Hilmo

0.00

-0.00

0.0

1.4

—

261.00

—

Alport

0.00

-0.00

0.0

1.3

—

205.87

—

Dysplastic lesion of the vagina of unknown severity

0.00

-0.00

0.0

1.0

—

282.38

—

Malignant neoplasm of other and unspecified male genital organs

0.00

-0.00

0.0

1.0

—

138.20

—

Other injuries involving multiple body regions, not elsewhere classified

0.00

-0.00

0.0

1.0

—

280.67

—

Brain mixed glioma

0.00

-0.00

0.0

1.2

—

241.67

—

Injury of blood vessels at ankle and foot level

0.00

-0.00

0.0

1.2

—

276.67

—

Colorectal squamous cell carcinoma

0.00

-0.00

0.0

1.0

—

448.14

—

Burn and corrosion of respiratory tract

0.00

-0.00

0.0

1.0

—

235.00

—

Pulmonary artery stenosis

0.00

-0.00

0.0

1.6

—

148.20

—

Tuberculosis of nervous system, including avohilmo

0.00

-0.00

0.0

1.0

—

234.83

—

Explicit viral Sepsis

0.00

-0.00

0.0

1.2

—

245.60

—

Tuberculosis of nervous system

0.00

-0.00

0.0

1.0

—

234.83

—

Pneumoconiosis due to other inorganic dusts

0.00

-0.00

0.0

1.0

—

174.00

—

Pneumoconiosis due to dust containing silica

0.00

-0.00

0.0

1.2

—

164.89

—

Other disturbances of cerebral status of newborn

0.00

-0.00

0.0

1.8

—

150.00

—

Other conditions originating in the perinatal period

0.00

-0.00

0.0

1.5

—

188.13

—

Single ventricle heart

0.00

-0.00

0.0

1.4

—

232.00

—

!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced

0.00

-0.00

0.0

1.0

—

144.40

—

Polydactyly

0.00

-0.00

0.0

1.0

—

175.14

—

Other zoonotic bacterial diseases, not elsewhere classified

0.00

-0.00

0.0

1.0

—

155.71

—

Congenital absence of the uterus

0.00

-0.00

0.0

1.3

—

235.33

—

Other congenital malformations of eye

0.00

-0.00

0.0

1.7

—

1544.00

—

Phlebitis and thrombophlebitis of unspecified site, drug-induced

0.00

-0.00

0.0

1.2

—

145.40

—

Pectus carinatum

0.00

-0.00

0.0

1.0

—

194.20

—

Turner's syndrome

0.00

-0.00

0.0

1.4

—

218.13

—

Congenital absence of the vagina

0.00

-0.00

0.0

1.3

—

213.00

—

Congenital glaucoma

0.00

-0.00

0.0

1.8

—

208.00

—

Ascariasis

0.00

-0.00

0.0

1.3

—

185.50

—

Macrocephaly

0.00

-0.00

0.0

2.0

—

1755.00

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Aldosterone [Moles/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS